Document:

<PAGE>
                                                                     EXHIBIT 4.3

--------------------------------------------------------------------------------

                           KING PHARMACEUTICALS, INC.,

                              SUBSIDIARY GUARANTORS

                                       and

                              THE BANK OF NEW YORK,

                                   as Trustee

                             ----------------------

                                    INDENTURE

                          Dated as of November 1, 2001

                             ----------------------

               2 3/4% Convertible Debentures due November 15, 2021

--------------------------------------------------------------------------------

<PAGE>
                                TABLE OF CONTENTS

<TABLE>
<S>                                                                                 <C>
ARTICLE 1  DEFINITIONS AND INCORPORATION BY REFERENCE

             1.01.   Definitions .................................................   1
             1.02.   Incorporation by Reference of Trust Indenture Act ...........   8
             1.03.   Rules of Construction .......................................   8

ARTICLE 2  THE SECURITIES

             2.01.   Form and Dating .............................................   9
             2.02.   Execution and Authentication ................................   9
             2.03.   Registrar, Paying Agent and Conversion Agent and New York
                     Presenting Agent ............................................  10
             2.04.   Payment on Securities; Paying Agent to Hold Money in Trust ..  10
             2.05.   Securityholder Lists ........................................  11
             2.06.   Transfer and Exchange .......................................  11
             2.07.   Replacement Securities ......................................  12
             2.08.   Outstanding Securities ......................................  12
             2.09.   Treasury Securities .........................................  13
             2.10.   Temporary Securities ........................................  13
             2.11.   Cancellation ................................................  13
             2.12.   Defaulted Interest ..........................................  13
             2.13.   CUSIP Numbers ...............................................  13
             2.14.   Additional Transfer and Exchange Requirements ...............  13

ARTICLE 3  REDEMPTION

             3.01.   Notices to Trustee ..........................................  18
             3.02.   Selection of Securities to Be Redeemed ......................  18
             3.03.   Notice of Redemption ........................................  18
             3.04.   Effect of Notice of Redemption ..............................  19
             3.05.   Deposit of Redemption Price .................................  19
             3.06.   Securities Redeemed in Part .................................  20

ARTICLE 4  REPURCHASES

             4.01.   Purchase of Securities at Option of the Holder ..............  20
             4.02.   Repurchase upon Change of Control ...........................  23

ARTICLE 5  COVENANTS

             5.01.   Payment of Securities .......................................  24
             5.02.   SEC Reports .................................................  24
             5.03.   Compliance Certificate ......................................  25
             5.04.   Corporate Existence .........................................  25
             5.05.   Notice of Defaults ..........................................  25
             5.06.   Further Instruments and Acts ................................  25
             5.07.   Resale of Certain Securities ................................  25
             5.08.   Restriction on Secured Debt .................................  25
</TABLE>

                                      -i-
<PAGE>
<TABLE>
<S>                                                                                 <C>
             5.09.   Restriction on Sale and Leaseback Transactions ..............  27
             5.10.   Restriction on Transfer of Principal Facility to Unrestricted
                     Subsidiaries ................................................  28
             5.11.   Future Guarantors ...........................................  28

ARTICLE 6  SUCCESSORS

             6.01.   When Company May Merge, Etc .................................  28

ARTICLE 7  DEFAULTS AND REMEDIES

             7.01.   Events of Default ...........................................  30
             7.02.   Acceleration ................................................  31
             7.03.   Other Remedies ..............................................  31
             7.04.   Waiver of Past Defaults .....................................  31
             7.05.   Control by Majority .........................................  31
             7.06.   Limitation on Suits .........................................  32
             7.07.   Rights of Holders to Receive Payment ........................  32
             7.08.   Collection Suit by Trustee ..................................  32
             7.09.   Trustee May File Proofs of Claim ............................  32
             7.10.   Priorities ..................................................  32
             7.11.   Undertaking for Costs .......................................  33

ARTICLE 8  TRUSTEE

             8.01.   Duties of Trustee ...........................................  33
             8.02.   Rights of Trustee ...........................................  34
             8.03.   Individual Rights of Trustee ................................  35
             8.04.   Trustee's Disclaimer ........................................  35
             8.05.   Notice of Defaults ..........................................  35
             8.06.   Reports by Trustee to Holders ...............................  35
             8.07.   Compensation and Indemnity ..................................  36
             8.08.   Replacement of Trustee ......................................  36
             8.09.   Successor Trustee, Agents by Merger, Etc ....................  37
             8.10.   Eligibility; Disqualification ...............................  37
             8.11.   Preferential Collection of Claims Against Company ...........  37

ARTICLE 9  DISCHARGE OF INDENTURE

             9.01.   Termination of Company's Obligations ........................  38

ARTICLE 10 AMENDMENTS, SUPPLEMENTS AND WAIVERS

             10.01.  Without Consent of Holders ..................................  38
             10.02.  With Consent of Holders .....................................  38
             10.03.  Compliance with Trust Indenture Act .........................  39
             10.04.  Revocation and Effect of Consents ...........................  39
             10.05.  Notation on or Exchange of Securities .......................  39
             10.06.  Trustee to Sign Amendments, Etc .............................  39
</TABLE>

                                      -ii-
<PAGE>
<TABLE>
<S>                                                                                 <C>
ARTICLE 11  CONVERSION

             11.01.  Conversion Privilege ........................................  40
             11.02.  Conversion Procedure ........................................  40
             11.03.  Fractional Shares ...........................................  41
             11.04.  Taxes on Conversion .........................................  41
             11.05.  Company to Provide Stock ....................................  41
             11.06.  Adjustment for Change in Capital Stock ......................  41
             11.07.  Adjustment for Rights Issue .................................  42
             11.08.  Adjustment for Certain Distributions ........................  43
             11.09.  Adjustment for All Cash Distribution ........................  44
             11.10.  Adjustment for Tender or Exchange Offer .....................  44
             11.11.  Current Market Price ........................................  45
             11.12.  When Adjustment May Be Deferred .............................  45
             11.13.  When No Adjustment Required .................................  46
             11.14.  Notice of Adjustment ........................................  46
             11.15.  Voluntary Reduction .........................................  46
             11.16.  Notice of Certain Transactions ..............................  46
             11.17.  Provisions in Case of Consolidation, Merger of the Company
                     or Transfer or Lease ........................................  46
             11.18.  Company Determination Final .................................  47
             11.19.  Trustee's Disclaimer ........................................  47

ARTICLE 12  SUBSIDIARY GUARANTIES

             12.01.  Guaranties ..................................................  47
             12.02.  Limitation on Liability .....................................  49
             12.03.  Successors and Assigns ......................................  49
             12.04.  No Waiver  ..................................................  49
             12.05.  Modification ................................................  49
             12.06.  Release of Subsidiary Guarantor .............................  49

ARTICLE 13  MISCELLANEOUS

             13.01.  Trust Indenture Act Controls ................................  50
             13.02.  Notices .....................................................  50
             13.03.  Communications by Holders with Other Holders ................  50
             13.04.  Certificate and Opinion as to Conditions Precedent ..........  50
             13.05.  Statements Required in Certificate or Opinion ...............  51
             13.06.  Rules by Trustee and Agents .................................  51
             13.07.  Legal Holidays ..............................................  51
             13.08.  Governing Law ...............................................  51
             13.09.  No Recourse Against Others ..................................  51
             13.10.  Successors ..................................................  51
             13.11.  Counterpart Originals .......................................  51
             13.12.  Severability ................................................  52

SIGNATURES

EXHIBIT A           -    FORM OF SECURITY
</TABLE>

----------------

Note: This Table of Contents shall not, for any purpose, be deemed to be a part
      of the Indenture.

                                      -iii-
<PAGE>

                  INDENTURE dated as of November 1, 2001, among KING
PHARMACEUTICALS, INC., a Tennessee corporation (the "Company"), the SUBSIDIARY
GUARANTORS listed on Schedule A hereto and THE BANK OF NEW YORK, a New York
banking corporation, as trustee (the "Trustee").

                  Each party agrees as follows for the benefit of the other
party and for the equal and ratable benefit of the Holders of the Company's 2
3/4% Convertible Debentures due November 15, 2021 (the "Securities"):

                                    ARTICLE 1

                   DEFINITIONS AND INCORPORATION BY REFERENCE

                  SECTION 1.01. Definitions.

                  "Affiliate" means any person, directly or indirectly,
controlling or controlled by or under direct or indirect common control with the
Company. For the purposes of this definition, "control" when used with respect
to any specified Person means the power to direct the management and policies of
such Person, directly or indirectly, whether through the ownership of voting
securities, by contract or otherwise, and the terms "controlling" and
"controlled" have meanings correlative to the foregoing.

                  "Agent" means any Registrar, Paying Agent, Conversion Agent,
New York Presenting Agent or Co-Registrar.

                  "Agent Members" has the meaning specified in Section 2.01.

                  "Applicable Procedures" means, with respect to any transfer or
exchange of beneficial ownership interests in a Global Security, the rules and
procedures of the Depositary that are applicable to such transfer or exchange.

                  "Associate" has the meaning ascribed to such term in Rule
12b-2 of the General Rules and Regulations under the Exchange Act, as in effect
on the date hereof.

                  "Bankruptcy Law" has the meaning specified in Section 7.01.

                  "Beneficial Holder" means each participant in the Depositary
who holds an interest in a Security as indicated in the Participants List
(provided that the Trustee shall be under no duty to make any inquiry regarding
the accuracy of the Participants List).

                  "Board of Directors" or "Board" means the Board of Directors
of the Company or any duly authorized committee of the Board.

                  "Business Day" means any day that is not a Legal Holiday.

                  "Capital Stock" shall mean capital stock of the Company that
does not rank prior, as to the payment of dividends or as to the distribution of
assets upon any voluntary or involuntary liquidation, dissolution or winding up
of the Company, to shares of capital stock of any other class of the Company.

                  "Certificated Security" means a Security that is in
substantially the form attached hereto as Exhibit A and that does not include
the information or the schedule called for by the footnotes thereof to be
included in a Global Security.

<PAGE>

                  "Change of Control" has the meaning specified in paragraph 6
of the Securities.

                  "Change of Control Company Notice" has the meaning specified
in paragraph 6 of the Securities.

                  "Change of Control Purchase Date" has the meaning specified in
paragraph 6 of the Securities.

                  "Change of Control Purchase Price" has the meaning specified
in paragraph 6 of the Securities.

                  "Common Stock" means the common stock, no par value, of the
Company as existing on the date of this Indenture or any other shares of Capital
Stock of the Company into which the Common Stock shall be reclassified or
changed.

                  "Company" means the party named as such above, until a
successor replaces it pursuant to the applicable provisions hereof and
thereafter means the successor.

                  "Company Order" means a written request or order signed in the
name of the Company by any two Officers.

                  "Company Notice" has the meaning specified in Section 4.01(c).

                  "Consolidated Net Tangible Assets" means the total amount of
assets which would be included on a consolidated balance sheet of the Company
and its Subsidiaries under generally accepted accounting principles (less
applicable reserves and other properly deductible items) after deducting
therefrom: (a) all short-term liabilities and liability items, except for
indebtedness payable by its terms more than one year from the date of incurrence
thereof (or renewable or extendible at the option of the obligor for a period
ending more than one year after such date of incurrence); and (b) all goodwill,
trade names, trademarks, patents, unamortized debt discount, unamortized expense
incurred in the issuance of debt, and other like intangibles (except prepaid
royalties).

                  "Conversion Agent" has the meaning specified in Section 2.03.

                  "Conversion Price" is the conversion price from time to time
as provided for in Article 11 and the Securities.

                  "Corporate Trust Office" means the principal office of the
Trustee at 101 Barclay Street, Floor 21 W, New York, New York 10286, Attention:
Corporate Trust Department, or such other office, designated by the Trustee by
written notice to the Company and approved by the Company, at which at any
particular time its corporate trust business shall be administered.

                  "Current Market Price" has the meaning specified in Section
11.11.

                  "Custodian" has the meaning specified in Section 7.01.

                  "Default" means any event which is, or after notice or passage
of time would be, an Event of Default.

                  "Depositary" has the meaning specified in Section 2.01(a).

                  "DTC" has the meaning specified in Section 2.01(a).

                                      -2-
<PAGE>

                  "Event of Default" has the meaning specified in Section 7.01.

                  "Exchange Act" means the Securities Exchange Act of 1934, as
amended.

                  "Expiration Time" has the meaning specified in Section 11.10.

                  "Final Surrender Date" has the meaning specified in paragraph
6 of the Securities.

                  "Global Security" means a permanent Global Security that is in
substantially the form attached hereto as Exhibit A and that includes the
information and schedule called for by the footnote thereof and which is
deposited with the Depositary or its custodian and registered in the name of the
Depositary or its nominee.

                  "Guaranty Agreement" means a supplemental indenture, in a form
satisfactory to the Trustee, pursuant to which a Subsidiary Guarantor guarantees
the Company's obligations with respect to the Securities on the terms provided
for in Article 12.

                  "Holder" or "Securityholder" means the person in whose name a
Security is registered on the Registrar's books.

                  "Indenture" means this Indenture, as amended or supplemented
from time to time.

                  "Initial Purchaser Option" means the option granted by the
Company to the initial purchasers party to the Purchase Agreement to purchase up
to $45,000,000 aggregate principal amount of additional Securities pursuant to
the Purchase Agreement.

                  "Legal Holiday" has the meaning specified in Section 13.07.

                  "New York Presenting Agent" has the meaning specified in
Section 2.03.

                  "Officer" means the Chairman, the President, any Executive or
Senior Vice President, the Treasurer or the Clerk of the Company.

                  "Officers' Certificate" means a certificate signed by two
Officers. See Sections 13.04 and 13.05.

                  "Opinion of Counsel" means a written opinion from legal
counsel who is acceptable to the Trustee. The counsel may be an employee of or
counsel to the Company.

                  "Participants List" means the position listings showing
persons that have a beneficial interest in the Securities evidenced by the
Security in global form held by the Depositary and the amount of such interest,
but only to the extent that a copy thereof is furnished by the Depositary to the
Trustee.

                  "Paying Agent" has the meaning specified in Section 2.03.

                  "Permitted Holders" means, collectively, John M. Gregory, Joan
P. Gregory, Jefferson J. Gregory, Terri D. White-Gregory, Joseph R. Gregory,
Hershel P. Blessing, Mary Ann Blessing, James E. Gregory, Dr. R. Henry Richards,
Jeanie Richards, Fred Jarvis and Mary Gregory-Jarvis, their respective estates,
spouses, ancestors and lineal descendants, the legal representatives of any of
the foregoing and the trustees of any bona fide trusts of which the foregoing
are the sole beneficiaries or the grantors, or any Person of which the foregoing
"beneficially owns" (as defined in Rules 13d-3 and 13d-5 under the Exchange Act)
voting securities representing at least 66 2/3% of the total voting power of all
classes of

                                      -3-
<PAGE>

ordinary voting stock or other similar interests of such Person (exclusive of
any matters as to which class voting rights exist), including S.J., L.L.C. and
Kingsway L.L.C. to the extent such entities adhere to the aforementioned minimum
beneficial ownership requirements.

                  "Person" means any individual, corporation, limited liability
company, partnership, joint venture, association, joint-stock company, trust,
unincorporated organization or government or any agency or political subdivision
thereof.

                  "Principal Facility" means any manufacturing plant, warehouse,
office building or parcel of real property (including fixtures but excluding
leases and other contract rights which might otherwise be deemed real property)
owned by the Company or any Restricted Subsidiary, whether owned on the date
hereof or thereafter acquired, provided each such plant, warehouse, office
building or parcel of real property has a gross book value (without deduction
for any depreciation reserves) in excess of 2% of Consolidated Net Tangible
Assets other than any such plant, warehouse, office building or parcel of real
property or portion thereof which, in the opinion of the Board of Directors
(evidenced by a Board Resolution) is not of material importance to the business
conducted by the Company and its Subsidiaries taken as a whole.

                  "Purchase Agreement" means the Purchase Agreement, dated
November 1, 2001, among the Company and Credit Suisse First Boston Corporation,
Banc of America Securities LLC, J.P. Morgan Securities Inc., UBS Warburg LLC, as
representatives of the initial purchasers.

                  "Purchase Notice" has the meaning specified in Section 4.01.

                  "Purchase Price" has the meaning specified in paragraph 6 of
the Securities.

                  "Purchased Shares" has the meaning specified in Section 11.10.

                  "QIB" has the meaning specified in Section 2.01(a).

                  "Quoted Prices" of the Common Stock means the last sale price
regular way or, in case no such sale takes place on such day, the average of the
closing bid and asked prices regular way, in either case, at 4:00 p.m. (or such
earlier time as the last sale prior to 4:00 p.m.), New York City time, on the
New York Stock Exchange Composite Tape, or, if the Common Stock is not listed or
admitted to trading on such Exchange, on the national securities exchange in or
nearest the City of New York on which the Common Stock is listed or admitted to
trading, or if the Common Stock is not listed or admitted to trading on any
national securities exchange, the last sale price regular way or, in case no
such sale takes place on such day, the average of the highest reported bid and
lowest reported asked prices as furnished by the National Association of
Securities Dealers, Inc. through Nasdaq or a similar organization if Nasdaq is
no longer reporting such information, or if on any such Trading Day the Common
Stock is not quoted by any such organization, the average of the highest
reported bid and lowest reported asked prices as available in any other
over-the-counter market, or if on such Trading Day the Common Stock is not
reported in any such market, the fair value of a share of Common Stock on such
day, as determined in good faith by, and evidenced by a resolution of, the Board
of Directors.

                  "Record Date," for purposes of Section 11.07, has the meaning
set forth in such Section and, for purposes of Section 11.08, has the meaning
set forth in such Section.

                  "Redemption Date" or "redemption date" shall mean the date
specified for redemption of the Securities in accordance with the terms of the
Securities and this Indenture.

                                      -4-
<PAGE>

                  "Redemption Price" or "redemption price" shall have the
meaning set forth in paragraph 5 of the Securities.

                  "Registrar" has the meaning specified in Section 2.03.

                  "Registration Default" has the meaning specified in Section
5.09.

                  "Responsible Officer" shall mean, when used with respect to
the Trustee, any officer within the corporate trust department of the Trustee,
including any vice president, assistant vice president, assistant secretary,
assistant treasurer, trust officer or any other officer of the Trustee who
customarily performs functions similar to those performed by the Persons who at
the time shall be such officers, respectively, or to whom any corporate trust
matter is referred because of such person's knowledge of and familiarity with
the particular subject and who shall have direct responsibility for the
administration of this Indenture.

                  "Restricted Certificated Security" means a Certificated
Security which is a Transfer Restricted Security.

                  "Restricted Global Security" means a Global Security that is a
Transfer Restricted Security.

                  "Restricted Subsidiary" means any Subsidiary that (1) is
designated a Restricted Subsidiary under with this Indenture by notice from the
Company to the Trustee or (2) (i) was a Subsidiary on the date of this Indenture
or is the successor to, or owns, any equity interest in, a corporation that was
a Subsidiary on the date of this Indenture, (ii) has its principal business and
assets in the United States (including Puerto Rico and other territories and
possessions), (iii) such business is other than the obtaining of financing in
capital markets outside the United States or the financing of the acquisition or
disposition of real or personal property or dealing in real property for
residential or office building purposes, and (iv) does not have assets
substantially all of which consist of the securities of one or more corporations
which are not Restricted Subsidiaries.

                  "Rule 144" means Rule 144 under the Securities Act or any
successor to such Rule.

                  "Sale and Leaseback Transaction" means any sale or transfer
made by the Company or one or more Restricted Subsidiaries (except a sale or
transfer made to the Company or one or more Restricted Subsidiaries) of any
Principal Facility which (in the case of a Principal Facility which is a
manufacturing plant, warehouse or office building) has been in operation, use,
or commercial production (exclusive of test and start-up periods) by the Company
or any Restricted Subsidiary for more than 120 days prior to such sale or
transfer or which (in the case of a Principal Facility which is a part of real
property other than a manufacturing plant, warehouse or office building) has
been owned by the Company or any Restricted Subsidiary for more than 120 days
prior to such sale or transfer, if such sale or transfer is made with the
intention of leasing, or as part of an arrangement involving the lease, of such
Principal Facility to the Company or a Restricted Subsidiary, except (a) a lease
for a period of not exceeding 36 months, made with the intention that the use of
the leased Principal Facility by the Company or such Restricted Subsidiary will
be discontinued on or before the expiration of such period and (b) a lease that
secures or relates to obligations issued by the United States of America or any
state, territory or possession of the United States of America or any political
subdivision of any of the foregoing, or at the District of Columbia, in
connection with the financing of the cost of construction or acquisition of such
Principal Facility or a part thereof. No Security Interest described in
subparagraphs (a) through (l) of Section 5.08 hereof shall be deemed to create
or be defined to be a Sale and Leaseback Transaction.

                                      -5-
<PAGE>

                  "SEC" means the Securities and Exchange Commission.

                  "Secured Debt" means any indebtedness for money borrowed by,
or evidenced by a note or other similar instrument of, the Company or a
Restricted Subsidiary, and any other indebtedness of the Company or a Restricted
Subsidiary on which by the terms of such indebtedness interest is paid or
payable, including obligations evidenced or secured by leases, installment sales
agreements or other instruments (other than indebtedness owned by a Restricted
Subsidiary to the Company, by a Restricted Subsidiary to another Restricted
Subsidiary or by the Company to a Restricted Subsidiary), which in any such case
is secured by (a) a Security Interest in any Principal Facility or portion
thereof or (b) a Security Interest in any shares of stock owned directly or
indirectly by the Company in a Restricted Subsidiary or in indebtedness for
money borrowed by a Restricted Subsidiary from the Company or another Restricted
Subsidiary. The securing in the foregoing manner of any debt which immediately
prior thereto was not Secured Debt shall be deemed to be the creation of Secured
Debt at the time such security is given. The amount of Secured Debt at any time
outstanding shall be the maximum aggregate amount then owing thereon by the
Company and its Restricted Subsidiaries.

                  "Securities" or "Debentures" means the Securities described in
the recitals above which are issued, authenticated and delivered under this
Indenture.

                  "Securities Act" means the Securities Act of 1933, as amended.

                  "Securities Custodian" means The Bank of New York, as
custodian with respect to the Securities in global form, or any successor entity
thereto.

                  "Security Interest" means any mortgage, pledge, lien,
encumbrance or other security interest which secures payment or performance of
an obligation.

                   "Subsidiary" means a corporation, a majority of the voting
stock of which is owned, directly or indirectly, by the Company or by one or
more Subsidiaries, or by the Company and one or more other Subsidiaries.

                  "Subsidiary Guarantor" means any Subsidiary of the Company
that guarantees the Company's obligation with respect to the Securities pursuant
to a Subsidiary Guaranty.

                  "Subsidiary Guaranty" means a guarantee by a Subsidiary
Guarantor of the Company's obligations with respect to the Securities pursuant
to Article 12 or pursuant to a Guaranty Agreement.

                  "Superior Indebtedness" means any obligation of the Company or
any Restricted Subsidiary which constituted funded debt as of the date of its
creation and which, in the case of such funded debt of the Company, is not
subordinate and junior in right of payment to the prior payment of the
Securities. As used herein "funded debt" shall mean any obligation payable by
its terms more than one year from the date of incurrence thereof (or renewable
or extendable at the option of the obligor for a period ending more than one
year after such date of incurrence), which under generally accepted accounting
principles should be shown on the consolidated balance sheet of the Company as a
liability.

                  "TIA" means the Trust Indenture Act of 1939, as amended by the
Trust Indenture Reform Act of 1990 and as in effect on the date of this
Indenture, except to the extent any amendment to the Trust Indenture Act
expressly provides for application of the Trust Indenture Act as in effect on
another date.

                  "Transfer Certificate" has the meaning specified in Section
2.14(f).

                                      -6-
<PAGE>

                  "Transfer Restricted Securities" has the meaning specified in
Section 2.14(f).

                  "Trading Day" means each Monday, Tuesday, Wednesday, Thursday
and Friday other than any day on which securities are not traded on the
principal exchange or market on which the securities in question are traded.

                  "Trustee" means the party named as such above until a
successor replaces it pursuant to the applicable provisions hereof and
thereafter means the successor.

                  "Unrestricted Global Security" means a Global Security that is
not a Transfer Restricted Security.

                  "U.S. Government Obligations" has the meaning specified in
Section 9.01.

                  "Voting Shares" has the meaning specified in Section 4.05(d).

                  "Interest payable on 5-year U.S. Treasury Notes" means, on any
date,

                  (i) the yield, under the heading which represents the average
for the immediately preceding week, appearing in the most recently published
statistical release designated "H.15(519)" or any successor publication which is
published weekly by the Board of Governors of the Federal Reserve System and
which establishes yields on actively traded United States Treasury securities
adjusted to constant maturity under the caption "Treasury Constant Maturities,"
for the Comparable Treasury Issue (if no maturity is within three months before
or after the fifth anniversary of such date, yields for the two published
maturities most closely corresponding to the Comparable Treasury Issue will be
determined and the interest payable on 5-year U.S. Treasury Notes shall be
interpolated or extrapolated from those yields on a straight line basis,
rounding to the nearest month) or

                  (ii) if the release referred to in (i) (or any successor
release) is not published during the week preceding such date or does not
contain the yields referred to above, the rate per annum equal to the semiannual
equivalent yield to maturity of the Comparable Treasury Issue, calculated using
a price for the Comparable Treasury Issue (expressed as a percentage of its
principal amount) equal to the Comparable Treasury Price for such date.

                  "Comparable Treasury Issue" means at any time the United
States Treasury security selected by an "Independent Investment Banker" as
having approximately a five year maturity and that would be utilized, at the
time of selection and in accordance with customary financial practice, in
pricing new issues of corporate debt securities with a five year maturity.
"Independent Investment Banker" means one of the Reference Treasury Dealers
appointed by the trustee after consultation with the Company.

                  "Comparable Treasury Price" means on any date

                  (i) the average of four Reference Treasury Dealer Quotations
(as defined below) for such date, after excluding the highest and lowest of
those Reference Treasury Dealer Quotations, or

                  (ii) if the trustee obtains fewer than four Reference Treasury
Dealer Quotations, the average of all quotations obtained.

                                      -7-
<PAGE>
                  "Reference Treasury Dealer" means each of Credit Suisse Fist
Boston Corporation, [J.P. Morgan Securities Inc., Banc of America Securities LLC
and UBS Warburg LLC](1) (each , a "Primary Treasury Dealer"). If any Reference
Treasury Dealer ceases to be a Primary Treasury Dealer, we will substitute
another Primary Treasury Dealer for that dealer.

                  "Reference Treasury Dealer Quotations" means, with respect to
each Reference Treasury Dealer and any date, the average, as determined by the
trustee, of the bid and asked prices for the Comparable Treasury Issue
(expressed in each case as a percentage of its principal amount) quoted in
writing to the trustee by that Reference Treasury Dealer at 5:00 p.m. on such
date.

                  SECTION 1.02. Incorporation by Reference of Trust Indenture
Act. Whenever this Indenture refers to a provision of the TIA, the provision is
incorporated by reference in and made a part of this Indenture. The following
TIA terms used in this Indenture have the following meanings:

                  "Commission" means the SEC.

                  "indenture securities" means the Securities and the Subsidiary
Guaranties.

                  "indenture security holder" means a Securityholder.

                  "indenture to be qualified" means this Indenture.

                  "indenture trustee" or "institutional trustee" means the
Trustee.

                  "obligor" on the indenture securities means the Company, each
Subsidiary Guarantor and any other obligor on the Securities.

                  All other TIA terms used in this Indenture that are defined by
the TIA, defined by TIA reference to another statute or defined by Commission
rule and not otherwise defined herein have the meanings assigned to them
therein.

                  SECTION 1.03. Rules of Construction. Unless the context
otherwise requires:

                  (1) a term has the meaning assigned to it;

                  (2) an accounting term not otherwise defined has the meaning
         assigned to it in accordance with generally accepted accounting
         principles in effect from time to time;

                  (3) "or" is not exclusive;

                  (4) "including" means "including without limitation";

                  (5) words in the singular include the plural, and words in the
         plural include the singular; and

----------

(1) CSFB trading desk to confirm that J.P. Morgan Securities Inc, Banc of
    America Securities LLC and UBS Warburg LLC are primary U.S. government
    securities dealers in New York City.

                                      -8-
<PAGE>

                  (6) provisions apply to successive events and transactions.

                                    ARTICLE 2

                                 THE SECURITIES

                  SECTION 2.01. Form and Dating. The Securities and the
Trustee's certificate of authentication shall be substantially in the respective
forms set forth in Exhibit A, which Exhibit is incorporated in and made part of
this Indenture. The Securities may have notations, legends or endorsements
required by law, stock exchange rule or usage. Each Security shall be dated the
date of its authentication. The Securities are being offered and sold by the
Company pursuant to the Purchase Agreement in transactions exempt from, or not
subject to, the registration requirements of the Securities Act.

                  (a) Restricted Global Securities. Securities offered and sold
to qualified institutional buyers as defined in Rule 144A (collectively, "QIBs"
or individually, each a "QIB") in reliance on Rule 144A under the Securities Act
shall be issued initially in the form of one or more Restricted Global
Securities, which shall be deposited on behalf of the purchasers of the
Securities represented thereby with the Trustee, at its Corporate Trust Office,
as custodian for the depositary, The Depository Trust Company ("DTC") (such
depositary, or any successor thereto, being hereinafter referred to as the
"Depositary"), and registered in the name of its nominee, Cede & Co., duly
executed by the Company and authenticated by the Trustee as hereinafter
provided. The aggregate principal amount of the Restricted Global Security may
from time to time be increased or decreased by adjustments made on the records
of the Securities Custodian as hereinafter provided, subject in each case to
compliance with the Applicable Procedures.

                  (b) Global Securities In General. Each Global Security shall
represent such of the outstanding Securities as shall be specified therein and
each shall provide that it shall represent the aggregate amount of outstanding
Securities from time to time endorsed thereon and that the aggregate amount of
outstanding Securities represented thereby may from time to time be reduced or
increased, as appropriate, to reflect exchanges, redemptions, purchases or
conversions of such Securities. Any endorsement of a Global Security to reflect
the amount of any increase or decrease in the amount of outstanding Securities
represented thereby shall be made by the Securities Custodian in accordance with
the standing instructions and procedures existing between the Depositary and the
Securities Custodian.

                  Members of, or participants in, the Depositary ("Agent
Members") shall have no rights under this Indenture with respect to any Global
Security held on their behalf by the Depositary or under any Global Security,
and the Depositary (including, for this purpose, its nominee) may be treated by
the Company, the Trustee and any agent of the Company or the Trustee as the
absolute owner and Holder of such Global Security for all purposes whatsoever.
Notwithstanding the foregoing, nothing herein shall (A) prevent the Company, the
Trustee or any agent of the Company or the Trustee from giving effect to any
written certification, proxy or other authorization furnished by the Depositary
or (B) impair, as between the Depositary and its Agent Members, the operation of
customary practices governing the exercise of the rights of a Holder of any
Security.

                  (c) Certificated Securities. Certificated Securities shall be
issued only under the limited circumstances provided in Section 2.14(a)(1)
hereof.

                  SECTION 2.02. Execution and Authentication. One Officer shall
sign the Securities on behalf of the Company by manual or facsimile signature.
The Company's seal may be reproduced on the Securities.

                                      -9-
<PAGE>

                  If an Officer whose signature is on a Security no longer holds
that office at the time the Security is authenticated, the Security shall
nevertheless be valid.

                  A Security shall not be valid until authenticated by the
manual signature of the Trustee. The Trustee's signature shall be conclusive
evidence that the Security has been authenticated under this Indenture.

                  The Trustee shall authenticate and make available for delivery
Securities for original issue in an aggregate principal amount of $300,000,000
upon a Company Order without any further action by the Company; provided,
however, that in the event that the Company sells any Securities pursuant to the
Initial Purchaser Option, then the Trustee shall authenticate and deliver
Securities for original issue in an aggregate principal amount of $300,000,000
plus up to an additional $45,000,000 aggregate principal amount of the
Securities sold pursuant to the Initial Purchaser Option upon a Company Order
without any further action by the Company. The aggregate principal amount of the
Securities outstanding at any time may not exceed the amount set forth in the
foregoing sentence, subject to the proviso set forth therein, except as provided
in Section 2.07.

                  The Trustee may appoint an authenticating agent acceptable to
the Company to authenticate Securities. An authenticating agent may authenticate
Securities whenever the Trustee may do so, other than upon original issuance or
pursuant to Section 2.07. Each reference in this Indenture to authentication by
the Trustee includes authentication by such agent. An authenticating agent has
the same rights as an Agent to deal with the Company or an Affiliate.

                  The Securities shall be issuable only in registered form
without coupons and only in denominations of $1,000 and any integral multiple
thereof.

                  SECTION 2.03. Registrar, Paying Agent, Conversion Agent and
New York Presenting Agent. The Company shall maintain an office or agency where
Securities may be presented for registration of transfer or exchange (the
"Registrar"), an office or agency where Securities may be presented for payment
(the "Paying Agent") and an office or agency where Securities may be presented
for conversion (the "Conversion Agent"). The Registrar shall keep a register of
the Securities and of their transfer and exchange. The Company may appoint one
or more Co-Registrars, one or more additional Paying Agents and one or more
additional Conversion Agents. The Company may act as Registrar, Paying Agent,
Conversion Agent or Co-Registrar. The term "Paying Agent" includes any
additional paying agent; the term "Conversion Agent" includes any additional
conversion agent. The Company shall notify the Trustee of the name and address
of any Agent not a party to this Indenture and shall give the Trustee at least
thirty days' notice prior to changing the Registrar, Paying Agent or Conversion
Agent. If the Company fails to maintain a Registrar, Paying Agent or Conversion
Agent, the Trustee shall act as such. The Company initially appoints the Trustee
as Paying Agent, Registrar and Conversion Agent.

                  If there is not at least one of each such Registrar or
Co-Registrar, Paying Agent and Conversion Agent located in the Borough of
Manhattan, the City of New York, the Company shall also maintain an office in
the Borough of Manhattan, the City of New York where the Securities may be
presented for purposes of transfer and exchange, payment and conversion (the
"New York Presenting Agent"). The Company initially appoints The Bank of New
York, having an office at 101 Barclay Street, Floor 21 W, New York, New York
10286, to serve as New York Presenting Agent.

                  SECTION 2.04. Payment on Securities; Paying Agent to Hold
Money in Trust.

                  (a) Subject to the following provisions, no later than 10:00
a.m. (New York City time) on the due date of principal of and premium, if any,
and interest on the Securities, the Company will

                                      -10-
<PAGE>

pay to the Paying Agent in immediately available funds the amounts, in money of
the United States that at the time of payment is legal tender for payment of
public or private debts, in the manner, at the times and for the purposes set
forth herein and in the text of the Securities, and the Company hereby
authorizes and directs the Paying Agent from funds so paid to it to make or
cause to be made payment of the principal of and premium, if any, and interest
on the Securities set forth herein and in the text of the Securities. The Paying
Agent will make payment, from the funds furnished by the Company, of the
principal of and premium, if any, and interest on the Securities by check drawn
upon a bank in the city in which the Paying Agent's principal office is located,
or make payment by wire transfer upon terms acceptable to the Paying Agent.

                  (b) Interest on a Security (other than defaulted interest)
shall be paid on each interest payment date to the Holder thereof at the close
of business on the relevant record date specified in the Securities. Principal
of and premium, if any, on Securities shall be payable only against presentation
and surrender thereof at the principal office of the Paying Agent, unless the
Company shall have otherwise instructed the Trustee in writing.

                  (c) The Company shall require each Paying Agent other than the
Trustee to agree in writing that the Paying Agent will hold in trust for the
benefit of Securityholders or the Trustee all money held by the Paying Agent for
the payment of principal of or premium, if any, or interest on the Securities,
and will notify the Trustee of any default by the Company in making any such
payment. While any such default continues, the Trustee may require a Paying
Agent to pay all money held by it to the Trustee. If the Company acts as Paying
Agent, it shall segregate the money held by it for the payment of principal of
and premium, if any, and interest on the Securities and hold it as a separate
trust fund. The Company shall provide ten days prior written notice to the
Trustee that it is to act as Paying Agent with respect to such payment and the
Trustee may rely on such notice. The Company at any time may require a Paying
Agent to pay all money held by the Paying Agent to the Trustee. Upon doing so
the Paying Agent shall have no further liability for the money so paid.

                  SECTION 2.05. Securityholder Lists. The Trustee shall preserve
in as current a form as is reasonably practicable the most recent list available
to it of the names and addresses of Securityholders. If the Trustee is not the
Registrar, the Company shall furnish to the Trustee not less than five days
prior to each interest payment date and at such other times as the Trustee may
request in writing a list in such form and as of such date as the Trustee may
reasonably require of the names and addresses of Securityholders.

                  SECTION 2.06. Transfer and Exchange.

                  (a) Subject to compliance with any applicable additional
requirements contained in Section 2.14, when a Security is presented to a
Registrar with a request to register a transfer thereof or to exchange such
Security for an equal principal amount of Securities of other authorized
denominations, the Registrar shall register the transfer or make the exchange as
requested; provided, that every Security presented or surrendered for
registration of transfer or exchange shall be duly endorsed or accompanied by an
assignment form and, if applicable, a transfer certificate each in the form
included in Exhibit A, duly executed by the Holder thereof or its attorney duly
authorized in writing. To permit registration of transfers and exchanges, upon
surrender of any Security for registration of transfer or exchange at an office
or agency maintained pursuant to Section 2.03, the Company shall execute and the
Trustee shall authenticate Securities of a like aggregate principal amount at
the Registrar's request. Any exchange or transfer shall be without charge,
except that the Company or the Registrar may require payment of a sum sufficient
to cover any tax or other governmental charge that may be imposed in relation
thereto, and provided, that this sentence shall not apply to any exchange
pursuant to Section 2.07, 2.10, 2.14(a)(1), 3.06, 4.01(g), 4.04(d), 10.05 or
11.02.

                                      -11-
<PAGE>

                  Neither the Company, any Registrar nor the Trustee shall be
required to exchange or register a transfer of (a) any Securities for a period
of 15 days next preceding any mailing of a notice of Securities to be redeemed,
(b) any Securities or portions thereof selected or called for redemption
(except, in the case of redemption of a Security in part, the portion not to be
redeemed) or (c) any Securities or portions thereof in respect of which a
Purchase Notice or Change of Control Purchase Notice has been delivered and not
withdrawn by the Holder thereof (except, in the case of the purchase of a
Security in part, the portion not to be purchased).

                  All Securities issued upon any transfer or exchange of
Securities shall be valid obligations of the Company, evidencing the same debt
and entitled to the same benefits under this Indenture, as the Securities
surrendered upon such transfer or exchange.

                  (b) Any Registrar appointed pursuant to Section 2.03 hereof
shall provide to the Trustee such information as the Trustee may reasonably
require in connection with the delivery by such Registrar of Securities upon
transfer or exchange of Securities.

                  (c) Each Holder of a Security agrees to indemnify the Company
and the Trustee against any liability that may result from the transfer,
exchange or assignment of such Holder's Security in violation of any provision
of this Indenture and/or applicable United States federal or state securities
law.

                  The Trustee shall have no obligation or duty to monitor,
determine or inquire as to compliance with any restrictions on transfer imposed
under this Indenture or under applicable law with respect to any transfer of any
interest in any Security (including any transfers between or among Agent Members
or other beneficial owners of interests in any Global Security) other than to
require delivery of such certificates and other documentation or evidence as are
expressly required by, and to do so if and when expressly required by the terms
of, this Indenture, and to examine the same to determine substantial compliance
as to form with the express requirements hereof.

                  SECTION 2.07. Replacement Securities. If the Holder of a
Security claims that the Security has been lost, destroyed or wrongfully taken,
or if a mutilated Security is surrendered to the Trustee, the Company shall
issue and the Trustee shall authenticate a replacement Security if the Trustee's
requirements are met. If an indemnity bond is required by the Trustee or the
Company, such bond must be sufficient, in the judgment of both the Trustee and
the Company, to protect the Company, the Trustee, any Agent or any
authenticating agent from any loss which any of them may suffer if a Security is
replaced. The Company may charge for its expenses incurred in replacing a
Security.

                  Every replacement Security shall be an additional obligation
of the Company.

                  SECTION 2.08. Outstanding Securities. The Securities
outstanding at any time are all Securities authenticated by the Trustee (or an
authenticating agent appointed pursuant to Section 2.02) except for those
cancelled by the Trustee, those delivered to the Trustee for cancellation, those
reductions in the interests in a global Security effected by the Trustee
hereunder, and those described in this Section as not outstanding.

                  A Security does not cease to be outstanding because the
Company or an Affiliate holds the Security.

                  If a Security is replaced pursuant to Section 2.07, it ceases
to be outstanding unless the Trustee receives proof satisfactory to it that the
replaced Security is held by a bona fide purchaser.

                                      -12-
<PAGE>

                  If Securities are considered paid under Section 5.01, they
cease to be outstanding and interest on them ceases to accrue.

                  SECTION 2.09. Treasury Securities. In determining whether the
Holders of the required principal amount of Securities have concurred in any
direction, waiver or consent, Securities owned by the Company or an Affiliate
shall be disregarded, except that for the purposes of determining whether the
Trustee shall be protected in relying on any such direction, waiver or consent,
only Securities which the Trustee knows are so owned shall be so disregarded.

                  SECTION 2.10. Temporary Securities. Until definitive
Securities are ready for delivery, the Company may prepare and execute and the
Trustee shall authenticate temporary Securities. Temporary Securities shall be
substantially in the form of definitive Securities but may have variations that
the Company considers appropriate for temporary Securities. Every temporary
Security shall be executed by the Company and authenticated by the Trustee, and
registered by the Registrar, upon the conditions, and with like effect, as a
definitive Security. Without unreasonable delay, the Company shall prepare and
the Trustee shall authenticate definitive Securities in exchange for temporary
Securities.

                  SECTION 2.11. Cancellation. The Company at any time may
deliver Securities to the Trustee for cancellation. The Registrar, Paying Agent
and Conversion Agent shall promptly forward to the Trustee any Securities
surrendered to them for registration of transfer, exchange, payment or
conversion. The Trustee shall cancel all Securities surrendered for registration
of transfer, exchange, payment, conversion or cancellation and may dispose of
cancelled Securities in accordance with its customary procedures, unless the
Company directs the Trustee to deliver cancelled Securities to the Company. The
Company may not issue new Securities to replace Securities that it has paid or
delivered to the Trustee for cancellation or that any Securityholder has
converted pursuant to Article 11.

                  SECTION 2.12. Defaulted Interest. If the Company defaults in a
payment of interest on the Securities, it shall pay the defaulted interest in
any lawful manner not inconsistent with the requirements of any securities
exchange on which the Securities are listed. It may pay the defaulted interest,
plus any interest payable on the defaulted interest, to the Persons who are
Securityholders on a subsequent special record date. The Company shall fix the
record date and payment date for the payment of any defaulted interest. At least
15 days before the record date, the Company shall mail to each Securityholder
and the Trustee a notice that states the record date, payment date and amount of
interest to be paid.

                  SECTION 2.13. CUSIP Numbers. The Company in issuing the
Securities may use "CUSIP" numbers (if then generally in use), and, if so, the
Trustee shall use "CUSIP" numbers in notices of redemption as a convenience to
Holders; provided, however, that any such notice may state that no
representation is made as to the correctness of such numbers either as printed
on the Securities or as contained in any notice of a redemption and that
reliance may be placed only on the other identification numbers printed on the
Securities, and any such redemption shall not be affected by any defect in or
omission of such numbers. The Company will promptly notify the Trustee of any
change in the CUSIP numbers.

                  SECTION 2.14. Additional Transfer and Exchange Requirements.

                  (a) Transfer and Exchange of Global Securities.

                   (1) Certificated Securities shall be issued in exchange for
         interests in the Global Securities only if (x) the Depositary notifies
         the Company that it is unwilling or unable to continue as depositary
         for the Global Securities or if it at any time ceases to be a "clearing

                                      -13-
<PAGE>

         agency" registered under the Exchange Act, if so required by applicable
         law or regulation and a successor depositary is not appointed by the
         Company within 90 days, or (y) an Event of Default has occurred and is
         continuing. In either case, the Company shall execute, and the Trustee
         shall, upon receipt of a Company order (which the Company agrees to
         delivery promptly), authenticate and deliver Certificated Securities in
         an aggregate principal amount equal to the principal amount of such
         Global Securities in exchange therefor. Only Restricted Certificated
         Securities shall be issued in exchange for beneficial interests in
         Restricted Global Securities, and only Unrestricted Certificated
         Securities shall be issued in exchange for beneficial interests in
         Unrestricted Global Securities. Certificated Securities issued in
         exchange for beneficial interests in Global Securities shall be
         registered in such names and shall be in such authorized denominations
         as the Depositary, pursuant to instructions from its direct or indirect
         participants or otherwise, shall instruct the Trustee. The Trustee
         shall deliver or cause to be delivered such Certificated Securities to
         the persons in whose names such Securities are so registered. Such
         exchange shall be effected in accordance with the Applicable
         Procedures.

                   (2) Notwithstanding any other provisions of this Indenture
         other than the provisions set forth in Section 2.14(a)(1), a Global
         Security may not be transferred as a whole except by the Depositary to
         a nominee of the Depositary or by a nominee of the Depositary to the
         Depositary or another nominee of the Depositary or by the Depositary or
         any such nominee to a successor Depositary or a nominee of such
         successor Depositary.

                  (b) Transfer and Exchange of Certificated Securities. In the
event that Certificated Securities are issued in exchange for beneficial
interests in Global Securities in accordance with Section 2.14(a)(1) of this
Indenture, on or after such event when Certificated Securities are presented by
a Holder to a Registrar with a request:

                  (x) to register the transfer of the Certificated Securities to
         a person who will take delivery thereof in the form of Certificated
         Securities only; or

                  (y) to exchange such Certificated Securities for an equal
         principal amount of Certificated Securities of other authorized
         denominations, such Registrar shall register the transfer or make the
         exchange as requested;

provided, however, that the Certificated Securities presented or surrendered for
register of transfer or exchange:

                  (1) shall be duly endorsed or accompanied by a written
         instrument of transfer in accordance with the proviso to the first
         paragraph of Section 2.06(a); and

                  (2) in the case of a Restricted Certificated Security, such
         request shall be accompanied by the following additional information
         and documents, as applicable:

                           (i) if such Restricted Certificated Security is
                  being delivered to the Registrar by a Holder for registration
                  in the name of such Holder, without transfer, or such
                  Restricted Certificated Security is being transferred to the
                  Company or a Subsidiary of the Company, a certification to
                  that effect from such Holder (in substantially the form set
                  forth in the Transfer Certificate);

                           (ii) if such Restricted Certificated Security is
                  being transferred to a person the Holder reasonably believes
                  is a QIB in accordance with Rule 144A or pursuant to an

                                      -14-
<PAGE>

                  effective registration statement under the Securities Act, a
                  certification to that effect from such Holder (in
                  substantially the form set forth in the Transfer Certificate);
                  or

                          (iii) if such Restricted Certificated Security is
                  being transferred (i) pursuant to an exemption from the
                  registration requirements of the Securities Act in accordance
                  with Rule 144 or (ii) pursuant to an exemption from the
                  registration requirements of the Securities Act (other than
                  pursuant to Rule 144A or Rule 144) and as a result of which,
                  in the case of a Security transferred pursuant to this clause
                  (ii), such Security shall cease to be a "restricted security"
                  within the meaning of Rule 144, a certification to that effect
                  from the Holder (in substantially the form set forth in the
                  Transfer Certificate) and, if the Company or such Registrar so
                  requests, a customary opinion of counsel, certificates and
                  other information reasonably acceptable to the Company and
                  such Registrar to the effect that such transfer is in
                  compliance with the registration requirements of the
                  Securities Act.

                  (c) Transfer of a Beneficial Interest in a Restricted Global
Security for a Beneficial Interest in an Unrestricted Global Security. Any
person having a beneficial interest in a Restricted Global Security may upon
request, subject to the Applicable Procedures, transfer such beneficial interest
to a person who is required or permitted to take delivery thereof in the form of
an Unrestricted Global Security. Upon receipt by the Trustee of written
instructions, or such other form of instructions as is customary for the
Depositary, from the Depositary or its nominee on behalf of any person having a
beneficial interest in a Restricted Global Security and the following additional
information and documents in such form as is customary for the Depositary from
the Depositary or its nominee on behalf of the person having such beneficial
interest in the Restricted Global Security (all of which may be submitted by
facsimile or electronically):

                  (1) if such beneficial interest is being transferred pursuant
         to an effective registration statement under the Securities Act, a
         certification to that effect from the transferor (in substantially the
         form set forth in the Transfer Certificate); or

                  (2) if such beneficial interest is being transferred (i)
         pursuant to an exemption from the registration requirements of the
         Securities Act in accordance with Rule 144 or (ii) pursuant to an
         exemption from the registration requirements of the Securities Act
         (other than pursuant to Rule 144A or Rule 144) and as a result of
         which, in the case of a Security transferred pursuant to this clause
         (ii), such Security shall cease to be a "restricted security" within
         the meaning of Rule 144, a certification to that effect from the
         transferor (in substantially the form set forth in the Transfer
         Certificate) and, if the Company or the Trustee so requests, a
         customary opinion of counsel, certificates and other information
         reasonably acceptable to the Company and the Trustee to the effect that
         such transfer is in compliance with the registration requirements of
         the Securities Act, the Trustee, as a Registrar and Securities
         Custodian, shall reduce or cause to be reduced the aggregate principal
         amount of the Restricted Global Security by the appropriate principal
         amount and shall increase or cause to be increased the aggregate
         principal amount of the Unrestricted Global Security by a like
         principal amount. Such transfer shall otherwise be effected in
         accordance with the Applicable Procedures. If no Unrestricted Global
         Security is then outstanding, the Company shall execute and the Trustee
         shall, upon receipt of a Company Order (which the Company agrees to
         deliver promptly), authenticate and deliver an Unrestricted Global
         Security.

                  (d) Transfer of a Beneficial Interest in an Unrestricted
Global Security for a Beneficial Interest in a Restricted Global Security. Any
person having a beneficial interest in an Unrestricted Global Security may upon
request, subject to the Applicable Procedures, transfer such

                                      -15-
<PAGE>

beneficial interest to a person who is required or permitted to take delivery
thereof in the form of a Restricted Global Security (it being understood that
only QIBs may own beneficial interests in Restricted Global Securities). Upon
receipt by the Trustee of written instructions or such other form of
instructions as is customary for the Depositary, from the Depositary or its
nominee, on behalf of any person having a beneficial interest in an Unrestricted
Global Security and, in such form as is customary for the Depositary, from the
Depositary or its nominee on behalf of the person having such beneficial
interest in the Unrestricted Global Security (all of which may be submitted by
facsimile or electronically) a certification from the transferor (in
substantially the form set forth in the Transfer Certificate) to the effect that
such beneficial interest is being transferred to a person that the transferor
reasonably believes is a QIB in accordance with Rule 144A. The Trustee, as a
Registrar and Securities Custodian, shall reduce or cause to be reduced the
aggregate principal amount of the Unrestricted Global Security by the
appropriate principal amount and shall increase or cause to be increased the
aggregate principal amount of the Restricted Global Security by a like principal
amount. Such transfer shall otherwise be effected in accordance with the
Applicable Procedures. If no Restricted Global Security is then outstanding, the
Company shall execute and the Trustee shall, upon receipt of a Company Order
(which the Company agrees to deliver promptly), authenticate and deliver a
Restricted Global Security.

                  (e) Transfers of Certificated Securities for Beneficial
Interest in Global Securities. In the event that Certificated Securities are
issued in exchange for beneficial interests in Global Securities and,
thereafter, the events or conditions specified in Section 2.14(a)(1) which
required such exchange shall cease to exist, the Company shall mail notice to
the Trustee and to the Holders stating that Holders may exchange Certificated
Securities for interests in Global Securities by complying with the procedures
set forth in this Indenture and briefly describing such procedures and the
events or circumstances requiring that such notice be given. Thereafter, if
Certificated Securities are presented by a Holder to a Registrar with a request:

                  (x) to register the transfer of such Certificated Securities
         to a person who will take delivery thereof in the form of a beneficial
         interest in a Global Security, which request shall specify whether such
         Global Security will be a Restricted Global Security or an Unrestricted
         Global Security; or

                  (y) to exchange such Certificated Securities for an equal
         principal amount of beneficial interests in a Global Security, which
         beneficial interests will be owned by the Holder transferring such
         Certificated Securities (provided that in the case of such an exchange,
         Restricted Certificated Securities may be exchanged only for Restricted
         Global Securities and Unrestricted Certificated Securities may be
         exchanged only for Unrestricted Global Securities), the Registrar shall
         register the transfer or make the exchange as requested by canceling
         such Certificated Security and causing, or directing the Securities
         Custodian to cause, the aggregate principal amount of the applicable
         Global Security to be increased accordingly and, if no such Global
         Security is then outstanding, the Company shall issue and the Trustee
         shall authenticate and deliver a new Global Security;

provided, however, that the Certificated Securities presented or surrendered for
registration of transfer or exchange:

                  (1) shall be duly endorsed or accompanied by a written
         instrument of transfer in accordance with the proviso to the first
         paragraph of Section 2.06(a);

                  (2) in the case of a Restricted Certificated Security to be
         transferred for a beneficial interest in an Unrestricted Global
         Security, such request shall be accompanied by the following additional
         information and documents, as applicable:

                                      -16-
<PAGE>

                            (i) if such Restricted Certificated Security is
                  being transferred pursuant to an effective registration
                  statement under the Securities Act, a certification to that
                  effect from such Holder (in substantially the form set forth
                  in the Transfer Certificate); or

                           (ii) if such Restricted Certificated Security is
                  being transferred pursuant to (i) an exemption from the
                  registration requirements of the Securities Act in accordance
                  with Rule 144 or (ii) pursuant to an exemption from the
                  registration requirements of the Securities Act (other than
                  pursuant to Rule 144A or Rule 144) and as a result of which,
                  in the case of a Security transferred pursuant to this clause
                  (ii), such Security shall cease to be a "restricted security"
                  within the meaning of Rule 144, a certification to that effect
                  from such Holder (in substantially the form set forth in the
                  Transfer Certificate), and, if the Company or the Registrar so
                  requests, a customary opinion of counsel, certificates and
                  other information reasonably acceptable to the Company and the
                  Trustee to the effect that such transfer is in compliance with
                  the registration requirements of the Securities Act;

                  (3) in the case of a Restricted Certificated Security to be
         transferred or exchanged for a beneficial interest in a Restricted
         Global Security, such request shall be accompanied by a certification
         from such Holder (in substantially the form set forth in the Transfer
         Certificate) to the effect that such Restricted Certificated Security
         is being transferred to a person the Holder reasonably believes is a
         QIB (which, in the case of an exchange, shall be such Holder) in
         accordance with Rule 144A;

                  (4) in the case of an Unrestricted Certificated Security to be
         transferred or exchanged for a beneficial interest in an Unrestricted
         Global Security, such request need not be accompanied by any additional
         information or documents; and

                  (5) in the case of an Unrestricted Certificated Security to be
         transferred or exchanged for a beneficial interest in a Restricted
         Global Security, such request shall be accompanied by a certification
         from such Holder (in substantially the form set forth in the Transfer
         Certificate) to the effect that such Unrestricted Certificated Security
         is being transferred to a person the Holder reasonably believes is a
         QIB (which, in the case of an exchange, shall be such Holder) in
         accordance with Rule 144A.

                  (f) Legends.

                  (1) Except as permitted by the following paragraphs (2) and
(3), each Global Security and Certificated Security (and all Securities issued
in exchange therefor or upon registration of transfer or replacement thereof)
shall bear a legend in substantially the form called for by Exhibit A hereto
(each a "Transfer Restricted Security" for so long as it is required by this
Indenture to bear such legend). Each Transfer Restricted Security shall have
attached thereto a certificate (a "Transfer Certificate") in substantially the
form called for by Exhibit A hereto.

                   (2) Upon any sale or transfer of a Transfer Restricted
Security (w) after the expiration of the holding period applicable to sales of
the Securities under Rule 144(k) of the Securities Act, (x) pursuant to Rule
144, (y) pursuant to an effective registration statement under the Securities
Act or (z) pursuant to any other available exemption (other than Rule 144A) from
the registration requirements of the Securities Act and as a result of which, in
the case of a Security transferred pursuant to this clause (z), such Security
shall cease to be a "restricted security" within the meaning of Rule 144:

                                      -17-
<PAGE>

                  (i) in the case of any Restricted Certificated Security, any
         Registrar shall permit the Holder thereof to exchange such Restricted
         Certificated Security for an Unrestricted Certificated Security, or
         (under the circumstances described in Section 2.14(e)) to transfer such
         Restricted Certificated Security to a transferee who shall take such
         Security in the form of a beneficial interest in an Unrestricted Global
         Security, and in each case shall rescind any restriction on the
         transfer of such Security; provided that the Holder of such Restricted
         Certificated Security shall, in connection with such exchange or
         transfer, comply with the other applicable provisions of this Section
         2.14; and

                  (ii) in the case of any beneficial interest in a Restricted
         Global Security, the Trustee shall permit the beneficial owner thereof
         to transfer such beneficial interest to a transferee who shall take
         such interest in the form of a beneficial interest in an Unrestricted
         Global Security and shall rescind any restriction on transfer of such
         beneficial interest; provided (x) that such Unrestricted Global
         Security shall continue to be subject to the provisions of Section
         2.14(a)(2); and (y) that the owner of such beneficial interest shall,
         in connection with such transfer, comply with the other applicable
         provisions of this Section 2.14.

                  (3) Upon the exchange, registration of transfer or replacement
of Securities not bearing the legend described in paragraph (1) above, the
Company shall execute, and the Trustee shall authenticate and deliver Securities
that do not bear such legend and that do not have a Transfer Certificate
attached thereto.

                  (4) After the expiration of the holding period pursuant to
Rule 144(k) of the Securities Act, the Company may with the consent of the
Holder of a Restricted Global Security or Restricted Certificated Security,
remove any restriction of transfer on such Security, and the Company shall
execute, and the Trustee shall authenticate and deliver Securities that do not
bear such legend and that do not have a Transfer Certificate attached thereto.

                                    ARTICLE 3

                                   REDEMPTION

                  SECTION 3.01. Notices to Trustee. If the Company wishes to
redeem Securities pursuant to paragraph 5 of the Securities, it shall notify the
Trustee of the Redemption Date and the principal amount of Securities to be
redeemed at least 45 days before the Redemption Date.

                  SECTION 3.02. Selection of Securities to Be Redeemed. If less
than all the Securities are to be redeemed, the Trustee shall select the
Securities to be redeemed by lot, or in its discretion, on a pro rata basis from
Securities outstanding and not previously called for redemption (unless the
Company specifically directs the Trustee otherwise), in such manner as the
Trustee shall deem fair and appropriate. The Trustee shall make the selection
(and provide the Company with written notice of such selection) at least 30 days
but not more than 60 days before the Redemption Date. Securities and portions of
them the Trustee selects for redemption shall be in amounts of $1,000 or
integral multiples of $1,000. In the event that the Trustee is not the
Registrar, the Registrar shall provide to the Trustee such information as the
Trustee may reasonably request to implement the selection. Provisions of this
Indenture that apply to Securities called for redemption also apply to portions
of Securities called for redemption.

                  SECTION 3.03. Notice of Redemption. At least 20 days but not
more than 60 days before a Redemption Date, the Company shall mail a notice of
redemption to the Trustee and each Holder whose Securities are to be redeemed.

                                      -18-
<PAGE>

                  The notice shall identify the Securities (including CUSIP
numbers, if any) to be redeemed and shall state:

                  (1) the Redemption Date;

                  (2) the Redemption Price;

                  (3) the Conversion Price;

                  (4) the name and address of the Paying Agent and Conversion
         Agent;

                  (5) that Securities called for redemption may be converted at
         any time before the close of business on the Business Day immediately
         preceding the Redemption Date;

                  (6) that Holders who want to convert Securities must satisfy
         the requirements set forth in paragraph 8 of the Securities;

                  (7) that Securities called for redemption must be surrendered
         to the Paying Agent in order to collect the Redemption Price;

                  (8) that interest on Securities called for redemption ceases
         to accrue on and after the Redemption Date (unless funds in the
         requisite amount are not paid or made available for payment on that
         date), and the amount of interest accrued on the Securities called for
         redemption up to but not including the Redemption Date;

                  (9) if less than all of any Security is to be redeemed, the
         principal amount of such Security to be redeemed;

                  (10) the CUSIP number, if any, printed on the Securities being
         redeemed; and

                  (11) that no representation is made as to the correctness or
         accuracy of the CUSIP number, if any, listed in such notice or printed
         on the Securities.

                  If any of the Securities to be redeemed is in the form of a
Global Security, then the Company shall modify such notice to the extent
necessary to accord with the procedures of the Depositary applicable to
redemptions. Upon ten days prior notice to the Trustee, the Company may request
that the Trustee mail the notice of redemption (prepared by the Company) in the
Company's name and at its expense.

                  SECTION 3.04. Effect of Notice of Redemption. Once notice of
redemption is mailed, Securities called for redemption, unless theretofore
converted into Common Stock pursuant to the terms of this Indenture, shall
become due and payable on the Redemption Date at the Redemption Price. Upon
surrender to the Paying Agent, such Securities shall be paid at the Redemption
Price; provided, however, if the Redemption Date is on or after a record date
but on or prior to the related interest payment date, interest will be payable
to the Holders in whose name the Securities are registered at the close of
business on the relevant record date.

                  SECTION 3.05. Deposit of Redemption Price. No later than 10:00
a.m. (New York City time) on the Redemption Date, the Company shall deposit in
immediately available funds with the Paying Agent money sufficient to pay the
Redemption Price on all Securities to be redeemed on that date other than
Securities or portions thereof called for redemption on that date which have
been delivered by

                                      -19-
<PAGE>

the Company to the Trustee for cancellation. The Paying Agent shall return to
the Company any money not required for that purpose because of conversion of
Securities.

                  SECTION 3.06. Securities Redeemed in Part. Upon surrender to
the Trustee of a Security that is redeemed in part, the Company shall execute
and the Trustee shall authenticate for the Holder a new Security equal in
principal amount to the unredeemed portion of the Security surrendered.

                                    ARTICLE 4

                                   REPURCHASES

                  SECTION 4.01. Purchase of Securities at Option of the Holder.
(a) Securities are subject to mandatory purchase by the Company in accordance
with the provisions of paragraph 6 of the Securities on each Purchase Date at
the Purchase Price; provided, however, that if the Purchase Date is on or after
a record date but on or prior to the related interest payment date, interest
will be payable to the Holders in whose names the Securities are registered at
the close of business on the relevant record date.

                  Purchases of Securities hereunder shall be made, at the option
of the Holder thereof, upon:

                  (1) delivery to the Paying Agent by the Holder of a written
         notice of purchase (a "Purchase Notice") at any time from the opening
         of business on the date that is 20 Business Days prior to the Purchase
         Date until the close of business on the fifth Business Day prior to
         such Purchase Date stating:

                  (A) the certificate number of the Security which the Holder
         will deliver to be purchased,

                  (B) the portion of the principal amount of the Security which
         the Holder will deliver to be purchased, which portion must be in
         principal amounts at maturity of $1,000 or an integral multiple
         thereof,

                  (C) that such Security shall be purchased as of the Purchase
         Date pursuant to the terms and conditions specified in paragraph 6 of
         the Securities and in this Indenture, and

                  (D) delivery of such Security to the Paying Agent prior to, on
         or after the Purchase Date (together with all necessary endorsements)
         at the offices of the Paying Agent, such delivery being a condition to
         receipt by the Holder of the Purchase Price therefor, together with all
         accrued interest, shall be so paid pursuant to this Section 4.01 only
         if the Security so delivered to the Paying Agent shall conform in all
         respects to the description thereof in the related Purchase Notice, as
         determined by the Company.

                  The Company shall purchase from the Holder thereof, pursuant
to this Section 4.01, a portion of a Security if the principal amount of such
portion is $1,000 or an integral multiple of $1,000. Provisions of this
Indenture that apply to the purchase of all of a Security also apply to the
purchase of such portion of such Security.

                  Any purchase by the Company contemplated pursuant to the
provisions of this Section 4.01 shall be consummated by the delivery of the
consideration to be received by the Holder promptly following the later of the
Purchase Date and the time of delivery of the Security.

                                      -20-
<PAGE>

                  Notwithstanding anything herein to the contrary, any Holder
delivering to the Paying Agent the Purchase Notice contemplated by this Section
4.01 shall have the right to withdraw such Purchase Notice at any time prior to
the close of business on the second Business Day prior to the Purchase Date by
delivery of a written notice of withdrawal to the Paying Agent in accordance
with Section 4.01(e).

                  The Paying Agent shall promptly notify the Company of the
receipt by it of any Purchase Notice or written notice of withdrawal thereof.

                  (b) The Purchase Price of Securities in respect of which a
Purchase Notice pursuant to Section 4.01(a) has been given shall be paid in U.S.
legal tender (cash).

                  (c) In connection with any purchase of Securities pursuant to
this Section 4.01, the Company shall give written notice of the Purchase Date to
the Holders (the "Company Notice"). The Company Notice shall be sent by
first-class mail to the Trustee and to each Holder (and to each beneficial owner
as required by applicable law) not less than 20 Business Days prior to any
Purchase Date (the "Company Notice Date"). Each Company Notice shall include a
form of Purchase Notice to be completed by a Securityholder and shall state:

                  (i) the Purchase Price and the Conversion Price;

                  (ii) the name and address of the Paying Agent and the
Conversion Agent;

                  (iii) that Securities as to which a Purchase Notice has been
given may be converted if they are otherwise convertible only in accordance with
Article 11 hereof and paragraph 8 of the Securities if the applicable Purchase
Notice has been withdrawn in accordance with the terms of this Indenture;

                  (iv) that Securities must be surrendered to the Paying Agent
to collect payment;

                  (v) that the Purchase Price for any Security as to which a
Purchase Notice has been given and not withdrawn will be paid promptly following
the later of the Purchase Date and the time of surrender of such Security as
described in subclause (iv) above;

                  (vi) the procedures the Holder must follow to exercise rights
under this Section and a brief description of those rights;

                  (vii) briefly, the conversion rights of the Securities;

                  (viii) the procedures for withdrawing a Purchase Notice
(including pursuant to the terms of Section 4.01(e));

                  (ix) that, unless the Company defaults in making payment on
Securities for which a Purchase Notice has been submitted, interest on such
Securities will cease to accrue on the Purchase Date; and

                  (x) the CUSIP number of the Securities.

                  If any of the Securities are to be repurchased in the form of
a Global Security, the Company shall modify the notice and delivery requirements
to the extent necessary to accord with the procedures of the Depositary
applicable to repurchases of Global Securities.

                                      -21-
<PAGE>

                  At the Company's request, the Trustee shall give such Company
Notice in the Company's name and at the Company's expense; provided, however,
that, in all cases, the text of such Company Notice shall be prepared by the
Company.

                  (d) The Company shall deposit cash, in respect of purchases
under this Section 4.01, at the time and in the manner as provided in Section
4.01(f), sufficient to pay the aggregate Purchase Price of all Securities to be
purchased pursuant to this Section 4.01.

                  (e) Upon receipt by the Paying Agent of the Purchase Notice
specified in Section 4.01(a), the Holder of the Security in respect of which
such Purchase Notice was given shall (unless such Purchase Notice is withdrawn
as specified in the following two paragraphs) thereafter be entitled to receive
solely the Purchase Price, together with all accrued interest to, but not
including, the Purchase Date thereon, with respect to such Security. Such
Purchase Price, together with all accrued interest to, but not including, the
Purchase Date thereon, shall be paid to such Holder, subject to receipt of funds
by the Paying Agent, promptly following the later of (x) the Purchase Date with
respect to such Security (provided the conditions in Section 4.01(a) have been
satisfied) and (y) the time of delivery of such Security to the Paying Agent by
the Holder thereof in the manner required by Section 4.01(a). Securities in
respect of which a Purchase Notice has been given by the Holder thereof may not
be converted pursuant to Article 11 hereof on or after the date of the delivery
of such Purchase Notice, unless such Purchase Notice has first been validly
withdrawn as specified in the following two paragraphs.

                  A Purchase Notice may be withdrawn by means of a written
notice of withdrawal delivered to the office of the Paying Agent in accordance
with the Purchase Notice at any time prior to the close of business on the
second Business Day prior to the Purchase Date specifying:

                  (1) the certificate number, if any, of the Security in respect
         of which such notice of withdrawal is being submitted,

                  (2) the principal amount of the Security with respect to which
         such notice of withdrawal is being submitted, and

                  (3) the principal amount, if any, of such Security which
         remains subject to the original Purchase Notice and which has been or
         will be delivered for purchase by the Company.

                  A written notice of withdrawal of a Purchase Notice shall be
in the form set forth in the preceding paragraph.

                  (f) Prior to 10:00 a.m. (New York City time) on the Purchase
Date, the Company shall deposit with the Trustee or with the Paying Agent (or,
if the Company or a Subsidiary or an Affiliate of either of them is acting as
the Paying Agent, shall segregate and hold in trust as provided in Section
2.04(c)) an amount of money (in immediately available funds if deposited on such
Purchase Date) sufficient to pay the aggregate Purchase Price of all the
Securities or portions thereof which are to be purchased as of the Purchase
Date.

                  (g) Any Security which is to be repurchased only in part shall
be surrendered to the Trustee (with, if the Company or the Trustee so requires,
due endorsement by, or a written instrument of transfer in form satisfactory to
the Company and the Trustee duly executed by, the Holder thereof or his attorney
duly authorized in writing), and the Company shall execute, and the Trustee
shall authenticate and deliver to the Holder without service charge, a new
Security or Securities, of any authorized

                                      -22-
<PAGE>

denomination as requested by such Holder in aggregate principal amount equal to
and in exchange for the unrepurchased portion of the principal of the Security
so surrendered.

                  (h) The Company shall comply, to the extent applicable, with
the requirements of Sections 13 and 14 of the Exchange Act and any other
securities laws or regulations in connection with the repurchase of Securities
pursuant to this Section. To the extent that the provisions of any securities
laws or regulations conflict with provisions of this Section, the Company shall
comply with the applicable securities laws and regulations and shall not be
deemed to have breached its obligations under this Section by virtue of its
compliance with such securities laws or regulations.

                  SECTION 4.02. Repurchase upon Change of Control. (a) The
Company covenants and agrees that, in the event that there occurs a Change of
Control, each Holder will have the right, at such Holder's option, to require
the Company to repurchase all, or any portion that is an integral multiple of
$1,000, of such Holder's Securities on the Change of Control Purchase Date
selected as provided below at the Change of Control Purchase Price.

                  (b) Unless the Company shall have theretofore called for
redemption all the outstanding Securities, on or before the 30th day after the
occurrence of a Change of Control, the Company shall deliver to the Trustee, and
the Company shall, or, if so requested by the Company upon ten days' prior
written notice, the Trustee shall, in the name of the Company and at its
expense, mail to each Holder at such Holder's address appearing in the
Securities Register a Change of Control Company Notice describing the occurrence
of the Change of Control and of the repurchase right set forth herein arising as
a result thereof, as well as stating the final date by which the Securities must
be surrendered for repurchase, the Conversion Price then in effect, the Change
of Control Purchase Date, the Change of Control Purchase Price and the procedure
which the Holder must follow to elect repurchase. The Company shall also cause a
copy of such notice of the repurchase right to be published in a newspaper of
general circulation in the Borough of Manhattan, The City of New York.

                  No failure of the Company to give the foregoing notices or
defect therein shall limit any Holder's right to exercise a repurchase right or
affect the validity of the proceedings for the repurchase of Securities.

                  If any of the Securities is in the form of a Global Security,
then the Company shall modify the notice and delivery requirements to the extent
necessary to accord with the procedures of the Depositary applicable to the
repurchase of Global Securities.

                  (c) To elect repurchase of any Securities or portion thereof
upon a Change of Control, the Holder will be required to surrender, on or before
the Final Surrender Date, (i) in the case of global Securities, to the
Conversion Agent by book-entry delivery of the interest in the Security in
global form to be repurchased, or (ii) in the case of definitive Securities, at
any place where principal is payable, such Security duly endorsed or assigned to
the Company or in blank, in any event together with written notice of the
Holder's election to have the Company repurchase all or any $1,000 portion of
such Security specified in such notice. Election of repurchase by a Holder shall
be irrevocable (unless the Company defaults in payment of the Change of Control
Purchase Price for the Securities on the Change of Control Purchase Date) and
the right to convert the Securities as to which such Holder has made such
election shall expire when such Securities are so surrendered (unless the
Company defaults in payment of the Change of Control Purchase Price for the
Securities on the Change of Control Purchase Date and such election is revoked).

                  (d) In the event a repurchase right shall be exercised in
accordance with the terms hereof, the Company shall pay or cause to be paid the
Change of Control Purchase Price in cash to the Holder on

                                      -23-
<PAGE>

the Change of Control Purchase Date; provided, however, that, if the Change of
Control Purchase Date is on or after a record date but on or prior to the
related interest payment date, interest will be payable to the Holders in whose
names the Securities are registered at the close of business on the relevant
record date.

                  (e) If any Security surrendered for repurchase shall not be so
paid on the Change of Control Purchase Date, the principal amount which is
payable at maturity shall, until the Change of Control Purchase Price is paid,
continue to bear interest from the Change of Control Purchase Date at the rate
borne by the Security and each such Security shall continue to remain
convertible into Common Stock until said Change of Control Purchase Price shall
have been paid to the Holder or duly provided for by deposit with the Paying
Agent in immediately available funds without restriction.

                  (f) Any Security which is to be repurchased only in part shall
be surrendered to the Trustee (with, if the Company or the Trustee so requires,
due endorsement by, or a written instrument of transfer in form satisfactory to
the Company and the Trustee duly executed by, the Holder thereof or his attorney
duly authorized in writing), and the Company shall execute, and the Trustee
shall authenticate and deliver to the Holder without service charge, a new
Security or Securities, of any authorized denomination as requested by such
Holder in aggregate principal amount equal to and in exchange for the
unrepurchased portion of the principal of the Security so surrendered.

                  (g) The Company shall comply, to the extent applicable, with
the requirements of Sections 13 and 14 of the Exchange Act and any other
securities laws or regulations in connection with the repurchase of Securities
pursuant to this Section. To the extent that the provisions of any securities
laws or regulations conflict with provisions of this Section, the Company shall
comply with the applicable securities laws and regulations and shall not be
deemed to have breached its obligations under this Section by virtue of its
compliance with such securities laws or regulations.

                                    ARTICLE 5

                                    COVENANTS

                  SECTION 5.01. Payment of Securities. The Company shall pay the
principal of and premium, if any, and interest on, and Purchase Price and Change
of Control Purchase Price, if any, of the Securities on the dates and in the
manner provided in the Securities and this Indenture. Principal, premium, if
any, Purchase Price and Change of Control Purchase Price, if any, and interest
shall be considered paid on the date due if the Paying Agent (other than the
Company) holds on that date money sufficient to pay all principal, premium, if
any, and interest then due and that is immediately available on such date for
payment to the Holders and that is not subject to restriction.

                  The Company shall pay interest on overdue principal and
premium, if any, at the rate per annum borne by the Securities; it shall pay
interest on overdue installments of interest at the same rate per annum to the
extent lawful.

                  SECTION 5.02. SEC Reports. The Company shall file with the
Trustee within 15 days after the Company is required to file them with the SEC
copies of the annual reports and the information, documents and other reports
(or copies of such portions of any of the foregoing as the SEC may by rules and
regulations prescribe) which the Company is required to file with the SEC
pursuant to Section 13 or 15(d) of the Exchange Act (as defined in Section
4.05). Notwithstanding that the Company may not be required to remain subject to
the reporting requirements of Section 13 or 15(d) of the Exchange Act, the
Company shall file with the SEC (unless the SEC will not accept such a filing)
and provide the Trustee and Securityholders with the annual reports and the
information, documents and other reports as are specified in Sections 13 and
15(d) of the Exchange Act and applicable to a U.S. corporation subject to

                                      -24-
<PAGE>

such Sections, such information, documents and other reports to be so filed and
provided at the times specified for the filing of such information, documents
and reports under such Sections. The Company also shall comply with the other
provisions of TIA ss. 314(a).

                  Delivery of such reports, information and documents to the
Trustee if for informational purposes only and the Trustee's receipt of such
shall not constitute constructive notice of any information contained therein or
determinable from information contained therein, including the Company's
compliance with any of its covenants hereunder (as to which the Trustee is
entitled to rely exclusively on Officers' Certificates).

                  SECTION 5.03. Compliance Certificate. The Company shall
deliver to the Trustee within 120 days after the end of each fiscal year of the
Company a brief certificate from the principal executive officer, principal
financial officer or principal accounting officer as to his or her knowledge of
the Company's compliance with all conditions and covenants under this Indenture.
For purposes of this Section 5.03, such compliance shall be determined without
regard to any period of grace or requirement of notice provided under this
Indenture. The first certificate pursuant to this Section shall be for the year
ending on December 31, 2002.

                  SECTION 5.04. Corporate Existence. Subject to Article 6, the
Company will do or cause to be done all things necessary to preserve and keep in
full force and effect its corporate existence, rights (charter and statutory)
and franchise; provided, however, that the Company shall not be required to
preserve any such right or franchise if the Board of Directors shall determine
that the preservation thereof is no longer desirable in the conduct of the
business of the Company and that the loss thereof is not disadvantageous in any
material respect to the Holders.

                  SECTION 5.05. Notice of Defaults. In the event that the
Company fails to make any payment in an amount in excess of $50,000,000 when
due, after any applicable grace period, in respect of indebtedness for borrowed
money of the Company or if indebtedness for borrowed money of the Company in an
amount in excess of $50,000,000 is accelerated because of the occurrence of any
default under such indebtedness, the Company will promptly give written notice
to the Trustee of such failure or acceleration, as the case may be, or of the
occurrence of an event which, with the giving of notice or the passage of time,
or both, would entitle the holder or holders of such indebtedness to declare
such indebtedness due and payable before its maturity.

                  SECTION 5.06. Further Instruments and Acts. Upon request of
the Trustee, the Company will execute and deliver such further instruments and
do such further acts as may be reasonably necessary or proper to carry out more
effectively the purposes of this Indenture.

                  SECTION 5.07. Resale of Certain Securities. During the period
beginning on the last date of original issuance of the Securities and ending on
the date that is two years from such date, the Company will not, and will use
its best efforts not to permit any of its "affiliates" (as defined under Rule
144 under the Securities Act or any successor provision thereto) to, resell (x)
any Securities which constitute "restricted securities" under Rule 144 or (y)
any securities into which the Securities have been converted under this
Indenture which constitute "restricted securities" under Rule 144, that in
either case have been reacquired by any of them. The Trustee shall have no
responsibility in respect of the Company's performance of its agreement in the
preceding sentence.

                  SECTION 5.08. Restriction on Secured Debt. After the date
hereof, the Company will not, and will not cause or permit a Restricted
Subsidiary to, create, incur, assume or guarantee, any Secured Debt (including
the creation of Secured Debt by the securing of existing indebtedness) without
first making effective provision (and the Company covenants that in such case it
will first make or cause

                                      -25-
<PAGE>

to be made effective provision) whereby the Securities then outstanding and any
other indebtedness of or guaranteed by the Company or such Restricted Subsidiary
then entitled thereto shall be secured equally and ratably with (or prior to)
any and all other obligations and indebtedness thereby secured, so long as any
such other obligations and indebtedness shall be so secured; provided that the
foregoing covenants shall not be applicable to Secured Debt secured solely by
one or more of the following Security Interests:

                  (a) Any Security Interest upon any property which is a parcel
of real property, a manufacturing plant, a warehouse or an office building and
which is hereafter acquired, constructed, developed or improved by the Company
or a Restricted Subsidiary, which Security Interest is created prior to or
contemporaneously with, or within 120 days after, (1) in the case of the
construction, development or improvement of such property, the later to occur of
the completion of such construction, development or improvement or the
commencement of operation, use of commercial production (exclusive of test and
start-up periods) of the property, which Security Interest secures or provides
for the payment of all or any part of the acquisition cost of such property or
the cost of construction, development or improvement thereof, as the case may
be; (2) the acquisition by the Company or a Restricted Subsidiary of property
subject to any Security Interest upon such property existing at the time of the
acquisition thereof, which Security Interest secures obligations assumed by the
Company or a Restricted Subsidiary; (3) any conditional sales agreement or other
title retention agreement with respect to any property acquired by the Company
or a Restricted Subsidiary; (4) any Security Interest existing on the property
or on the outstanding shares or indebtedness of a corporation or firm at the
time such corporation or firm shall become a Restricted Subsidiary or is merged
into or consolidated with the Company or a Restricted Subsidiary; or (5) any
Security Interest existing on property of a corporation or firm at the time of a
sale, lease or other disposition of such property of a corporation or firm as an
entirety or substantially as an entirety to the Company or a Restricted
Subsidiary; provided in each case that any such Security Interest described in
clauses (2), (3), (4) or (5) does not attach to or affect property owned by the
Company or such Restricted Subsidiary prior to the event referred to in such
clauses;

                  (b) Any Security Interest to secure indebtedness of a
Restricted Subsidiary to the Company or to another Restricted Subsidiary;

                  (c) Mechanics', materialmen's, carriers' or other like liens
arising in the ordinary course of business (including construction of
facilities) in respect of obligations which are not due or which are being
contested in good faith;

                  (d) Any Security Interest arising by reason of deposits with,
or the giving of any form of security to, any governmental agency or any body
created or approved by law or governmental requisitions, which is required by
law or governmental requisition as a condition to the transaction of any
business, or the exercise of any privilege, franchise or license;

                  (e) Security Interests for taxes, assessments or governmental
charges or levies not yet delinquent or Security Interests for taxes,
assessments or governmental charges or levies already delinquent but the
validity of which is being contested in good faith;

                  (f) Security Interests (including judgment liens) arising in
connection with legal proceedings so long as such proceedings are being
contested in good faith and, in the case of judgment liens, execution thereon is
stayed;

                  (g) Landlords' liens on fixtures located on premises leased by
the Company or a Restricted Subsidiary in the ordinary course of business;

                                      -26-
<PAGE>

                   (h) Any Security Interest that secures an obligation issued
by the United States of America or any state, territory or possession of the
United States, or any political subdivision of any of the foregoing, or the
District of Columbia, in connection with the financing of the cost of the
construction or acquisition of a Principal Facility or a part thereof;

                  (i) Any Security Interest arising by reason of deposits to
qualify the Company or a Restricted Subsidiary to conduct business, to maintain
self-insurance, or to obtain the benefit of, or comply with, laws;

                  (j) The extension of any Security Interest existing as of the
date of this Indenture on a Principal Facility to additions, extensions or
improvements thereto and not as the result of borrowing money or the securing of
indebtedness incurred after that date;

                  (k) Security Interests securing any debt up to $1.0 billion
plus related interest and fees to be incurred in the future under one or more
senior secured credit facilities; or

                  (l) Any extension, renewal or refunding (or successive
extensions, renewals or refunding) in whole or in part of any Secured Debt
secured by any Security Interest referred to in the foregoing subparagraphs (a)
through (k), inclusive, provided that the principal amount of such Secured Debt
secured thereby shall not exceed the principal amount outstanding immediately
prior to such extension, renewal or refunding, and that the Security Interest
securing such Secured Debt shall be limited to the property which, immediately
prior to such extension, renewal or refunding, secured such Secured Debt and
additions to such property.

                  Notwithstanding the foregoing provisions of this Section 5.08,
the Company and any one or more Restricted Subsidiaries may create, incur,
assume or guarantee Secured Debt (not including Secured Debt permitted to be
secured under subparagraphs (a) through (l), inclusive, above), without equally
and ratably securing the Securities, in an aggregate amount which, together with
all other Secured Debt (not including Secured Debt permitted to be secured under
subparagraphs (a) though (l), inclusive above) of the Company and its Restricted
Subsidiaries which is created, incurred, assumed or guaranteed after the date
hereof and the aggregate value or all Sale and Leaseback Transactions entered
into after the date hereof (not including Sale and Leaseback Transactions
referred to in clause (b) of Section 5.09), does not at the time exceed 5% of
Consolidated Net Tangible Assets. The term "value" shall mean, with respect to a
Sale and Leaseback Transaction, as of any particular time, the present value
(discounted at the rate of interest implicit in the lease involved in such Sale
and Leaseback Transaction, as determined in good faith by the Company) of the
obligation of the lessee thereunder for rental payments (excluding any amounts
required to be paid by such lessee, whether or not designated as rent or
additional rent on account of maintenance and repairs, insurance, taxes,
assessments, water rates or similar charges or any amounts required to be paid
by such lessee thereunder contingent upon the amount of sales, maintenance and
repairs, insurance, taxes, assessments, water rates or similar charges) during
the remaining term of such lease (including any period for which such lease has
been extended or may, at the option of the lessor, be extended).

                  SECTION 5.09. Restriction on Sale and Leaseback Transactions.
After the date hereof, the Company will not, and will not permit any Restricted
Subsidiary to, enter into any Sale and Leaseback Transaction, unless (a) the
Company or such Restricted Subsidiary would be entitled to incur Secured Debt
only by reason of the last paragraph of Section 5.08 equal in amount to the
value of the Sale and Leaseback Transaction without equally and ratably securing
the Securities as provided in said Section or (b) the Company or a Restricted
Subsidiary shall apply, within one year after the effective date of such sale or
transfer, or shall have committed within one year after such effective date to
apply, an amount at least equal to the net proceeds of the sale of the property
sold or transferred or to be sold or to be

                                      -27-
<PAGE>

transferred pursuant to such Sale and Leaseback Transaction to (1) the
acquisition, construction, development or improvement of properties, facilities
or equipment which are, or, upon such acquisition, construction development or
improvement will be, a Principal Facility or a part thereof or (2) the optional
redemption of Securities in accordance with the provisions of Article 3 and at
the redemption price applicable at the time of such redemption, or to the
repayment of Superior Indebtedness of the Company or of any Restricted
Subsidiary (other than Superior Indebtedness owed to the Company or any
Restricted Subsidiary), or in part to such acquisition, construction,
development or improvement and in part so such redemption or repayment; provided
that in lieu of applying an amount equal to all or part of such net proceeds to
such redemption, the Company may, within one year after such sale or transfer,
deliver to the Trustee Securities (other than Securities made the basis of a
reduction in any mandatory sinking fund payment provisions contained in any
series of Securities) for cancellation and thereby reduce the amount to be
applied to the redemption of Securities pursuant to clause (2) above by an
amount equal to the aggregate principal amount of Securities so delivered.
Securities redeemed or delivered to the Trustee for cancellation pursuant to
this Section 5.09 shall not be used as credits against mandatory sinking fund
payments.

                  SECTION 5.10. Restriction on Transfer of Principal Facility to
Unrestricted Subsidiaries. After the date hereof, the Company will not itself,
and will not cause or permit any Restricted Subsidiary to, transfer (whether by
merger, consolidation or otherwise) any Principal Facility to any other
Subsidiary, unless it shall apply, within one year after the effective date of
such transaction, or shall have committed within one year after such effective
date to apply, an amount equal to the fair value of such Principal Facility at
the time of such transfer, as determined by the Board of Directors (evidenced by
a Board Resolution), to (a) the acquisition, construction, development or
improvement of properties, facilities or equipment which are, or, upon such
acquisition, construction, development or improvement will be, a Principal
Facility or a part thereof or (b) the optional redemption of Securities in
accordance with the provisions of Article 3 and at the redemption price
applicable at the time of such redemption or to the repayment of Superior
Indebtedness of the Company or of any Restricted Subsidiary (other than Superior
Indebtedness owed to the Company or any Restricted Subsidiary), or in part to
such acquisition, construction, development or improvement and in part such
redemption or repayment; provided that in lieu of applying an amount equivalent
to all or any part of such fair value to such redemption, the Company may,
within one year after such transfer, deliver to the Trustee Securities (other
than Securities made the basis of a reduction in any mandatory sinking fund
payment provisions contained in any series of Securities) for cancellation and
thereby reduce the amount to be applied to the redemption of Securities pursuant
to clause (b) above by an amount equal to the aggregate principal amount of
Securities so delivered. Securities redeemed or delivered to the Trustee for
cancellation pursuant to this Section 5.10 shall not be used as credits against
mandatory sinking fund payments.

                  SECTION 5.11. Future Guarantors. The Company shall cause each
domestic Subsidiary organized or acquired after the date on which the Securities
are originally issued to execute and deliver to the Trustee a Guaranty Agreement
pursuant to which such Subsidiary shall guarantee payment of the Securities on
the same terms and conditions as those set forth in Article 12.

                                    ARTICLE 6

                                   SUCCESSORS

                  SECTION 6.01. When Company May Merge, Etc. (a) The Company
shall not consolidate or merge with or into, or sell, lease, convey or otherwise
dispose of all or substantially all of its assets to, any Person and the Company
shall not permit any Person to merge into the Company unless:

                                      -28-
<PAGE>

                  (1) the Company is the surviving person or that Person is a
         corporation organized under the laws of the United States, any state
         thereof or the District of Columbia or a corporation or comparable
         legal entity organized under the laws of a foreign jurisdiction and
         whose equity securities are listed on a national securities exchange in
         the United States or authorized for quotation on the Nasdaq National
         Market;

                  (2) that Person assumes by supplemental indenture executed and
         delivered to the Trustee, in form satisfactory to the Trustee, all the
         obligations of the Company under the Securities and this Indenture,
         except that it need not assume the obligations of the Company as to
         conversion of Securities if pursuant to Section 11.17 the Company or
         another Person enters into a supplemental indenture obligating it to
         deliver securities, cash or other assets upon conversion of Securities;

                  (3) immediately after giving effect to such transaction, no
         Default shall have occurred and be continuing; and

                  (4) each of the predecessor Company and the successor Company
         has delivered to the Trustee an Officers' Certificate and an Opinion of
         Counsel, each stating that such consolidation, merger, transfer or
         lease and such supplemental indenture comply with this Article and that
         all conditions precedent herein provided for related to such
         transaction have been complied with.

                  The surviving, transferee or lessee corporation shall be the
successor Company, but the predecessor Company in the case of a transfer or
lease shall not be released from the obligation to pay the principal amount or
Purchase Price or Change of Control Purchase Price of and premium, if any, and
interest on the Securities.

                  (b) The Company shall not permit any Subsidiary Guarantor to
consolidate or merge with or into, or sell, lease, convey or otherwise dispose
of all or substantially all of its assets to, any Person and the Company shall
not permit any Person to merge into a Subsidiary Guarantor unless:

                  (1) the Subsidiary Guarantor is the surviving person or that
         Person is a corporation organized under the laws of the United States,
         any state thereof or the District of Columbia;

                  (2) that Person assumes by a Guaranty Agreement executed and
         delivered to the Trustee, in form satisfactory to the Trustee, all the
         obligations of such Subsidiary Guarantor under the Securities and this
         Indenture;

                  (3) immediately after giving effect to such transaction, no
         Default shall have occurred and be continuing; and

                  (4) each of the predecessor Subsidiary Guarantor and the
         successor Subsidiary Guarantor has delivered to the Trustee an
         Officers' Certificate and an Opinion of Counsel, each stating that such
         consolidation, merger, transfer or lease and such supplemental
         indenture comply with this Article and that all conditions precedent
         herein provided for related to such transaction have been complied
         with;

provided, however, that this clause (b) shall not be applicable if, in
connection with such transaction, the Subsidiary Guarantor shall be released
from its obligations under its Subsidiary Guaranty pursuant to Article 12 or any
comparable provision contained in a Guaranty Agreement.

                                      -29-
<PAGE>

                                    ARTICLE 7

                              DEFAULTS AND REMEDIES

                  SECTION 7.01. Events of Default. An "Event of Default" occurs
if:

                  (1) the Company defaults in the payment of interest on any
         Security when the same becomes due and payable and the Default
         continues uncured for a period of 30 days;

                  (2) the Company defaults in the payment of (A) principal of or
         premium, if any, on any Security when the same becomes due and payable,
         whether at maturity, upon redemption or otherwise, or (B) the Purchase
         Price or Change of Control Purchase Price in respect of any Security
         when due;

                  (3) the Company fails to comply with any of its other
         covenants or agreements set forth in this Indenture and the Default
         continues for a period of 60 days after the written notice specified
         below;

                  (4) the Company fails to make any payment when due, including
         any applicable grace period, in respect of indebtedness for borrowed
         money of the Company, which payment is in an amount in excess of
         $50,000,000, or the Company defaults with respect to any indebtedness
         for borrowed money of the Company, which default results in
         acceleration of any such indebtedness which is in an amount of in
         excess of $50,000,000;

                  (5) the Company pursuant to or within the meaning of any
         Bankruptcy Law (as defined below):

                                    (A) commences a voluntary case;

                                    (B) consents to the entry of an order for
                  relief against it in an involuntary case;

                                    (C) consents to the appointment of a
                  Custodian (as defined below) of it or for all or substantially
                  all of its property; or

                                    (D) makes a general assignment for the
                  benefit of its creditors;

                  (6) a court of competent jurisdiction enters an order or
         decree under any Bankruptcy Law that:

                                    (A) is for relief against the Company in an
                  involuntary case;

                                    (B) appoints a Custodian of the Company or
                  for all or substantially all of its property; or

                                    (C) orders the liquidation of the Company,

         and the order or decree remains unstayed and in effect for 90
         consecutive days; or

                  (7) any Subsidiary Guarantor ceases to be in full force and
         effect (other than in accordance with its terms) or a Subsidiary
         Guarantor denies or disaffirms its obligations under its Subsidiary
         Guaranty.

                                      -30-
<PAGE>

                  The term "Bankruptcy Law" means Title 11, U.S. Code or any
         similar federal or state law for the relief of debtors. The term
         "Custodian" means any receiver, trustee, assignee, liquidator or
         similar official under any Bankruptcy Law.

                  A Default under clause (3) above is not an Event of Default
until the Trustee or the Holders of at least 25% in principal amount of the
Securities notify the Company in writing of the Default and the Company does not
cure the Default within 60 days after receipt of the notice. The notice must
specify the Default, demand that it be remedied and state that the notice is a
"Notice of Default." When a Default is cured, it ceases to exist.

                  SECTION 7.02. Acceleration. If any Event of Default (other
than an Event of Default with respect to the Company described in section
7.01(5) or 7.01(6)) occurs and is continuing, the Trustee, by written notice to
the Company, or the Holders of at least 25% in aggregate principal amount of the
outstanding Securities, by written notice to the Company and the Trustee, may
declare the principal of and accrued interest on all Securities to be due and
payable. Upon such declaration such principal and interest shall be due and
payable immediately. If any Event of Default described in Section 7.01(5) or (6)
with respect to the Company occurs, the principal of and accrued interest on all
Securities shall automatically become due and payable, without any action
required of the Trustee or the Holders. The Holders of a majority in principal
amount of the Securities by notice to the Trustee may rescind an acceleration
and its consequences if all existing Events of Default have been cured or waived
except nonpayment of principal or interest that has become due solely because of
the acceleration, if the rescission would not conflict with any judgment or
decree of a court of competent jurisdiction, and if all payments (including fees
and expenses) due to the Trustee have been paid.

                  SECTION 7.03. Other Remedies. If an Event of Default occurs
and is continuing, the Trustee may pursue any available remedy to collect the
payment of principal or the Purchase Price or Change of Control Purchase Price
of or premium, if any, or interest on the Securities or to enforce the
performance of any provision of the Securities or this Indenture.

                  The Trustee may maintain a proceeding even if the Trustee does
not possess any of the Securities or does not produce any of them in the
proceeding. A delay or omission by the Trustee or any Securityholder in
exercising any right or remedy accruing upon an Event of Default shall not
impair the right or remedy or constitute a waiver of or acquiescence in the
Event of Default. To the extent permitted by law, no remedy is exclusive of any
other remedy and all remedies are cumulative.

                  SECTION 7.04. Waiver of Past Defaults. The Holders of a
majority in aggregate principal amount of the Securities by written notice to
the Trustee may waive an existing Default and its consequences except a Default
in the payment of the principal of or premium, if any, or interest on any
Security or a Default under Article 11. When a Default is waived, it is cured
and ceases to exist. This Section 7.04 shall be in lieu of TIA ss. 316(a)(1)(B),
and TIA ss. 316(a)(1)(B) is hereby expressly excluded from this Indenture and
Section, as permitted by the TIA.

                  SECTION 7.05. Control by Majority. The Holders of a majority
in aggregate principal amount of the Securities may direct the time, method and
place of conducting any proceeding for any remedy available to the Trustee or
exercising any trust or power conferred on it. However, the Trustee may refuse
to follow any direction that conflicts with law or this Indenture, is unduly
prejudicial to the rights of another Securityholder, or would expose the Trustee
to liability or expense for which it has not been offered reasonably
satisfactory indemnity. This Section 7.05 shall be in lieu of TIA ss.
316(a)(1)(A), and TIA ss. 316(a)(1)(A) is hereby expressly excluded from this
Indenture and Section, as permitted by the TIA.

                                      -31-
<PAGE>

                  SECTION 7.06. Limitation on Suits. A Securityholder may pursue
any remedy with respect to this Indenture or the Securities only if:

                  (1) the Holder gives to the Trustee written notice of a
         continuing Event of Default;

                  (2) the Holders of at least 25% in principal amount of the
         Securities make a written request to the Trustee to pursue the remedy;

                  (3) such Holder or Holders offer to the Trustee indemnity
         satisfactory to the Trustee against any loss, liability or expense to
         be, or which may be, incurred by the Trustee in pursuing the remedy;

                  (4) the Trustee does not comply with the request within 60
         days after receipt of the request and the offer of indemnity; and

                  (5) during such 60-day period the Holders of a majority in
         principal amount of the Securities do not give the Trustee a direction
         inconsistent with the request.

A Securityholder may not use this Indenture to prejudice the rights of another
Securityholder or to obtain a preference or priority over another
Securityholder.

                  SECTION 7.07. Rights of Holders to Receive Payment.
Notwithstanding any other provision of this Indenture, the right of any Holder
to receive payment of the principal of and premium, if any, and interest on the
Security on or after the respective due dates expressed in the Security, and to
convert such Security in accordance with Article 11, or to bring suit for the
enforcement of any such payment on or after such respective due dates and such
right to convert, is absolute and unconditional and shall not be impaired or
affected without the consent of the Holder.

                  SECTION 7.08. Collection Suit by Trustee. If an Event of
Default specified in Section 7.01(1) or (2) occurs and is continuing, the
Trustee may recover judgment in its own name and as Trustee of an express trust
against the Company for the whole amount of principal, premium, if any, Purchase
Price or Change of Control Purchase Price, if any, and interest remaining unpaid
together with interest on overdue principal and premium, if any, and on the
principal amount of any Security for which the Purchase Price or Change of
Control Purchase Price is overdue, and, to the extent that payment of such
interest is lawful, interest on overdue installments of interest, in each case
at the rate per annum set forth in the title of the Securities.

                  SECTION 7.09. Trustee May File Proofs of Claim. The Trustee
may file such proofs of claim and other papers or documents as may be necessary
or advisable in order to have the claims of the Trustee and the Securityholders
allowed in any judicial proceeding relative to the Company, its creditors or its
property.

                  Nothing herein contained shall be deemed to authorize the
Trustee to authorize or consent to or accept or adopt on behalf of any
Securityholder any plan of reorganization, arrangement, adjustment or
composition affecting the Securities or the rights of any Holder thereof, or to
authorize the Trustee to vote in respect of the claim of any Securityholder in
any such proceedings.

                  SECTION 7.10. Priorities. If the Trustee collects any money or
property pursuant to this Article 7, it shall pay out the money or property in
the following order:

                                      -32-
<PAGE>

                  First: to the Trustee for amounts due under Section 8.07 or
         any other provision of this Indenture;

                  Second: to Securityholders for amounts due and unpaid on the
         Securities for principal, premium, if any, Purchase Price or Change of
         Control Purchase Price, if any, and interest, ratably, without
         preference or priority of any kind, according to the amounts due and
         payable on the Securities for principal, premium, if any, Purchase
         Price or Change of Control Purchase Price, if any, and interest,
         respectively; and

                  Third: to the Company.

                  The Trustee may fix a record date and payment date for any
payment to Securityholders pursuant to this Section 7.10.

                  SECTION 7.11. Undertaking for Costs. In any suit for the
enforcement of any right or remedy under this Indenture or in any suit against
the Trustee for any action taken or omitted by it as Trustee, a court in its
discretion may require the filing by any party litigant in the suit of an
undertaking to pay the costs of the suit, and the court in its discretion may
assess reasonable costs, including reasonable attorneys' fees, against any party
litigant in the suit, having due regard to the merits and good faith of the
claims or defenses made by the party litigant. This Section does not apply to a
suit by the Trustee, a suit by a Holder pursuant to Section 7.07, or a suit by a
Holder or Holders of more than 10% in aggregate principal amount of the
Securities then outstanding.

                                    ARTICLE 8

                                     TRUSTEE

                  SECTION 8.01. Duties of Trustee. (a) If to the knowledge of
the Trustee an Event of Default has occurred and is continuing, the Trustee
shall exercise such of the rights and powers vested in it by this Indenture and
use the same degree of care and skill in their exercise as a prudent person
would exercise or use under the circumstances in the conduct of his own affairs.

                  (b)  Except during the continuance of an Event of Default:

                  (1) the Trustee need perform only those duties that are
         specifically set forth in this Indenture and no others; and

                  (2) in the absence of bad faith on its part, the Trustee may
         conclusively rely, as to the truth of the statements and the
         correctness of the opinions expressed therein, upon certificates or
         opinions furnished to the Trustee and conforming to the requirements of
         this Indenture. However, the Trustee shall examine the certificates and
         opinions to determine whether or not they conform to the requirements
         of this Indenture, but need not verify the accuracy of the contents
         thereof.

                  (c) The Trustee may not be relieved from liability for its own
negligent action, its own negligent failure to act, or its own willful
misconduct, except that:

                  (1) this paragraph does not limit the effect of paragraph (b)
         of this Section;

                                      -33-
<PAGE>

                   (2) the Trustee shall not be liable for any error of judgment
         made in good faith by a Responsible Officer, unless it is proved that
         the Trustee was negligent in ascertaining the pertinent facts;

                   (3) the Trustee shall not be liable with respect to any
         action it takes or omits to take in good faith in accordance with a
         direction received by it pursuant to Section 7.05; and

                   (4) no provision of this Indenture shall require the Trustee
         to expend or risk its own funds or otherwise incur any financial
         liability in the performance of any of its duties hereunder, or in the
         exercise of any of its rights or powers, if it shall have reasonable
         grounds for believing that repayment of such funds or adequate
         indemnity against such risk or liability is not reasonably assured to
         it.

                  (d) Every provision of this Indenture that in any way relates
to the Trustee is subject to paragraphs (a), (b) and (c) of this Section.

                  (e) The Trustee shall not be liable for interest on any money
received by it except as the Trustee may agree with the Company. Money held in
trust by the Trustee need not be segregated from other funds except to the
extent required by law and need not be invested except as agreed to by the
Trustee.

                  SECTION 8.02. Rights of Trustee. Subject to Section 8.01:

                  (a) the Trustee may conclusively rely on any document believed
         by it to be genuine and to have been signed or presented by the proper
         person. The Trustee need not investigate any fact or matter stated in
         the document;

                  (b) before the Trustee acts or refrains from acting, it may
         require an Officers' Certificate or an Opinion of Counsel. The Trustee
         shall not be liable for any action it takes or omits to take in good
         faith in reliance on such Officers' Certificate or Opinion of Counsel;

                  (c) the Trustee may act through agents and shall not be
         responsible for the misconduct or negligence of any agent appointed
         with due care;

                  (d) the Trustee shall not be liable for any action it takes or
         omits to take in good faith which it believes to be authorized or
         within its rights or powers;

                  (e) the Trustee may consult with counsel of its selection, and
         the advice or opinion of such counsel as to matters of law shall be
         full and complete authorization and protection in respect of any action
         taken, omitted or suffered by it hereunder in good faith and in
         accordance with the advice or opinion of such counsel;

                  (f) the Trustee shall not be bound to ascertain or inquire as
         to the performance or observance of any covenants, conditions or
         agreements on the part of the Company under this Indenture; but the
         Trustee may require of the Company full information and advice as to
         the performance of the covenants, conditions and agreements aforesaid;

                  (g) the Trustee shall not be required to give any bond or
         surety in respect of the execution of its trusts and powers or in
         respect of this Indenture;

                                      -34-
<PAGE>

                  (h) the Trustee shall be under no obligation to exercise any
         of the rights or powers vested in it by this Indenture at the request
         or direction of any of the Holders pursuant to this Indenture, unless
         such Holders shall have offered to the Trustee security or indemnity
         satisfactory to the Trustee against the costs, expenses and liabilities
         which might be incurred by it in compliance with such request or
         direction;

                  (i) the Trustee shall not be deemed to have notice of any
         Default or Event of Default unless a Responsible Officer of the Trustee
         has actual knowledge thereof or unless written notice of any event
         which is in fact such a default is received by the Trustee at the
         Corporate Trust Office of the Trustee, and such notice references the
         Securities and this Indenture;

                  (j) the rights, privileges, protections, immunities and
         benefits given to the Trustee, including, without limitation, its right
         to be indemnified, are extended to, and shall be enforceable by, the
         Trustee in each of its capacities hereunder, and each agent, custodian
         and other Person employed to act hereunder; and

                  (k) the Trustee may request that the Company deliver an
         Officers' Certificate setting forth the names of individuals and/or
         titles of officers authorized at such time to take specified actions
         pursuant to this Indenture, which Officers' Certificate may be signed
         by any person authorized to sign an Officers' Certificate, including
         any person specified as so authorized in any such certificate
         previously delivered and not superseded.

                  SECTION 8.03. Individual Rights of Trustee. The Trustee in its
individual or any other capacity may become the owner or pledgee of Securities
and may otherwise deal with the Company or an Affiliate with the same rights the
Trustee would have if it were not Trustee. Any Agent may do the same with like
rights.

                  SECTION 8.04. Trustee's Disclaimer. The Trustee makes no
representation as to the validity or adequacy of this Indenture or the
Securities, shall not be accountable for the Company's use of the proceeds from
the sale of the Securities or the use or application of any money received by
any Paying Agent other than the Trustee, and shall not be responsible for any
statement in the Securities other than the Trustee's certificate of
authentication.

                  SECTION 8.05. Notice of Defaults. If a Default occurs and is
continuing and if it is known to the Trustee, the Trustee shall mail to each
Securityholder, at the name and address which appear in the Securities Register,
a notice of the Default within 90 days after the Default occurs. Except in the
case of a Default in payment of the principal of or premium, if any, or interest
on any Security, the Trustee may withhold the notice if and so long as its board
of directors, the executive committee, or a trust committee of its directors
and/or responsible officers in good faith determines that withholding the notice
is in the interests of Securityholders. The Trustee shall not be deemed to have
notice of any Default or Event of Default other than as described in clauses (1)
or (2) of Section 7.01 unless it shall have received written notice thereof from
the Company or any Securityholder, or a Responsible Officer has actual knowledge
thereof. The foregoing sentence of this Section 8.05 shall be in lieu of the
proviso to TIA ss. 315(b), and such proviso to TIA ss. 315(b) is hereby
expressly excluded from this Indenture and Section, as permitted by the TIA.

                  SECTION 8.06. Reports by Trustee to Holders. If required by
TIA ss. 313(a), within 60 days after each May 15 beginning with the May 15
following the date of this Indenture, the Trustee shall mail to each
Securityholder a report dated as of such May 15 that complies with TIA ss.
313(a). The Trustee also shall comply with TIA ss. 313(b), (c) and (d).

                                      -35-
<PAGE>

                  A copy of each such report at the time of its mailing to
Securityholders shall also be mailed to the Company and shall be filed with the
SEC and each stock exchange, if any, on which the Securities are listed.

                  The Company shall promptly notify the Trustee in writing if
the Securities become listed on any stock exchange or of any delisting thereof.

                  SECTION 8.07. Compensation and Indemnity. The Company shall
from time to time pay to the Trustee such compensation for its services as the
Company and the Trustee shall agree on in writing. The Trustee's compensation
shall not be limited by any law on compensation of a trustee of an express
trust. The Company shall reimburse the Trustee, within 30 days after receiving
request therefor, for all reasonable disbursements, fees and expenses incurred
by the Trustee in connection with the performance of its duties under this
Indenture, including without limitation those incurred in connection with the
enforcement of any remedy hereunder or the interpretation of any provision
hereunder. Such expenses may include the reasonable compensation and expenses of
the Trustee's agents and counsel. All rights, protections and benefits of the
Trustee shall extend to the Trustee acting as Conversion Agent, Paying Agent,
Registrar or other Agent with respect hereto.

                  The Company shall indemnify the Trustee and any predecessor
Trustee for, and hold it harmless against, any loss, damage, claim, liability or
expense (including taxes (other than taxes based upon, measured by or determined
by the income of the Trustee)) incurred by it in connection with this Indenture,
including the costs and expenses of defending itself against any claim (whether
asserted by the Company, any Holder or any other Person). The Trustee shall
promptly notify the Company of any claim for which the Trustee may seek
indemnity, including costs and expenses of defending itself against any claim
for liability arising from the exercise or performance of any of its powers or
duties hereunder.

                  The Company need not reimburse any expense or indemnify
against any loss or liability incurred by the Trustee through its negligence or
bad faith.

                  To secure the Company's payment obligations in this Section,
the Trustee shall have a lien prior to the Securities on all money or property
held or collected by the Trustee, except that held in trust to pay principal of,
premium, if any, and interest on particular Securities.

                  When the Trustee incurs expenses or renders services after an
Event of Default specified in Section 7.01(5) or (6) occurs, the expenses and
the compensation for such services are intended to constitute expenses of
administration under any Bankruptcy Law.

                  Notwithstanding any provision hereof to the contrary, the
Trustee's lien shall not be subordinated to that of Senior Indebtedness.

                  The provisions of this Section 8.07 shall survive the
termination of the Indenture or the resignation or removal of the Trustee.

                  SECTION 8.08. Replacement of Trustee. A resignation or removal
of the Trustee and appointment of a successor Trustee shall become effective
only upon the successor Trustee's acceptance of appointment as provided in this
Section.

                  The Trustee may resign by so notifying the Company. The
Holders of a majority in principal amount of the Securities may remove the
Trustee by so notifying the Trustee and the Company. The Company may remove the
Trustee if:

                                      -36-
<PAGE>

                  (1) the Trustee fails to comply with Section 8.10;

                  (2) the Trustee is adjudged a bankrupt or an insolvent;

                  (3) a receiver or other public officer takes charge of the
         Trustee or its property; or

                  (4) the Trustee becomes incapable of acting.

                  If the Trustee resigns or is removed or if a vacancy exists in
the office of Trustee for any reason, the Company shall promptly appoint a
successor Trustee. Within one year after the successor Trustee takes office, the
Holders of a majority in principal amount of the Securities may appoint a
successor Trustee to replace the successor Trustee appointed by the Company.

                  If a successor Trustee does not take office within 60 days
after the retiring Trustee resigns or is removed, the retiring Trustee, the
Company or the Holders of at least 10% in principal amount of the Securities may
petition any court of competent jurisdiction, in the case of the retiring
Trustee, at the expense of the Company for the appointment of a successor
Trustee.

                  If the Trustee fails to comply with Section 8.10, any
Securityholder or Beneficial Holder may petition any court of competent
jurisdiction for the removal of the Trustee and the appointment of a successor
Trustee.

                  A successor Trustee shall deliver a written acceptance of its
appointment to the retiring Trustee and to the Company. Thereupon the retiring
Trustee shall transfer all property held by it as Trustee to the successor
Trustee (subject to the lien provided for in Section 8.07), the resignation or
removal of the retiring Trustee shall become effective, and the successor
Trustee shall have all the rights, powers and duties of the Trustee under this
Indenture. The successor Trustee shall mail a notice of its succession to
Securityholders.

                  SECTION 8.09. Successor Trustee, Agents by Merger, Etc. If the
Trustee or any Agent consolidates with, merges or converts into, or transfers
all or substantially all of its corporate trust business to, another
corporation, the successor corporation without any further act shall be the
successor Trustee or Agent, as the case may be.

                  SECTION 8.10. Eligibility; Disqualification. This Indenture
shall always have a Trustee who satisfies the requirement of TIA ss.ss.
310(a)(1) and 310(a)(5). The Trustee (or in the case of a corporation included
in a bank holding company system, the related bank holding company) shall have a
combined capital and surplus of at least $100,000,000 as set forth in its most
recent published annual report of condition. In addition, if the Trustee is a
corporation included in a bank holding company system, the Trustee,
independently of such bank holding company, shall meet the capital requirements
of TIA ss. 310(a)(2). The Trustee shall comply with TIA ss. 310(b).

                  SECTION 8.11. Preferential Collection of Claims Against
Company. The Trustee shall comply with TIA ss. 311(a), excluding any creditor
relationship listed in TIA ss. 311(b). A Trustee who has resigned or been
removed shall be subject to TIA ss. 311(a) to the extent indicated therein.

                                      -37-
<PAGE>

                                    ARTICLE 9

                             DISCHARGE OF INDENTURE

                  SECTION 9.01. Termination of Company's Obligations. The
Company may terminate all of its obligations under this Indenture if all
Securities previously authenticated and delivered (other than destroyed, lost or
stolen Securities which have been replaced or paid or Securities for whose
payment money or securities have theretofore been held in trust and thereafter
repaid to the Company) have been delivered to the Trustee for cancellation and
the Company has paid all sums payable by it hereunder.

                  However, the obligations in Sections 2.03, 2.04, 2.05, 2.06,
2.07, 2.14, 5.01, 8.07 and 8.08 and in Article 11 shall survive until the
Securities are no longer outstanding. Thereafter the obligations in Section 8.07
shall survive.

                  After a termination of the Company's obligations in accordance
with this Section, the Trustee upon request shall acknowledge in writing the
discharge of the Company's obligations under this Indenture except for those
surviving obligations specified above.

                                   ARTICLE 10

                       AMENDMENTS, SUPPLEMENTS AND WAIVERS

                  SECTION 10.01. Without Consent of Holders. The Company and the
Trustee may amend or supplement this Indenture or the Securities without the
consent of any Securityholder:

                  (1) to cure any ambiguity, defect or inconsistency herein or
         in the Securities;

                  (2) to comply with Section 6.01;

                  (3) to make any change that does not materially adversely
         affect the rights of any Securityholder; or

                  (4) to make provision with respect to the conversion rights of
         Holders pursuant to the requirements of Section 11.17.

                  SECTION 10.02. With Consent of Holders. The Company and the
Trustee may amend or supplement this Indenture or the Securities with the
written consent of the Holders of at least a majority in aggregate principal
amount of the Securities, and the Holders of a majority in aggregate principal
amount of the Securities may waive compliance by the Company with any provision
of this Indenture or the Securities. However, without the consent of each
Securityholder affected, an amendment, supplement or waiver under this Section
may not:

                  (1) change the stated maturity date of the principal of, or
         interest on, any Security or adversely affect the right of a Holder to
         convert any Security;

                  (2) reduce the principal amount, Purchase Price or Change of
         Control Purchase Price of, or premium, if any, or interest on, any
         Security;

                                      -38-
<PAGE>

                  (3) change the currency for payment of principal of, Purchase
         Price of, Change of Control Purchase Price of or interest on, any
         Security;

                  (4) impair the right to institute suit for the enforcement of
         any payment on or with respect to any Security;

                  (5) reduce the principal amount of Securities whose Holders
         must consent to an amendment or supplement of this Indenture or the
         waiver of defaults or compliance hereunder;

                  (6) make any change in Section 7.04, 7.07 or this 10.02
         (second sentence); or

                  (7) make any change in any Subsidiary Guaranty that is in any
         manner adverse to the Holders of the Securities.

                  It shall not be necessary for the consent of the Holders under
this Section to approve the particular form of any proposed amendment,
supplement or waiver, but it shall be sufficient if such consent approves the
substance thereof. The Company may establish, by delivery of an Officers'
Certificate to the Trustee, a record date for determining Securityholders of
record entitled to give any consent or waiver.

                  After an amendment or supplement under this Section becomes
effective, the Company shall mail to Securityholders a notice briefly describing
the amendment or supplement. Any failure of the Company to mail any such notice,
or any defect therein, shall not, however, in any way impair or affect the
validity of any supplemental indenture.

                  SECTION 10.03. Compliance with Trust Indenture Act. Every
amendment to or supplement of this Indenture or the Securities shall comply with
the TIA as then in effect.

                  SECTION 10.04. Revocation and Effect of Consents. Until an
amendment, supplement or waiver becomes effective, a consent to it by a Holder
of a Security is a continuing consent by the Holder and every subsequent Holder
of a Security or portion of a Security that evidences the same debt as the
consenting Holder's Security, even if notation of the consent is not made on any
Security. However, any such Holder or subsequent Holder may revoke the consent
as to such Security or portion of a Security if a Responsible Officer of the
Trustee receives the notice of revocation before the date the amendment,
supplement or waiver becomes effective. An amendment, supplement or waiver
becomes effective in accordance with its terms and thereafter binds every
Securityholder. Notwithstanding the foregoing, if a record date has been
established for the purpose of determining Securityholders entitled to consent,
such written notice of revocation must be signed by the Securityholder of record
as of the record date or his duly appointed proxy.

                  SECTION 10.05. Notation on or Exchange of Securities. The
Trustee may place an appropriate notation relating to an amendment, supplement
or waiver on any Security thereafter authenticated. The Company in exchange for
all Securities may issue, and the Trustee shall authenticate, new Securities
that reflect the amendment, supplement or waiver.

                  SECTION 10.06. Trustee to Sign Amendments, Etc. In executing,
or accepting the additional trusts created by, any supplemental indenture
permitted by this Article or Section 11.15 or the modifications thereby of the
trusts created by this Indenture, the Trustee shall be entitled to receive, and
(subject to Section 8.01) shall be fully protected in relying upon, an Opinion
of Counsel and an Officers' Certificate stating that the execution of such
supplemental indenture is authorized or permitted by this Indenture.

                                      -39-
<PAGE>

                  The Trustee shall sign any amendment or supplement authorized
pursuant to this Article if the amendment or supplement does not adversely
affect the rights of the Trustee. If the amendment or supplement does adversely
affect the Trustee's rights, the Trustee may, but need not, sign it.

                                   ARTICLE 11

                                   CONVERSION

                  SECTION 11.01. Conversion Privilege. A Holder of a Security
may convert it into fully paid and non-assessable shares of Common Stock at any
time subject to the terms stated herein and in paragraph 8 of the Securities.
The number of shares issuable upon conversion of a Security is determined by
dividing the principal amount to be converted by the Conversion Price in effect
on the conversion date, and rounding the result to the nearest 1/l00th of a
share, with 500/1,000 of a share to be rounded up.

                  The initial Conversion Price is stated in paragraph 8 of the
Securities. The Conversion Price is subject to adjustment as provided in this
Article 11.

                  Upon receipt of a conversion notice from a Holder, the Company
shall direct the Conversion Agent, on the Company's behalf, to determine the
Quoted Price for the Common Stock. The Conversion Agent shall determine whether
the Securities are then eligible to be converted based solely on such Quoted
Prices for the relevant period, as provided in the first sentence of paragraph 8
of the Securities, and shall notify the Company and the Trustee accordingly. The
Conversion Agent shall have no liability for any determination made by it
hereunder in good faith, and, in the absence of manifest error, any such
determination by the Conversion Agent shall be binding on the Company, the
Trustee and the Holders. In all other cases, the Company shall determine and
advise the Conversion Agent and the Trustee in writing whether the Securities
are eligible for conversion, and the Conversion Agent and Trustee may
conclusively rely on any such determination by the Company.

                  A Holder may convert a portion of a Security if the portion is
$1,000 or a whole multiple of $1,000. Provisions of this Indenture that apply to
conversion of all of a Security also apply to conversion of a portion of it.

                  SECTION 11.02. Conversion Procedure. To convert a Security a
Holder must satisfy the requirements set forth in paragraph 8 of the Securities.
The first date on which the Holder satisfies all those requirements in respect
of a Security is the conversion date. As soon as practical on or after the
conversion date, the Company shall deliver through the Conversion Agent a
certificate for the number of full shares of Common Stock issuable upon the
conversion of that Security and a check for any fractional share. The person in
whose name the certificate is registered shall be treated as a shareholder of
record on and after the conversion date. Anything herein to the contrary
notwithstanding, in the case of Global Securities, conversion notices may be
delivered and such Securities may be surrendered for conversion in accordance
with the Applicable Procedures as in effect from time to time.

                  Except as provided in this paragraph, no Holder of a Security
will be entitled upon conversion of the Security to any actual payment or
adjustment on account of accrued and unpaid interest on the Security or on
account of dividends on shares of Common Stock issued in connection with the
conversion. If any Holder surrenders a Security for conversion between the close
of business on any record date for the payment of an installment of interest and
the opening of business on the related interest payment date, the Holder must
deliver payment to the Company of an amount equal to the interest payable on the
interest payment date on the principal amount converted together with the
Security being surrendered; provided, however, that no such payment is required
with respect to Securities called for redemption on a Redemption Date or subject
to a Change of Control Company Notice with a Final

                                      -40-
<PAGE>

Surrender Date within the period between the close of business on the interest
record date and interest payment date.

                  If a Holder converts more than one Security at the same time,
the number of full shares issuable upon the conversion shall be based on the
total principal amount of the Securities converted.

                  If Common Stock is to be issued in the name of a Person other
than the Holder thereof, and the restrictions on transfer of such Security set
forth in the first paragraph of the face of the Security remain in effect, the
Holder must provide certification regarding compliance with the restrictions on
transfer, by executing an assignment in the form attached to the Security.

                  Upon surrender of a Security that is converted in part, the
Company shall execute and the Trustee shall authenticate for the Holder a new
Security equal in principal amount to the unconverted portion of the Security
surrendered.

                  If the last day on which a Security may be converted is a
Legal Holiday in a place where a Conversion Agent is located, the Security may
be surrendered to that Conversion Agent on the next succeeding business day that
is not a Legal Holiday with the same force and effect as if surrendered on such
last day.

                  SECTION 11.03. Fractional Shares. The Company will not issue a
fractional share of Common Stock upon conversion of a Security. Instead the
Company will deliver to the converting Securityholder its check for the current
market value of the fractional share. The current market value of a fraction of
a share is determined by multiplying the current market price of a full share by
the fraction, and rounding the result to the nearest cent, with 0.5 cents to be
rounded up.

                  For purposes of this Section, the current market price of a
share of Common Stock is the Quoted Price of the Common Stock on the last
Trading Day prior to the conversion date.

                  SECTION 11.04. Taxes on Conversion. If a Holder of a Security
converts it, the Company shall pay any documentary, stamp or similar issue or
transfer tax due on the issue of shares of Common Stock upon the conversion.
However, the Holder shall pay any such tax which is due because the shares are
issued in a name other than such Holder's.

                  SECTION 11.05. Company to Provide Stock. The Company shall
reserve at all times and keep available, free from preemptive rights, out of its
authorized but unissued Common Stock, enough shares of Common Stock to permit
the conversion of the Securities.

                  All shares of Common Stock which may be issued upon conversion
of the Securities shall be fully paid and nonassessable.

                  The Company shall endeavor to comply with all applicable
securities laws regulating the offer and delivery of shares of Common Stock upon
conversion of Securities and shall endeavor to list such shares on each national
securities exchange on which the Common Stock is listed, or to have such shares
approved for quotation on the Nasdaq National Market or other over-the-counter
market on which the Common Stock is traded.

                  SECTION 11.06. Adjustment for Change in Capital Stock. If the
Company:

                  (1) issues any shares of its capital stock as a dividend (or
         other distribution) on its Common Stock;

                                      -41-
<PAGE>
                  (2) subdivides its outstanding shares of Common Stock into a
         greater number of shares;

                  (3) combines its outstanding shares of Common Stock into a
         smaller number of shares; or

                  (4) issues by reclassification of its Common Stock any shares
         of its capital stock,

                  then the conversion privilege and the Conversion Price in
effect immediately prior to such action shall be adjusted so that the Holder of
a Security thereafter converted will receive the number of shares of capital
stock of the Company that would have been received (and if there is more than
one class or series of such capital stock, then shares of each class or series
in the same proportions that would have been received) upon consummation of such
action by a holder of the number of shares of Common Stock into which such
Security might have been converted immediately prior to such action, with the
aggregate Conversion Price to be divided evenly among the shares to be issued
upon conversion thereof.

                  The adjustment described in the preceding paragraph shall
become effective immediately after the record date in the case of a dividend or
distribution and immediately after the effective date in the case of a
subdivision, combination or reclassification.

                  If, after an adjustment, a Holder of a Security may receive
shares of two or more classes or series of capital stock of the Company upon
conversion of such Security, the Company shall determine the allocation of the
adjusted Conversion Price between or among such classes or series of capital
stock. After such allocation, the conversion privilege and the Conversion Price
of each class of capital stock shall thereafter be subject to adjustment on
terms comparable to those applicable to Common Stock in this Article.

                  SECTION 11.07. Adjustment for Rights Issue. If the Company
distributes any rights or warrants to all holders of its Common Stock entitling
them to subscribe for or purchase shares of Common Stock at a price per share
less than the current market price per share (as defined in Section 11.11),
then, on the Record Date (as defined in this Section 11.07), the Conversion
Price shall be adjusted in accordance with the formula:

                                    O + (N x P)
                  AC = CC x              M
                                    -----------
                                       O + N

                  where:

                        AC =  the adjusted Conversion Price.

                        CC =  the current Conversion Price.

                        O  =  the number of shares of Common Stock outstanding
                              on the Record Date.

                        N  =  the number of additional shares of Common Stock
                              offered.

                        P  =  the offering price per share of the additional
                              shares.

                                      -42-
<PAGE>
                        M  =  the current market price per share of Common Stock
                              on the Record Date (as defined in this
                              Section 11.07).

                  The adjustment shall become effective immediately after the
record date for the determination of stockholders entitled to receive such
rights or warrants (for purposes of this Section 11.07 only, the "Record Date").

                  SECTION 11.08. Adjustment for Certain Distributions. Subject
to the last paragraph of this Section 11.08, if the Company distributes to all
holders of its Common Stock any cash, debt securities (or other evidences of
indebtedness) or other assets (excluding dividends or distributions for which
adjustment is required to be made under Sections 11.06, 11.07 or 11.09), the
Conversion Price shall be reduced in accordance with the following formula:

                                    AC = CC x M - P
                                              -----
                                                M
                  where:

                        AC =  the adjusted Conversion Price.

                        CC =  the current Conversion Price.

                        M  =  the current market price per share of Common
                              Stock on the Record Date (as defined in this
                              Section 11.08).

                        P  =  the aggregate fair market value on the Record
                              Date (as defined in this Section 11.08) (as
                              determined in good faith by the Board of
                              Directors and set forth in a certified
                              resolution filed with the Trustee) of the cash,
                              debt securities (or other evidences of
                              indebtedness) or other assets distributed
                              applicable to one share of Common Stock.

                  The adjustment shall become effective immediately after the
record date for the determination of stockholders entitled to receive such
distribution (for purposes of this Section 11.08 only, the "Record Date").

                  No adjustment will be made with respect to this Section 11.08
if, in lieu of such adjustment, the Holders of the Securities, upon conversion,
will be entitled to receive, in addition to the shares of Common Stock into
which such Securities are convertible, the kind and amount of cash, debt
securities (or other evidences of indebtedness) or other assets comprising the
distribution that such Holders would have received had they converted their
Securities immediately prior to the Record Date (as defined in this Section
11.08). In addition, no adjustment will be made in the event that the then fair
market value (as so determined) of the cash, debt securities (or other evidences
of indebtedness) or other assets so distributed applicable to one share of
Common Stock is equal to or greater than the current market price per share of
the Common Stock, in which case, in lieu of such adjustment, adequate provision
shall be made so that each Holder of Securities shall have the right to receive
upon conversion the amount of cash, debt securities (or other evidences of
indebtedness) or other assets such Holder would have received had such Holder
converted each Security on the Record Date (as defined in this Section 11.08).

                                      -43-
<PAGE>

                  SECTION 11.09. Adjustment for All Cash Distribution. Subject
to the last two paragraphs of this Section 11.09, if the Company shall pay or
make a dividend or other distribution consisting exclusively of cash to all
holders of its Common Stock, the Conversion Price shall be reduced in accordance
with the following formula:

                                    AC = CC x M - C
                                              -----
                                                M
                  where:

                        AC =  the adjusted Conversion Price.

                        CC =  the current Conversion Price.

                        M  =  the current market price per share of Common
                              Stock on the date fixed for payment of such
                              distribution.

                        C  =  the amount of cash so distributed and not
                              excluded (as provided below) applicable to one
                              share of Common Stock.

                  The adjustment shall become effective immediately prior to the
opening of business on the day following the date fixed for payment of such
distribution.

                  For the purposes of this Section 11.09, (A) the portion of
regular cash dividends on the Common Stock that does not exceed the per share
amount of the immediately preceding regular cash dividend on the Common Stock
(as adjusted to reflect any of the events referred to in Sections 11.06, 11.07,
11.08, 11.09 and 11.10) shall be excluded and (B) the portion of such regular
cash dividends on the Common Stock, to the extent that the annualized per share
amount thereof does not exceed 15% of the current market price per share of the
Common Stock as of the Trading Day immediately preceding the date of declaration
of such dividend, shall be excluded.

                  No adjustment will be made in the event that the amount of
cash so distributed applicable to one share of Common Stock is equal to or
greater than the current market price per share of the Common Stock, in which
case, in lieu of such adjustment, adequate provision shall be made so that each
Securityholder shall have the right to receive upon conversion the amount of
cash such Holder would have received had such Holder converted each Security
immediately prior to the record date for the distribution of the cash.

                  SECTION 11.10. Adjustment for Tender or Exchange Offer.
Subject to the last paragraph of this Section 11.10, in the event that a tender
or exchange offer (other than an odd-lot offer) made by the Company or any
subsidiary of the Company for all or a portion of the Common Stock shall expire
and such tender or exchange offer (including any amendment in effect immediately
prior to the expiration thereof) shall require the payment to stockholders of
consideration per share of Common Stock having a fair market value (as
determined in good faith by the Board of Directors and set forth in a certified
resolution filed with the Trustee) that, as of the last time (the "Expiration
Time") tenders or exchanges may be made pursuant to such tender or exchange
offer, exceeds 110% of the current market price per share of Common Stock at the
Expiration Time, the conversion price shall be reduced in accordance with the
following formula:

                                      -44-
<PAGE>

                                    AC = CC x     O x M
                                               -----------
                                               P + (T x M)
                  where:

                         AC = the adjusted Conversion Price.

                         CC = the current Conversion Price.

                         O  = the number of shares of Common Stock
                              outstanding (including any tendered or exchanged
                              shares) at the Expiration Time.

                         P  = the fair market value of the aggregate
                              consideration payable to stockholders of Common
                              Stock based on the acceptance (up to any maximum
                              specified in the terms of the tender or exchange
                              offer) of all shares of Common Stock validly
                              tendered or exchanged and not withdrawn as of
                              the Expiration Time (the shares of Common Stock
                              so accepted, up to any such maximum, being
                              referred to as the "Purchased Shares").

                         T  = the number of shares of Common Stock
                              outstanding (less any Purchased Shares) on the
                              Expiration Time.

                         M  = the current market price per share of Common
                              Stock at the Expiration Time.

                  The adjustment shall become effective immediately prior to the
opening of business on the day following the Expiration Time.

                  In the event that the Company or its Subsidiary, if
applicable, is permanently prevented by applicable law from effecting any such
purchases or all such purchases are rescinded, the Conversion Price shall again
be adjusted to be the Conversion Price which would then be in effect if such
tender or exchange offer had not been made.

                  SECTION 11.11. Current Market Price. For purposes of Sections
11.07, 11.08, 11.09 and 11.10, the current market price per share of Common
Stock on any date is the average of the Quoted Prices of the Common Stock for
five consecutive Trading Days selected by the Company commencing not more than
20 Trading Days before, and ending not later than, the earlier of the date in
question and the Trading Day before the "ex" date, if any, with respect to the
issuance or distribution requiring such computation. The term "`ex' date," when
used with respect to any issuance or distribution, means the first Trading Day
on which the Common Stock trades regular way in the market from which the Quoted
Price is then to be determined without the right to receive such issuance or
distribution.

                  SECTION 11.12. When Adjustment May Be Deferred. No adjustment
in the Conversion Price need be made unless the adjustment would require an
increase or decrease of at least 1% in the Conversion Price then in effect. Any
adjustments which are not made shall be carried forward and taken into account
in any subsequent adjustment.

                  All calculations under this Article shall be made to the
nearest cent or to the nearest 1/100th of a share, as the case may be, with .005
cents and 500/1,000 of a share to be rounded up.

                                      -45-
<PAGE>

                  SECTION 11.13. When No Adjustment Required. No adjustment need
be made for rights to purchase Common Stock pursuant to a Company plan for
reinvestment of dividends or interest.

                  No adjustment need be made for a change in the par value
(including a change to no par value) of the Common Stock.

                  To the extent the Securities become convertible into cash, no
adjustment need be made thereafter as to the cash. Interest will not accrue on
the cash.

                  SECTION 11.14. Notice of Adjustment. Whenever the Conversion
Price is adjusted, the Company shall promptly mail to Securityholders a notice
of the adjustment and file with the Trustee a certificate from the Company's
independent public accountant briefly stating the facts requiring the adjustment
and the manner of computing it. In the absence of manifest error, such
certificate shall be presumptive evidence that the adjustment is correct.

                  SECTION 11.15. Voluntary Reduction. The Company from time to
time may reduce the Conversion Price by any amount for any period of time if the
period is at least 20 days and if the reduction is irrevocable during the
period. Notwithstanding any provision to the contrary in this Indenture, the
reduction of the Conversion Price pursuant to this Section 11.15 shall not
require the consent of the Trustee or any Securityholder.

                  Whenever the Conversion Price is reduced, the Company shall
mail to Securityholders and the Trustee a notice of the reduction. The Company
shall mail the notice at least 15 days before the date the reduced Conversion
Price takes effect. The notice shall state the reduced Conversion Price and the
period during which it will be in effect.

                  A reduction of the Conversion Price is deemed not to be in
effect for purposes of calculating adjustments pursuant to Sections 11.06
through 11.10.

                  SECTION 11.16. Notice of Certain Transactions. If:

                  (1) the Company takes any action which would require an
         adjustment in the Conversion Price pursuant to Section 11.08 but, in
         lieu of such adjustment, the Securityholders are entitled to
         participate therein (as described in the last paragraph of Section
         11.08);

                  (2) the Company takes any action that would require a
         supplemental indenture pursuant to Section 11.17; or

                  (3) there is a dissolution or liquidation of the Company,

the Company shall mail to Securityholders and the Trustee a notice stating the
record date for any such distribution or the effective date of any such
subdivision, combination, reclassification, consolidation, merger, transfer,
lease, liquidation or dissolution. The Company shall mail the notice at least 15
days before such date. Failure to mail the notice or any defect in it shall not
affect the validity of any transaction referred to in clause (1), (2) or (3) of
this Section.

                  SECTION 11.17. Provisions in Case of Consolidation, Merger of
the Company or Transfer or Lease. If the Company is a party to a consolidation
or merger or a transfer or lease of all or substantially all of its assets not
prohibited by Section 6.01 or a merger which reclassifies or changes its
outstanding Common Stock, the Person formed by such consolidation or resulting
from such merger or which assumes or leases such assets shall enter into a
supplemental indenture.

                                      -46-
<PAGE>

                  The supplemental indenture shall provide that the Holder of a
Security may convert it into the kind and amount of securities, cash or other
assets receivable upon the consolidation, merger, transfer or lease by a holder
(other than any party to such transaction or any of its affiliates) of the
number of shares of Common Stock into which such Security might have been
converted immediately before the effective date of such transaction, assuming
such holder of Common Stock failed to exercise his rights of election, if any,
as to the kind or amount of securities, cash or other property receivable upon
such consolidation, merger, transfer or lease (provided that, if the kind or
amount of securities, cash or other property receivable upon such consolidation,
merger, transfer or lease is not the same for each share of Common Stock held
immediately prior to such consolidation, merger, transfer or lease by others
than the parties to such transaction or their affiliates and in respect of which
such rights of election shall not have been exercised ("non-electing share"),
then for the purposes of this Section the kind and amount of securities, cash
and other property receivable upon such consolidation, merger, transfer or lease
by each non-electing share shall be deemed to be the kind and amount so
receivable per share by a plurality of the non-electing shares). The
supplemental indenture shall provide for adjustments which shall be as nearly
equivalent as may be practical to the adjustments provided for in this Article.
If the issuer of securities deliverable upon conversion of Securities is an
affiliate of the surviving, transferee or lessee corporation, that issuer shall
join in the supplemental indenture. The successor Company shall mail to each
Securityholder a notice briefly describing the supplemental indenture.

                  If this Section applies to a particular event, Section 11.06
shall not apply to such event.

                  SECTION 11.18. Company Determination Final. Subject to
compliance with the terms of this Indenture (including without limitation
Section 11.14) and of the Securities, any determination which the Company or its
Board of Directors must make pursuant to Section 11.03, 11.06, 11.08, 11.10,
11.11 or 11.12 shall be conclusive.

                  SECTION 11.19. Trustee's Disclaimer. The Trustee has no duty
to determine when an adjustment under this Article should be made, how it should
be made or what it should be. The Trustee has no duty to determine the market
price or market value of any fractional or other share. The Trustee has no duty
to determine whether any provisions of a supplemental indenture under Section
11.17 are correct. The Trustee makes no representation as to the validity or
value of any securities or assets issued upon conversion of the Securities. The
Trustee shall not be responsible for the Company's failure to comply with this
Article. Each Conversion Agent other than the Company shall have the same
protection under this Section as the Trustee.

                                   ARTICLE 12

                              SUBSIDIARY GUARANTIES

                  SECTION 12.01. Guaranties. Each Subsidiary Guarantor hereby
unconditionally and irrevocably guarantees, jointly and severally, to each
Holder and to the Trustee and its successors and assigns (a) the full and
punctual payment of principal of and interest on the Securities when due,
whether at maturity, by acceleration, by redemption or otherwise, and all other
monetary obligations of the Company under this Indenture and the Securities and
(b) the full and punctual performance within applicable grace periods of all
other obligations of the Company under this Indenture and the Securities (all
the foregoing being hereinafter collectively called the "Obligations"). Each
Subsidiary Guarantor further agrees that the Obligations may be extended or
renewed, in whole or in part, without notice or further assent from such
Subsidiary Guarantor and that such Subsidiary Guarantor will remain bound under
this Article 12 notwithstanding any extension or renewal of any Obligation.

                                      -47-
<PAGE>

                  Each Subsidiary Guarantor waives presentation to, demand of,
payment from and protest to the Company of any of the Obligations and also
waives notice of protest for nonpayment. Each Subsidiary Guarantor waives notice
of any default under the Securities or the Obligations. The Obligations of each
Subsidiary Guarantor hereunder shall not be affected by (a) the failure of any
Holder or the Trustee to assert any claim or demand or to enforce any right or
remedy against the Company or any other Person under this Indenture, the
Securities or any other agreement or otherwise; (b) any extension or renewal of
any thereof; (c) any rescission, waiver, amendment or modification of any of the
terms or provisions of this Indenture, the Securities or any other agreement;
(d) the release of any security held by any Holder or the Trustee for the
Obligations or any of them; (e) the failure of any Holder or the Trustee to
exercise any right or remedy against any other guarantor of the Obligations; or
(f) any change in the ownership of such Subsidiary Guarantor.

                  Each Subsidiary Guarantor further agrees that its Subsidiary
Guaranty herein constitutes a guarantee of payment, performance and compliance
when due (and not a guarantee of collection) and waives any right to require
that any resort be had by any Holder or the Trustee to any security held for
payment of the Obligations.

                  Except as expressly set forth in Sections 9.01, 12.02 and
12.06, the Obligations of each Subsidiary Guarantor hereunder shall not be
subject to any reduction, limitation, impairment or termination for any reason,
including any claim of waiver, release, surrender, alteration or compromise, and
shall not be subject to any defense of setoff, counterclaim, recoupment or
termination whatsoever or by reason of the invalidity, illegality or
unenforceability of the Obligations or otherwise. Without limiting the
generality of the foregoing, the Obligations of each Subsidiary Guarantor herein
shall not be discharged or impaired or otherwise affected by the failure of any
Holder or the Trustee to assert any claim or demand or to enforce any remedy
under this Indenture, the Securities or any other agreement, by any waiver or
modification of any thereof, by any default, failure or delay, willful or
otherwise, in the performance of the Obligations, or by any other act or thing
or omission or delay to do any other act or thing which may or might in any
manner or to any extent vary the risk of such Subsidiary Guarantor or would
otherwise operate as a discharge of such Subsidiary Guarantor as a matter of law
or equity.

                  Each Subsidiary Guarantor further agrees that its Subsidiary
Guaranty herein shall continue to be effective or be reinstated, as the case may
be, if at any time payment, or any part thereof, of principal of or interest on
any Obligation is rescinded or must otherwise be restored by any Holder or the
Trustee upon the bankruptcy or reorganization of the Company or otherwise.

                  In furtherance of the foregoing and not in limitation of any
other right which any Holder or the Trustee has at law or in equity against any
Subsidiary Guarantor by virtue hereof, upon the failure of the Company to pay
the principal of or interest on any Obligation when and as the same shall become
due, whether at maturity, by acceleration, by redemption or otherwise, or to
perform or comply with any other Obligation, each Subsidiary Guarantor hereby
promises to and will, upon receipt of written demand by the Trustee, forthwith
pay, or cause to be paid, in cash, to the Holders or the Trustee an amount equal
to the sum of (i) the unpaid amount of such Obligations, (ii) accrued and unpaid
interest on such Obligations (but only to the extent not prohibited by law) and
(iii) all other monetary Obligations of the Company to the Holders and the
Trustee.

                  Each Subsidiary Guarantor agrees that it shall not be entitled
to any right of subrogation in respect of any Obligations guaranteed hereby
until payment in full of all Obligations. Each Subsidiary Guarantor further
agrees that, as between it, on the one hand, and the Holders and the Trustee, on
the other hand, (x) the maturity of the Obligations guaranteed hereby may be
accelerated as provided in Article 7 for the purposes of such Subsidiary
Guarantor's Subsidiary Guaranty herein, notwithstanding any stay, injunction or
other prohibition preventing such acceleration in respect of the Obligations

                                      -48-
<PAGE>

guaranteed hereby, and (y) in the event of any declaration of acceleration of
such Obligations as provided in Article 7, such Obligations (whether or not due
and payable) shall forthwith become due and payable by such Subsidiary Guarantor
for the purposes of this Section.

                  Each Subsidiary Guarantor also agrees to pay any and all costs
and expenses (including reasonable attorneys' fees) incurred by the Trustee or
any Holder in enforcing any rights under this Article 12.

                  Each Subsidiary Guarantor (the "Applicable Guarantor") also
agrees that, to the extent any other Subsidiary Guarantor makes any payment
pursuant to its Subsidiary Guaranty, such Applicable Guarantor will be obligated
to contribute to such other Subsidiary Guarantor an amount equal to the
Applicable Guarantor's pro rata portion of such payment based on the respective
net assets of all the Subsidiary Guarantors at the time of such payment
determined in accordance with generally accepted accounting principles in the
United States of America.

                  SECTION 12.02. Limitation on Liability. Any term or provision
of this Indenture to the contrary notwithstanding, the maximum, aggregate amount
of the Obligations guaranteed hereunder by any Subsidiary Guarantor shall not
exceed the maximum amount that can be hereby guaranteed without rendering this
Indenture, as it relates to such Subsidiary Guarantor, voidable under applicable
law relating to fraudulent conveyance or fraudulent transfer or similar laws
affecting the rights of creditors generally.

                  SECTION 12.03. Successors and Assigns. This Article 12 shall
be binding upon each Subsidiary Guarantor and its successors and assigns and
shall enure to the benefit of the successors and assigns of the Trustee and the
Holders and, in the event of any transfer or assignment of rights by any Holder
or the Trustee, the rights and privileges conferred upon that party in this
Indenture and in the Securities shall automatically extend to and be vested in
such transferee or assignee, all subject to the terms and conditions of this
Indenture.

                  SECTION 12.04. No Waiver. Neither a failure nor a delay on the
part of either the Trustee or the Holders in exercising any right, power or
privilege under this Article 12 shall operate as a waiver thereof, nor shall a
single or partial exercise thereof preclude any other or further exercise of any
right, power or privilege. The rights, remedies and benefits of the Trustee and
the Holders herein expressly specified are cumulative and not exclusive of any
other rights, remedies or benefits which either may have under this Article 12
at law, in equity, by statute or otherwise.

                  SECTION 12.05. Modification. No modification, amendment or
waiver of any provision of this Article 12, nor the consent to any departure by
any Subsidiary Guarantor therefrom, shall in any event be effective unless the
same shall be in writing and signed by the Trustee, and then such waiver or
consent shall be effective only in the specific instance and for the purpose for
which given. No notice to or demand on any Subsidiary Guarantor in any case
shall entitle such Subsidiary Guarantor to any other or further notice or demand
in the same, similar or other circumstances.

                  SECTION 12.06. Release of Subsidiary Guarantor. Upon the sale
or other disposition (including by way of consolidation or merger) of a
Subsidiary Guarantor or the sale or disposition of all or substantially all the
assets of such Subsidiary Guarantor (in each case other than to the Company or
an Affiliate of the Company), such Subsidiary Guarantor shall be deemed released
from all Obligations under this Article 12 without any further action required
on the part of the Trustee or any Holder. At the request of the Company, the
Trustee shall execute and deliver an appropriate instrument evidencing such
release.

                                      -49-
<PAGE>

                                   ARTICLE 13

                                  MISCELLANEOUS

                  SECTION 13.01. Trust Indenture Act Controls. If any provision
of this Indenture limits, qualifies, or conflicts with another provision which
is required to be included in this Indenture by the TIA, the required provision
shall control.

                  SECTION 13.02. Notices. Any notice or communication to the
Company or the Trustee by the other shall be duly given if in writing and
delivered in person or by overnight courier or mailed by first class mail or
transmitted by telephone facsimile transmission (and receipt confirmed)
addressed as follows:

                   If to the Company:        King Pharmaceuticals, Inc.
                                             501 Fifth Street
                                             Bristol, Tennessee 37620
                                             Attention: Kyle P. Macione, Vice
                                             President, Corporate Affairs
                                             Facsimile: (432) 274-8677

                   If to the Trustee:        The Bank of New York
                                             101 Barclay Street
                                             Floor 21 W
                                             New York, New York 10286
                                             Attention: Corporate Trust
                                             Administration
                                             Facsimile: (212) 896-7298

                  The Company or the Trustee by notice to the other may
designate additional or different addresses for subsequent notices or
communications.

                  Any notice or communication to a Securityholder shall be
mailed by first-class mail to his address as shown on the register kept by the
Registrar. Failure to mail a notice or communication to a Securityholder or any
defect in it shall not affect its sufficiency with respect to other
Securityholders. If the Company mails a notice or communication to
Securityholders, it shall mail a copy to the Trustee and each Agent at the same
time.

                  If a notice or communication is delivered, mailed or
transmitted in the manner provided above within the time prescribed, it is duly
given, whether or not the addressee receives it.

                  SECTION 13.03. Communications by Holders with Other Holders.
Securityholders may communicate pursuant to TIA ss. 312(b) with other
Securityholders with respect to their rights under this Indenture or the
Securities. The Company, the Trustee, the Registrar and any other person shall
have the protection of TIA ss. 312(c).

                  SECTION 13.04. Certificate and Opinion as to Conditions
Precedent. Upon any request or application by the Company to the Trustee to take
any action under this Indenture, the Company shall furnish to the Trustee:

                   (1) an Officers' Certificate stating that, in the opinion of
         the signers, all conditions precedent, if any, provided for in this
         Indenture relating to the proposed action have been complied with; and

                                      -50-
<PAGE>

                   (2) an Opinion of Counsel stating that, in the opinion of
         such counsel, all such conditions precedent have been complied with.

                  SECTION 13.05. Statements Required in Certificate or Opinion.
Each certificate or opinion with respect to compliance with a condition or
covenant provided for in this Indenture (other than pursuant to Section 5.03)
shall include:

                  (1) a statement that the Person making such certificate or
         opinion has read such covenant or condition;

                  (2) a brief statement as to the nature and scope of the
         examination or investigation upon which the statements or opinions
         contained in such certificate or opinion are based;

                  (3) a statement that, in the opinion of such Person, such
         examination or investigation as is necessary to enable him to express
         an informed opinion as to whether or not such covenant or condition has
         been complied with; and

                  (4) a statement as to whether or not, in the opinion of such
         Person, such condition or covenant has been complied with.

                  SECTION 13.06. Rules by Trustee and Agents. The Trustee may
make reasonable rules for action by or a meeting of Securityholders. The
Registrar, Paying Agent, New York Presenting Agent and Conversion Agent may each
make reasonable rules and set reasonable requirements for its respective
functions.

                  SECTION 13.07. Legal Holidays. A "Legal Holiday" is a
Saturday, Sunday or a day on which banking institutions in New York, New York,
or in the case of any conversion, the location of the Conversion Agent, are not
required to be open. If a payment date is a Legal Holiday at a place of payment,
payment may be made at such place on the next succeeding day that is not a Legal
Holiday, and no interest shall accrue for the intervening period. If a regular
record date is a Legal Holiday, the record date shall not be affected.

                  SECTION 13.08. Governing Law. The laws of the State of New
York shall govern this Indenture and the Securities.

                  SECTION 13.09. No Recourse Against Others. A director,
officer, employee or stockholder, as such, of the Company or any Subsidiary
Guarantor shall not have any liability for any obligations of the Company or any
Subsidiary Guarantor under the Securities or this Indenture or for any claim
based on, in respect of or by reason of such obligations or their creation. Each
Securityholder by accepting a Security waives and releases all such liability.
The waiver and release are part of the consideration for the issue of the
Securities.

                  SECTION 13.10. Successors. All agreements of the Company in
this Indenture and the Securities shall bind its successors. All agreements of
the Trustee in this Indenture shall bind its successors.

                  SECTION 13.11. Counterpart Originals. The parties may sign any
number of copies of this Indenture. Each signed copy shall be an original, but
all of them together represent the same agreement.

                                      -51-
<PAGE>

                  SECTION 13.12. Severability. In case any provision in this
Indenture or in the Securities shall be invalid, illegal or unenforceable, the
validity, legality and enforceability of the remaining provisions shall not in
any way be affected or impaired thereby, and a Holder shall have no claim
therefor against any party hereto.

[remainder of page intentionally blank]

                                      -52-
<PAGE>

                  IN WITNESS WHEREOF, the parties hereto have caused this
Indenture to be duly executed as of the date first written above.

                                    KING PHARMACEUTICALS, INC.

                                    By: /s/ Jefferson J. Gregory
                                        ----------------------------------------
                                        Name: Jefferson J. Gregory
                                        Title: President

                                    THE BANK OF NEW YORK

                                    By: /s/ Robert A. Massimillo
                                        ----------------------------------------
                                        Name: Robert A. Massimillo
                                        Title: Vice President

                                    KING PHARMACEUTICALS OF NEVADA, INC.

                                    By: /s/ Jefferson J. Gregory
                                        ----------------------------------------
                                        Name: Jefferson J. Gregory
                                        Title: President

                                    JONES PHARMA INCORPORATED

                                    By: /s/ Jefferson J. Gregory
                                        ----------------------------------------
                                        Name: Jefferson J. Gregory
                                        Title: President

                                    KING RESEARCH AND DEVELOPMENT, INC

                                    By: /s/ Jefferson J. Gregory
                                        ----------------------------------------
                                        Name: Jefferson J. Gregory
                                        Title:

                                    PARKEDALE PHARMACEUTICALS, INC.

                                    By: /s/ Jefferson J. Gregory
                                        ----------------------------------------
                                        Name: Jefferson J. Gregory
                                        Title: President and Chief Executive
                                               Officer

                                    MONARCH PHARMACEUTICALS, INC.

                                    By: /s/ Joseph J. Gregory
                                        ----------------------------------------
                                        Name: Joseph J. Gregory
                                        Title: President and Chief Executive
                                               Officer

                                      -53-

<PAGE>
                                                                      SCHEDULE A

                              SUBSIDIARY GUARANTORS

<TABLE>
<CAPTION>
                                                                     Jurisdiction
Subsidiary                                                         of Incorporation
----------                                                         ----------------
<S>                                                                <C>
King Pharmaceuticals of Nevada, Inc.                                    Nevada
Jones Pharma Incorporated                                              Delaware
King Research and Development, Inc.                                    Delaware
Parkedale Pharmaceuticals, Inc.                                        Michigan
Monarch Pharmaceuticals, Inc.                                          Tennessee
</TABLE>

                                      -54-

<PAGE>
                                                                       EXHIBIT A

                           [FORM OF FACE OF SECURITY]

        UNLESS THIS CERTIFICATE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF
THE DEPOSITORY TRUST COMPANY TO KING PHARMACEUTICALS, INC. (THE "COMPANY" OR
"KING") OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY
CERTIFICATE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO. OR IN SUCH OTHER NAME
AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY
(AND ANY PAYMENT HEREON IS MADE TO CEDE & CO. OR TO SUCH OTHER ENTITY AS IS
REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY), ANY
TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON
IS WRONGFUL SINCE THE REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST
HEREIN.

        TRANSFERS OF THIS GLOBAL SECURITY SHALL BE LIMITED TO TRANSFERS TO
NOMINEES OF THE DEPOSITORY TRUST COMPANY, OR TO A SUCCESSOR THEREOF OR SUCH
SUCCESSOR'S NOMINEE AND TRANSFERS OF PORTIONS OF THIS GLOBAL SECURITY SHALL BE
LIMITED TO TRANSFERS MADE IN ACCORDANCE WITH THE RESTRICTIONS SET FORTH IN
ARTICLE TWO OF THE INDENTURE REFERRED TO ON THE REVERSE HEREOF.

        THIS DEBENTURE (OR ITS PREDECESSOR) WAS ORIGINALLY ISSUED IN A
TRANSACTION EXEMPT FROM REGISTRATION UNDER THE UNITED STATES SECURITIES ACT OF
1933, AS AMENDED (THE "SECURITIES ACT"), AND THIS DEBENTURE AND THE KING COMMON
STOCK ISSUABLE UPON CONVERSION THEREOF MAY NOT BE OFFERED, SOLD OR OTHERWISE
TRANSFERRED IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE EXEMPTION
THEREFROM. EACH PURCHASER OF THIS DEBENTURE IS HEREBY NOTIFIED THAT THE SELLER
OF THIS DEBENTURE MAY BE RELYING ON THE EXEMPTION FROM THE PROVISIONS OF SECTION
5 OF THE SECURITIES ACT PROVIDED BY RULE 144A THEREUNDER.

        THE HOLDER OF THIS DEBENTURE AGREES FOR THE BENEFIT OF KING THAT (A)
THIS DEBENTURE AND THE KING COMMON STOCK ISSUABLE UPON CONVERSION THEREOF MAY BE
OFFERED, RESOLD, PLEDGED OR OTHERWISE TRANSFERRED, ONLY (i) IN THE UNITED STATES
TO A PERSON WHOM THE SELLER REASONABLY BELIEVES IS A QUALIFIED INSTITUTIONAL
BUYER (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN A TRANSACTION
MEETING THE REQUIREMENTS OF RULE 144A, (ii) PURSUANT TO AN EXEMPTION FROM
REGISTRATION UNDER THE SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER (IF
AVAILABLE) OR (iii) PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER THE
SECURITIES ACT, IN EACH OF CASES (i) THROUGH (iii) IN ACCORDANCE WITH ANY
APPLICABLE SECURITIES LAWS OF ANY STATE OF THE UNITED STATES, AND (B) THE HOLDER
WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY PURCHASER OF THIS
DEBENTURE FROM IT OF THE RESALE RESTRICTIONS REFERRED TO IN (A) ABOVE.

        THE FOREGOING LEGEND MAY BE REMOVED FROM THIS DEBENTURE ON SATISFACTION
OF THE CONDITIONS SPECIFIED IN THE INDENTURE.

                                      A-1
<PAGE>

No. 1                                                               $300,000,000
CUSIP No. 495582 AF 5

                           KING PHARMACEUTICALS, INC.

               2 3/4% Convertible Debenture due November 15, 2021

        King Pharmaceuticals, Inc., a Tennessee corporation, promises to pay to
CEDE & Co. or registered assigns, the principal sum of THREE HUNDRED MILLION
DOLLARS on November 15, 2021 or such greater or lesser amount as is indicated on
the Schedule of Exchanges of Securities on the other side of this Security.

        Interest Payment Dates:  May 15 and November 15.

        Record Dates:  May 1 and November 1.

                                      A-2
<PAGE>

        Reference is hereby made to the further provisions of this Security set
forth on the reverse hereof, which further provisions shall for all purposes
have the same effect as if set forth at this place.

Dated: November 7, 2001
                                       KING PHARMACEUTICALS, INC.

                                       By:
                                           -----------------------------------
                                           Name:
                                           Title

Authenticated:

THE BANK OF NEW YORK,
    as Trustee

By:
   ----------------------------------
       Authorized Signatory

                                      A-3
<PAGE>

                              (Reverse of Security)

                           KING PHARMACEUTICALS, INC.

               2 3/4% Convertible Debenture due November 15, 2021

1.       INTEREST.

                  KING PHARMACEUTICALS, INC. (the "Company"), a Tennessee
corporation, promises to pay interest on the principal amount of this Security
at the rate of 2 3/4% per annum. The Company will pay interest semiannually on
May 15 and November 15 each year, commencing on May 15, 2002 to Holders of
Securities at the close of business on the relevant record dates specified on
the front of this Security. Interest on the Securities will accrue from the most
recent date to which interest has been paid or, if no interest has been paid,
from November 7, 2001. Notwithstanding the foregoing, at the close of business
on May 15, 2006, May 15, 2011 and May 15, 2016 (each, a "Reset Date") the
interest rate on this Security shall be automatically reset, and this Security
shall accrue interest, from such Reset Date to but not including the next
succeeding Reset Date, or, in the case of May 15, 2016, until maturity, at a
rate per annum equal to the interest rate payable on the date 120 days prior to
such reset date on 5-year U.S. Treasury Notes minus 78 basis points; provided
that in no event will the interest rate on the Securities be reset below 2 3/4%
per annum or above 4 1/2% per annum. Any change in the interest rate pursuant to
the preceding sentence shall not have any effect on any other provision of the
Indenture or this Security. Interest will be computed on the basis of a 360-day
year of twelve 30-day months.

2.       METHOD OF PAYMENT.

                  The Company will pay interest on the Securities (except
defaulted interest) to the persons who are registered Holders of Securities at
the close of business on the record date next preceding the interest payment
date (including Securities that are cancelled after the record date and on or
before the interest payment date). Holders must surrender Securities to a Paying
Agent to collect principal and any premium payments. The Company will pay
principal, premium, if any, and interest in money of the United States that at
the time of payment is legal tender for payment of public and private debts.

3.       PAYING AGENT, REGISTRAR, CONVERSION AGENT.

                  Initially, The Bank of New York (the "Trustee") will act as
Paying Agent, Registrar and Conversion Agent. The Company may change any Paying
Agent, Registrar, Conversion Agent or co-registrar by giving notice to the
Trustee. The Company may act as Paying Agent, Registrar, Conversion Agent or
co-registrar.

4.       INDENTURE.

                  The Company issued this Security as one of a duly authorized
issue of securities of the Company designated as its 2 3/4% Convertible
Debentures due November 15, 2021 (the "Securities") under an Indenture dated as
of November 1, 2001 (the "Indenture"), among the Company, the Subsidiary
Guarantors and the Trustee. The terms of the Securities include those stated in
the Indenture. The Securities are subject to all such terms, and Securityholders
are referred to the Indenture for a statement of such terms. The payment of all
amounts due and owing with respect to the Securities have been guaranteed by the
Subsidiary Guarantors, on the terms and subject to the conditions contained in
the Indenture. Terms used herein that are defined in the Indenture shall have
the respective meanings

                                      A-4
<PAGE>

assigned thereto in the Indenture. The Securities are general unsecured
unsubordinated obligations of the Company limited to $300,000,000 in aggregate
principal amount ($345,000,000 if the Initial Purchaser Option is exercised in
full).

5.       OPTIONAL REDEMPTION.

                  The Securities may not be redeemed prior to November 20, 2006,
and are redeemable, on such date and thereafter at the option of the Company, as
a whole or from time to time in part, in integral multiples of $1,000, at any
time by the Company at 100% of the principal amount of the Securities, plus
accrued and unpaid interest to, but not including, the Redemption Date (the
"Redemption Price"). If the Redemption Date is on or after a record date but on
or prior to the related interest payment date, interest will be payable to the
Holders in whose names the Securities are registered at the close of business on
the relevant record date.

6.       PURCHASE AT OPTION OF HOLDER.

                  Subject to the terms and conditions of the Indenture, the
Company shall become obligated to purchase, at the option of the Holder, all or
any portion of the Securities held by such Holder, in any integral multiple of
$1,000, on November 15, 2006, November 15, 2011 and November 15, 2016 (each, a
"Purchase Date") at a purchase price per Security equal to 100% of the principal
amount of the Security, plus accrued and unpaid interest to, but not including,
the Purchase Date (the "Purchase Price") upon delivery of a Purchase Notice
containing the information set forth in the Indenture, at any time from the
opening of business on the date that is 20 Business Days prior to such Purchase
Date until the close of business on the fifth Business Day prior to such
Purchase Date, and upon delivery of the Securities to the Paying Agent by the
Holder as set forth in the Indenture; provided, however, that, if the Purchase
Date is on or after a record date but on or prior to the related interest
payment date, interest will be payable to the Holders in whose names the
Securities are registered at the close of business on the relevant record date.
Holders have the right to withdraw any Purchase Notice by delivering to the
Paying Agent a written notice of withdrawal in accordance with the provisions of
the Indenture. If cash sufficient to pay the Purchase Price of all Securities or
portions thereof to be purchased as of the Purchase Date is deposited with the
Paying Agent on the Purchase Date, the Holder thereof shall have no other rights
other than the right to receive the Purchase Price upon surrender of such
Security.

                  If a Change of Control occurs, each Holder of Securities shall
have the right, at the Holder's option, to require the Company to repurchase all
of such Holder's Securities, or any portion thereof that is an integral multiple
of $1,000, on the date (the "Change of Control Purchase Date") selected by the
Company that is not less than 10 nor more than 30 days after the Final Surrender
Date, at a price equal to 100% of the principal amount thereof plus accrued and
unpaid interest to, but not including, the Change of Control Purchase Date (the
"Change of Control Purchase Price"); provided, however, that, if the Change of
Control Purchase Date is on or after a record date but on or prior to the
related interest payment date, interest will be payable to the Holders in whose
names the Securities are registered at the close of business on the relevant
record date. Unless the Company shall have theretofore called for redemption all
the outstanding Securities, on or before the 30th day after the occurrence of a
Change of Control, the Company is obligated to mail or cause the Trustee to mail
to all Holders of record of the Securities a notice (the "Change of Control
Company Notice") describing, among other things, the occurrence of such Change
of Control and of the repurchase right arising as a result thereof. The Company
must deliver a copy of the Change of Control Company Notice to the Trustee and
cause a copy of such notice to be published in a newspaper of general
circulation in the Borough of Manhattan, The City of New York. To exercise the
repurchase right, a Holder of Securities must surrender, on or before the date
which, subject to any contrary requirements of applicable law, is 60 days after
the date of mailing of the Change of Control Company Notice (the "Final
Surrender Date") the Securities with respect to

                                      A-5
<PAGE>

which the right is being exercised, which, in the case of definitive Securities,
must be duly endorsed for transfer to the Company.

                  The term "Change of Control" shall mean either:

                  (i) a report is filed on Schedule 13D or TO (or any successor
         schedule, form or report) pursuant to the Exchange Act, disclosing that
         any person (for the purposes of this paragraph 6 only, as the term
         "person" is used in Section 13(d)(3) or Section 14(d)(2) of the
         Exchange Act) has become the beneficial owner (as the term "beneficial
         owner" is defined under Rule 13d-3 or any successor rule or regulation
         promulgated under the Exchange Act) of 50% or more of the voting power
         of the Common Shares then outstanding; provided that a person shall not
         be deemed beneficial owner of, or to own beneficially, (A) any
         securities tendered pursuant to a tender or exchange offer made by or
         on behalf of such person or any of such person's Affiliates or
         Associates until such tendered securities are accepted for purchase or
         exchange thereunder or (B) any securities if such beneficial ownership
         (1) arises solely as a result of a revocable proxy delivered in
         response to a proxy or consent solicitation made pursuant to the
         applicable rules and regulations under the Exchange Act and (2) is not
         also then reportable on Schedule 13D (or any successor schedule) under
         the Exchange Act; or

                    (ii) any share exchange, consolidation or merger of the
         Company is consummated pursuant to which the Common Shares would be
         converted into cash, securities or other property, in each case other
         than a share exchange, consolidation or merger of the Company in which
         the holders of the Common Shares immediately prior to the share
         exchange, consolidation or merger have, directly or indirectly, at
         least a majority of the total voting power in the aggregate of all
         classes of Capital Stock of the continuing or surviving corporation
         immediately after the share exchange, consolidation or merger.

         Notwithstanding the foregoing, a Change in Control shall not be deemed
         to have occurred by virtue of the Company, any Subsidiary, any employee
         stock ownership plan or any other employee benefit plan of the Company
         or any Subsidiary, or any person holding Common Shares for or pursuant
         to the terms of any such employee benefit plan or any Permitted Holder,
         filing or becoming obligated to file a report under or in response to
         Schedule 13D or Schedule TO (or any successor schedule, form or report)
         under the Exchange Act disclosing beneficial ownership by it of shares
         of Common Shares, whether in excess of 50% or otherwise.

7.       NOTICE OF REDEMPTION.

                  Notice of redemption pursuant to paragraph 5 must be mailed at
least 20 days, but not more than 60 days, before the Redemption Date to the
Trustee and each Holder of Securities to be redeemed at his address as shown on
the register kept by the Registrar. Securities in denominations larger than
$1,000 may be redeemed in part, but only in integral multiples of $1,000. On and
after the Redemption Date, interest shall cease to accrue on Securities or any
portion of them called for redemption; provided, however, that funds in the
requisite amount are paid or made available for payment on that date.

8.       CONVERSION.

                  The Securities are subject to conversion on the terms and
subject to the conditions contained in the Indenture and the Securities. Holders
may surrender Securities for conversion into shares of Common Stock on a
conversion date if, as of such conversion date, the Quoted Price of the Common
Stock for at least 20 Trading Days in the 30 Trading Day period ending on the
Trading Day prior to the

                                      A-6
<PAGE>

conversion date is more than 110% of the Conversion Price per share of Common
Stock on the Trading Day prior to such conversion date. In addition, a Holder
may surrender for conversion a Security which has been called for redemption
pursuant to paragraph 5 hereof, even if the foregoing provision has not been
satisfied, and such Security may be surrendered for conversion until the close
of business on the day that is two Business Days prior to the Redemption Date.
In the event that the Company declares a dividend or distribution described in
Section 11.7 of the Indenture, or a dividend or distribution described in
Section 11.8 of the Indenture where the fair market value of such dividend or
distribution per share of Common Stock, as determined in the Indenture exceeds
15% of the current Market Price of the Common Stock as of the Trading Day
immediately prior to the date of declaration, the Securities may be surrendered
for conversion beginning on the date the Company gives notice to the Holders of
such right, which shall be not less than 20 days prior to the ex-dividend time
for such dividend or distribution and Securities may be surrendered for
conversion at any time thereafter until the close of business on the Business
Day prior to the ex-dividend time or until the Company announces that such
distribution will not take place. Finally, in the event that the Company is a
party to a consolidation or merger, or transfer or lease of all or substantially
all of its assets pursuant to which the Common Stock would be converted into
cash, securities or other assets as set forth in Section 11.17 of the Indenture,
(1) the Securities may be surrendered for conversion at any time from or after
the date which is 15 days prior to the anticipated effective time of the
transaction until 15 days after the actual date of such transaction and (2) at
the effective time of the transaction, the right to convert a Security into
Common Stock will become a right to convert the Security into the kind and
amount of cash, securities or other property which the Holder of such Security
would have received if the Holder had converted such Security immediately prior
to the transaction (assuming, in a case in which the Company's stockholders may
exercise rights of election, that the Holder of such Security would not have
exercised any rights of election as to the stock, other securities or other
property or assets receivable in connection therewith and received per share the
kind and amount received per share by plurality of nonelecting shares).

                  Except as described in this paragraph, no Holder of a Security
will be entitled upon conversion of the Security to any actual payment or
adjustment on account of accrued and unpaid interest with respect to such
Security or on account of dividends on shares of Common Stock issued in
connection with the conversion. If any Holder surrenders a Security for
conversion between the close of business on any record date for the payment of
an installment of interest and the opening of business on the related interest
payment date, the Holder must deliver payment to the Company of an amount equal
to the interest payable on the interest payment date on the principal amount
converted together with the Security being surrendered. The foregoing sentence
does not apply to Securities called for redemption on a Redemption Date or
subject to a "change of control" purchase offer on a Change of Control Purchase
Date within the period between and including the record date and interest
payment date.

                  A Security in respect of which a Holder has delivered a
Purchase Notice or Change of Control Purchase Notice exercising the option of
such Holder to require the Company to purchase such Security may be converted
only if such notice of exercise is withdrawn in accordance with the terms of the
Indenture.

                  The initial Conversion Price is $50.16 per share of Common
Stock, subject to adjustment in certain events described in the Indenture. A
Holder that surrenders Securities for conversion will receive a check in lieu of
any fractional shares of Common Stock.

                  To convert a Security, a Holder must (1) complete and sign the
conversion notice on the reverse of the Security, (2) surrender the Security to
the Conversion Agent, (3) furnish the appropriate endorsements and transfer
documents if required by the Registrar or Conversion Agent, and (4) pay any tax
or duty which may be payable in respect of any transfer involving the issue or
delivery of Common Stock in the name of a Person other than the Holder thereof.
However, if the Security is represented by a

                                      A-7

<PAGE>

Global Security, notice, surrender and transfer may be made pursuant to standard
procedures of the Depositary. A Holder may convert a portion of a Security if
the portion is $1,000 or an integral multiple of $1,000.

                  The Conversion Price will be subject to adjustment pursuant to
Article 11 of the Indenture.

9.       DENOMINATIONS, TRANSFER, EXCHANGE.

                  The Securities are in registered form without coupons in
denominations of $1,000 and integral multiples of $1,000. A Holder may register
the transfer of or exchange Securities in accordance with the Indenture. The
Registrar may require a Holder, among other things, to furnish appropriate
endorsements and transfer documents and to pay any taxes or other governmental
charges that may be imposed in relation thereto by law or permitted by the
Indenture.

10.      AMENDMENT, SUPPLEMENT, WAIVER.

                  Subject to certain exceptions, the Indenture or the Securities
may be amended or supplemented, with the consent of the Company and the Holders
of a majority in aggregate principal amount of the Securities, and any existing
default may be waived with the consent of the Holders of a majority in aggregate
principal amount of the Securities. Without the consent of any Securityholder,
the Indenture or the Securities may be amended, inter alia, to cure any
ambiguity, defect or inconsistency, to provide for assumption of Company
obligations to Securityholders in the case of a merger or acquisition, or to
make any change that does not materially adversely affect the rights of any
Securityholder.

11.      DEFAULTS AND REMEDIES.

                  An Event of Default is default in the payment of interest on
the Securities continued for 30 days or more after such payment is due, default
in payment of principal of or premium, if any, on the Securities when due and
payable, default in payment of the Purchase Price or Change of Control Purchase
Price to be paid upon a repurchase at the option of the Holder pursuant to
paragraph 6; failure by the Company for 60 days after certain notice to it to
comply with any of its other agreements in the Indenture; default in the payment
of other evidences of indebtedness of the Company if such payment exceeds
$50,000,000 or acceleration of payments with respect to indebtedness of the
Company in excess of $50,000,000; failure of a Subsidiary Guaranty to be in full
force and effect (other than in accordance with its terms) or a where a
Subsidiary Guarantor denies or disaffirms its obligations under its Subsidiary
Guaranty; and certain events of bankruptcy or insolvency. If an Event of Default
occurs and is continuing, the Trustee or the Holders of at least 25% in
aggregate principal amount of the Securities may declare the principal of, and
accrued interest on, all the Securities to be due and payable immediately.
Events of bankruptcy or insolvency with respect to the Company are Events of
Default which will result in the Securities being due and payable immediately
upon the occurrence of such Events of Default.

                  Securityholders may not enforce the Indenture or the
Securities except as provided in the Indenture. The Trustee may require
indemnity satisfactory to it before it enforces the Indenture or the Securities.
Subject to certain limitations, Holders of a majority in aggregate principal
amount of the Securities may direct the Trustee in its exercise of any trust or
power. The Trustee may withhold from Securityholders notice of any continuing
default (except a default in payment of principal or premium, if any, or
interest) if it determines that withholding notice is in their interests. The
Company must furnish an annual compliance certificate to the Trustee.

                                      A-8
<PAGE>

12.      TRUSTEE DEALINGS WITH COMPANY.

                  The Bank of New York, the Trustee and any agent under the
Indenture, in its individual or any other capacity, may make loans to, accept
deposits from, and perform services for the Company or its Affiliates, and may
otherwise deal with the Company or its Affiliates, as if it were not Trustee or
agent.

13.      NO RECOURSE AGAINST OTHERS.

                  A director, officer, employee or stockholder, as such, of the
Company or any Subsidiary Guarantor shall not have any liability for any
obligations of the Company or any Subsidiary Guarantor under the Securities or
the Indenture or for any claim based on, in respect of or by reason of, such
obligations or their creation. Each Securityholder by accepting a Security
waives and releases all such liability. The waiver and release are part of the
consideration for the issue of the Securities.

14.      AUTHENTICATION.

                  This Security shall not be valid until authenticated by the
manual signature of the Trustee or an authenticating agent on the face hereof.

15.      ABBREVIATIONS.

                  Customary abbreviations may be used in the name of a
Securityholder or an assignee, such as: TEN COM (= tenants in common), TEN ENT
(= tenants by the entireties), JT TEN (= joint tenants with right of
survivorship and not as tenants in common), CUST (= Custodian), and U/G/M/A (=
Uniform Gifts to Minors Act).

16.      CUSIP NUMBERS.

                  Pursuant to a recommendation promulgated by the Committee on
Uniform Security Identification Procedures the Company has caused CUSIP numbers
to be printed on the Securities and has directed the Trustee to use CUSIP
numbers in notices of redemption as a convenience to Securityholders. No
representation is made as to the accuracy of such numbers either as printed on
the Securities or as contained in any notice of redemption.

17.      GOVERNING LAW.

                  The laws of the State of New York shall govern the Indenture
and the Securities.

                  THE COMPANY WILL FURNISH TO ANY SECURITYHOLDER UPON WRITTEN
REQUEST AND WITHOUT CHARGE A COPY OF THE INDENTURE. IT ALSO WILL FURNISH THE
TEXT OF THIS SECURITY IN LARGER TYPE. REQUESTS MAY BE MADE TO: KING
PHARMACEUTICALS, INC., 501 FIFTH STREET, BRISTOL, TENNESSEE 37620, ATTENTION:
CORPORATE AFFAIRS DEPARTMENT.

                     [Remainder of Page Intentionally Blank]

                                      A-9
<PAGE>

                                CONVERSION NOTICE

To King Pharmaceuticals, Inc.:

                  The undersigned owner of this Security hereby irrevocably
exercises the option to convert this Security, or the portion hereof (which is
$1,000 or an integral multiple thereof) below designated, into shares of King
Common Stock in accordance with the terms of the Indenture referred to in this
Security, and directs that the shares issuable and deliverable upon conversion,
together with any check in payment for fractional shares and any Securities
representing any unconverted principal amount hereof, be issued and delivered to
the registered Holder hereof unless a different name has been indicated below.
If shares are to be issued in the name of a Person other than the undersigned,
the undersigned will pay all transfer taxes payable with respect thereto.

                  To convert this Security into King Common Stock, check the
box: [ ]

                  To convert only part of this Security, state the amount (must
be $1,000 or any whole multiple thereof): $________

                  If you want the stock certificate made out in another Person's
name, fill in the form below:

________________________________________________________________________________

________________________________________________________________________________
                     (Insert other Person's social security
                          or tax identification number)

________________________________________________________________________________
            (Print or type other Person's name, address and zip code)

Date:_______________  Your signature: __________________________________________
                                       (Sign exactly as your name appears on the
                                       face of this Security)

Signature Guaranteed: __________________________________________________________

                                      A-10
<PAGE>

                                 ASSIGNMENT FORM

                  To assign this Security or, in the event of conversion, shares
of King Common Stock, fill in the form below:

I or we assign and transfer this Security or, __ shares of King Common Stock, to

________________________________________________________________________________

________________________________________________________________________________
                       (Insert assignee's social security
                          or tax identification number)

________________________________________________________________________________

________________________________________________________________________________

________________________________________________________________________________

________________________________________________________________________________
              (Print or type assignee's name, address and zip code)

and irrevocably appoint ______________________________________ agent to transfer
this Security on the books of the Company. The agent may substitute another to
act for him.

Date:_______________  Your signature: __________________________________________
                                      (Sign exactly as your name appears on the
                                      face of this Security)

Signature Guaranteed: __________________________________________________________

                                      A-11
<PAGE>

                      SCHEDULE OF EXCHANGES OF SECURITIES*

                  The following exchanges, redemptions, repurchases or
conversions of a part of this global Security have been made:

<TABLE>
<S>                             <C>                        <C>                      <C>
                                                                  Amount of         Amount of Increase in
  Principal Amount of this                                 Decrease in Principal     Principal Amount of
  Global Security Following     Authorized Signatory of    Amount of this Global         this Global
 Such Decrease (or Increase)      Securities Custodian            Security               Security
 ---------------------------    -----------------------    ---------------------    ---------------------
</TABLE>

----------------------------------
* Should be included only if the Security is a Global Security.

                                      A-12
<PAGE>

            CERTIFICATE TO BE DELIVERED UPON EXCHANGE OR REGISTRATION
                  OF TRANSFER OF TRANSFER RESTRICTED SECURITIES

Re:      2 3/4% Convertible Debentures due November 15, 2021
         (the "Securities") of King Pharmaceuticals, Inc.

                  This certificate relates to $_______ principal amount of
Securities owned in (check applicable box)

                  [ ] book-entry or [ ] definitive form by _______________
(the "Transferor").

                  The Transferor has requested a Registrar or the Trustee to
exchange or register the transfer of such Securities.

                  In connection with such request and in respect of each such
Security, the Transferor does hereby certify that the Transferor is familiar
with transfer restrictions relating to the Securities as provided in Section 2
of the Indenture dated as of November 1, 2001 among King Pharmaceuticals, Inc.,
certain subsidiaries of King Pharmaceuticals, Inc. and The Bank of New York (the
"Indenture"), and the transfer of such Security is being made pursuant to an
effective registration statement under the Securities Act of 1933, as amended
(the "Securities Act") (check applicable box) or the transfer or exchange, as
the case may be, of such Security does not require registration under the
Securities Act because (check applicable box):

         [ ]      Such Security is being transferred pursuant to an effective
                  registration statement under the Securities Act.

         [ ]      Such Security is being acquired for the Transferor's own
                  account, without transfer.

         [ ]      Such Security is being transferred to the Company or a
                  Subsidiary (as defined in the Indenture) of the Company.

         [ ]      Such Security is being transferred to a person the Transferor
                  reasonably believes is a "qualified institutional buyer" (as
                  defined in Rule 144A or any successor provision thereto ("Rule
                  144A") under the Securities Act) that is purchasing for its
                  own account or for the account of a "qualified institutional
                  buyer", in each case to whom notice has been given that the
                  transfer is being made in reliance on such Rule 144A, and in
                  each case in reliance on Rule 144A.

         [ ]      Such Security is being transferred pursuant to and in
                  compliance with an exemption from the registration
                  requirements under the Securities Act in accordance with Rule
                  144 (or any successor thereto) ("Rule 144") under the
                  Securities Act.

         [ ]      Such Security is being transferred pursuant to and in
                  compliance with an exemption from the registration
                  requirements of the Securities Act (other than an exemption
                  referred to above) and as a result of which such Security
                  will, upon such transfer, cease to be a "restricted security"
                  within the meaning of Rule 144 under the Securities Act.

                                      A-13
<PAGE>

                  The Transferor acknowledges and agrees that, if the transferee
will hold any such Securities in the form of beneficial interests in a global
Security which is a "restricted security" within the meaning of Rule 144 under
the Securities Act, then such transfer can only be made pursuant to Rule 144A
under the Securities Act and such transferee must be a "qualified institutional
buyer" (as defined in Rule 144A).

Date:
     ----------------------              ---------------------------------------
                                         (Insert Name of Transferor)

                                      A-14<PAGE>
                                                                     EXHIBIT 4.5

                                  $300,000,000

                           KING PHARMACEUTICALS, INC.

               2 3/4% CONVERTIBLE DEBENTURES DUE NOVEMBER 15, 2021

                          REGISTRATION RIGHTS AGREEMENT

                                                                November 1, 2001

CREDIT SUISSE FIRST BOSTON CORPORATION
J.P. MORGAN SECURITIES INC.
BANC OF AMERICA SECURITIES LLC
UBS WARBURG LLC,
c/o Credit Suisse First Boston Corporation
    Eleven Madison Avenue
    New York, New York 10010-3629

Dear Sirs:

         King Pharmaceuticals, Inc., a Tennessee corporation (the "COMPANY"),
proposes to issue and sell to the several initial purchasers named in Schedule A
hereto (each a "PURCHASER"), upon the terms set forth in a purchase agreement
dated November 1, 2001 (the "PURCHASE AGREEMENT"), $300,000,000 aggregate
principal amount of its 2 3/4% Convertible Debentures due November 15, 2021 (the
"OFFERED SECURITIES") to be guaranteed (each, a "SUBSIDIARY GUARANTEE") on an
unsecured, senior subordinated basis by each of the Company's subsidiaries
listed on Schedule B to the Purchase Agreement (the "SUBSIDIARY GUARANTORS").
The Offered Securities will be issued pursuant to an Indenture, dated as
November 1, 2001 (the "INDENTURE"), among the Company, the Subsidiary Guarantors
and The Bank of New York, as trustee (the "TRUSTEE"). Under the terms of the
Indenture, the Offered Securities are convertible, in whole or in part, into
shares of the Company's common stock, no par value (the "UNDERLYING SHARES", and
together with the Offered Securities, the "SECURITIES"). As an inducement, the
Company agrees with the Purchasers, for the benefit of the holders of the
Offered Securities (including, without limitation, the Purchasers) and
Underlying Shares (collectively the "HOLDERS"), as follows:

                  1. Shelf Registration. (a) The Company shall promptly (but in
         no event more than 90 days after the first date of initial issuance of
         the Offered Securities (such 90th day being the "FILING DEADLINE")) use
         its reasonable best efforts to file with the Securities and Exchange
         Commission (the "COMMISSION") and thereafter use its reasonable best
         efforts to cause to be declared effective no later than 180 days after
         the first date of initial issuance of the Offered Securities (such
         180th day being the "EFFECTIVENESS DEADLINE") a registration statement
         (the "REGISTRATION STATEMENT") on an appropriate form under the
         Securities Act of 1933, as amended (the "SECURITIES ACT"), relating to
         the offer and sale of the Transfer Restricted Securities (as defined in
         Section 5 hereof) by the Holders thereof from time to time in
         accordance with the methods of distribution set forth in the
         Registration Statement and Rule 415 under the Securities Act
         (hereinafter, the "SHELF REGISTRATION"); provided, however, that no
         Holder (other than a Purchaser) shall be entitled to have the
         Securities held by it covered by such Registration Statement unless
         such Holder agrees in writing to be bound by all the provisions of this
         Agreement applicable to such Holder.

                  (b) The Company shall use its reasonable best efforts to keep
         the Registration Statement continuously effective in order to permit
         the prospectus included therein to be lawfully delivered by the Holders
         of the relevant Securities, for a period of two years (or for such
         longer period if extended pursuant to Section 2(h) below) from the date
         of its effectiveness or such shorter period that will terminate when
         all the Securities covered by the Registration Statement (i) have been
         sold pursuant thereto or (ii) are no longer restricted securities (as
         defined in Rule 144 under the Securities Act) (in any such case, such
         period being called the "SHELF REGISTRATION PERIOD"). The Company shall
         be deemed not to have used its best

<PAGE>

         efforts to keep the Registration Statement effective during the
         requisite period if it voluntarily takes any action that would result
         in Holders of Securities covered thereby not being able to offer and
         sell such Securities during that period, unless such action is required
         by applicable law.

                  (c) Notwithstanding any other provisions of this Agreement to
         the contrary, the Company shall cause the Registration Statement and
         the related prospectus and any amendment or supplement thereto, as of
         the effective date of the Registration Statement, amendment or
         supplement, (i) to comply in all material respects with the applicable
         requirements of the Securities Act and the rules and regulations of the
         Commission and (ii) not to contain any untrue statement of a material
         fact or omit to state a material fact required to be stated therein or
         necessary in order to make the statements therein, in the light of the
         circumstances under which they were made, not misleading.

              2. Registration Procedures. In connection with the Shelf
Registration contemplated by Section 1 hereof the following provisions shall
apply:

         (a) The Company shall (i) furnish to each Purchaser, prior to the
filing thereof with the Commission, a copy of the Registration Statement and
each amendment thereof and each supplement, if any, to the prospectus included
therein and, in the event that a Purchaser (with respect to any portion of an
unsold allotment from the original offering) is participating in the
Registration Statement, the Company shall use its reasonable best efforts to
reflect in each such document, when so filed with the Commission, such comments
as such Purchaser reasonably may propose; and (ii) subject to paragraph (l) of
this Section 2, include the names of the Holders who propose to sell Securities
pursuant to the Registration Statement as selling securityholders.

         (b) The Company shall give written notice to the Purchasers and the
Holders of the Securities (which notice pursuant to clauses (ii)-(v) hereof
shall be accompanied by an instruction to suspend the use of the prospectus
until the requisite changes have been made):

                        (i) when the Registration Statement or any amendment
                thereto has been filed with the Commission and when the
                Registration Statement or any post-effective amendment thereto
                has become effective;

                        (ii) of any request by the Commission for amendments or
                supplements to the Registration Statement or the prospectus
                included therein or for additional information;

                        (iii) of the issuance by the Commission of any stop
                order suspending the effectiveness of the Registration Statement
                or the initiation of any proceedings for that purpose;

                        (iv) of the receipt by the Company or its legal counsel
                of any notification with respect to the suspension of the
                qualification of the Securities for sale in any jurisdiction or
                the initiation or threatening of any proceeding for such
                purpose; and

                        (v) of the happening of any event that requires the
                Company to make changes in the Registration Statement or the
                prospectus in order that the Registration Statement or the
                prospectus do not contain an untrue statement of a material fact
                nor omit to state a material fact required to be stated therein
                or necessary to make the statements therein (in the case of the
                prospectus, in the light of the circumstances under which they
                were made) not misleading.

         (c) The Company shall make every reasonable effort to obtain the
withdrawal at the earliest possible time, of any order suspending the
effectiveness of the Registration Statement.

         (d) The Company shall furnish to each Holder of Securities included
within the coverage of the Shelf Registration, without charge, at least one copy
of the Registration Statement and any post-effective amendment thereto,
including financial statements and schedules, and, if the Holder so requests in
writing, all exhibits thereto (including those, if any, incorporated by
reference).

                                       2
<PAGE>

         (e) The Company shall, during the Shelf Registration Period, deliver to
each Holder of Securities included within the coverage of the Shelf
Registration, without charge, as many copies of the prospectus (including each
preliminary prospectus) included in the Registration Statement and any amendment
or supplement thereto as such person may reasonably request. The Company
consents, subject to the provisions of this Agreement, to the use of the
prospectus or any amendment or supplement thereto by each of the selling Holders
of the Securities in connection with the offering and sale of the Securities
covered by the prospectus, or any amendment or supplement thereto, included in
the Registration Statement.

         (f) Prior to any public offering of the Securities pursuant to any
Registration Statement the Company shall register or qualify or cooperate with
the Holders of the Securities included therein and their respective counsel in
connection with the registration or qualification of the Securities for offer
and sale under the securities or "blue sky" laws of such states of the United
States as any Holder of the Securities reasonably requests in writing and do any
and all other acts or things necessary or advisable to enable the offer and sale
in such jurisdictions of the Securities covered by such Registration Statement;
provided, however, that the Company shall not be required to (i) qualify
generally to do business in any jurisdiction where it is not then so qualified
or (ii) take any action which would subject it to general service of process or
to taxation in any jurisdiction where it is not then so subject.

         (g) The Company shall cooperate with the Holders of the Securities to
facilitate the timely preparation and delivery of certificates representing the
Securities to be sold pursuant to any Registration Statement free of any
restrictive legends and in such denominations and registered in such names as
the Holders may request a reasonable period of time prior to sales of the
Securities pursuant to such Registration Statement.

         (h) Upon the occurrence of any event contemplated by paragraphs (ii)
through (v) of Section 2(b) above during the Shelf Registration Period, the
Company shall promptly prepare and file a post-effective amendment to the
Registration Statement or a supplement to the related prospectus and any other
required document so that, as thereafter delivered to Holders of the Securities
or purchasers of Securities, the prospectus will not contain an untrue statement
of a material fact or omit to state any material fact required to be stated
therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading; provided, however,
that the Company may delay preparing, filing and distributing any such
supplement or amendment if the Company determines in good faith that such
supplement or amendment would, in the reasonable judgment of the Company, (i)
interfere with or affect the negotiation or completion of a transaction that is
being contemplated by the Company (whether or not a final decision has been made
to undertake such transaction) or (ii) involve initial or continuing disclosure
obligations that are not in the best interests of the Company's stockholders at
such time; provided further, however, that such delay shall not extend for a
period of more than 30 business days in any three month period or more than 60
business days in any twelve month period. If the Company notifies the Purchasers
and the Holders of the Securities in accordance with paragraphs (ii) through (v)
of Section 2(b) above to suspend the use of the prospectus until the requisite
changes to the prospectus have been made, then the Purchasers and the Holders of
the Securities shall suspend use of such prospectus, and the Shelf Registration
Period shall be extended by the number of days from and including the date of
the giving of such notice to and including the date when the Purchasers and the
Holders of the Securities shall have received such amended or supplemented
prospectus pursuant to this Section 2(h).

         (i) Not later than the effective date of the applicable Registration
Statement, the Company will provide a CUSIP number for the Offered Securities
and the Underlying Shares registered under the Registration Statement and
provide the Trustee with printed certificates for the Offered Securities in a
form eligible for deposit with The Depository Trust Company.

         (j) The Company will comply with all rules and regulations of the
Commission to the extent and so long as they are applicable to the Shelf
Registration and will make generally available to its security holders (or
otherwise provide in accordance with Section 11(a) of the Securities Act) an
earnings statement satisfying the provisions of Section 11(a) of the Securities
Act, no later than 45 days after the end of a 12-month period (or 90 days, if
such period is a fiscal year) beginning with the first month of the Company's
first fiscal quarter commencing after the effective date of the Registration
Statement, which statement shall cover such 12-month period.

                                       3
<PAGE>

         (k) The Company shall cause the Indenture to be qualified under the
Trust Indenture Act of 1939 as amended (the "TRUST INDENTURE ACT"), in a timely
manner and containing such changes, if any, as shall be necessary for such
qualification. In the event that such qualification would require the
appointment of a new trustee under the Indenture, the Company shall appoint a
new trustee thereunder pursuant to the applicable provisions of the Indenture.

         (l) The Company may require each Holder of Securities to be sold
pursuant to the Registration Statement to furnish to the Company such
information regarding the Holder and the distribution of the Securities as the
Company may from time to time reasonably require for inclusion in the
Registration Statement, and the Company may exclude from such registration the
Securities of any Holder that unreasonably fails to furnish such information
within a reasonable time after receiving such request.

         (m) The Company shall enter into such customary agreements (including,
if requested, an underwriting agreement in customary form) and take all such
other action, if any, as any Holder of the Securities shall reasonably request
in order to facilitate the disposition of the Securities pursuant to any Shelf
Registration.

         (o) The Company shall (i) make reasonably available for inspection by
the Holders of the Securities, any underwriter participating in any disposition
pursuant to the Registration Statement and any attorney, accountant or other
agent retained by the Holders of the Securities or any such underwriter all
relevant financial and other records, pertinent corporate documents and
properties of the Company and (ii) cause the Company's officers, directors,
employees, accountants and auditors to supply all relevant information
reasonably requested by the Holders of the Securities or any such underwriter,
attorney, accountant or agent in connection with the Registration Statement, in
each case, as shall be reasonably necessary to enable such persons, to conduct a
reasonable investigation within the meaning of Section 11 of the Securities Act;
provided, however, that the foregoing inspection and information gathering shall
be coordinated on behalf of the Purchasers by Credit Suisse First Boston
Corporation and on behalf of the other parties, by one counsel designated by and
on behalf of such other parties as described in Section 3 hereof.

         (p) The Company, if requested by any Holder of Securities covered by
the Registration Statement, shall cause (i) its counsel to deliver an opinion
and updates thereof relating to the Securities in customary form addressed to
such Holders and the managing underwriters, if any, thereof and dated, in the
case of the initial opinion, the effective date of such Registration Statement
(it being agreed that the matters to be covered by such opinion shall include,
without limitation, the due incorporation and good standing of the Company and
its subsidiaries; the qualification of the Company and its subsidiaries to
transact business as foreign corporations; the due authorization, execution and
delivery of the relevant agreement of the type referred to in Section 2(m)
hereof; the due authorization, execution, authentication and issuance, and the
validity and enforceability, of the applicable Securities; the absence of
material legal or governmental proceedings involving the Company and its
subsidiaries; the absence of governmental approvals required to be obtained in
connection with the Registration Statement, the offering and sale of the
applicable Securities, or any agreement of the type referred to in Section 2(m)
hereof; the compliance as to form of such Registration Statement and any
documents incorporated by reference therein and of the Indenture with the
requirements of the Securities Act and the Trust Indenture Act, respectively;
and, as of the date of the opinion and as of the effective date of the
Registration Statement or most recent post-effective amendment thereto, as the
case may be, the absence from such Registration Statement and the prospectus
included therein, as then amended or supplemented, and from any documents
incorporated by reference therein, of an untrue statement of a material fact or
the omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading (in the case of any such
documents, in the light of the circumstances existing at the time that such
documents were filed with the Commission under the Securities Exchange Act of
1934, as amended, the "Exchange Act"); (ii) its officers to execute and deliver
all customary documents and certificates and updates thereof requested by any
underwriters of the applicable Securities and (iii) its independent public
accountants and the independent public accountants with respect to any other
entity for which financial information is provided in the Registration Statement
to provide to the selling Holders of the applicable Securities and any
underwriter therefor a comfort letter in customary form and covering matters of
the type customarily covered in comfort letters in connection with primary
underwritten offerings, subject to receipt of appropriate

                                       4

<PAGE>

documentation as contemplated, and only if permitted, by Statement of Auditing
Standards No. 72, as amended or supplemented.

         (q) The Company will use its reasonable best efforts to (a) if the
Offered Securities have been rated prior to the initial sale of such Offered
Securities, confirm such ratings will apply to the Securities covered by a
Registration Statement, or (b) if the Offered Securities were not previously
rated, cause the Securities covered by a Registration Statement to be rated with
the appropriate rating agencies, if so requested by Holders of a majority in
aggregate principal amount of Securities covered by such Registration Statement,
or by the managing underwriters, if any.

         (r) In the event that any broker-dealer registered under the Exchange
Act shall underwrite any Securities or participate as a member of an
underwriting syndicate or selling group or "assist in the distribution" (within
the meaning of the Conduct Rules (the "RULES") of the National Association of
Securities Dealers, Inc. ("NASD")) thereof, whether as a Holder of such
Securities or as an underwriter, a placement or sales agent or a broker or
dealer in respect thereof, or otherwise, the Company will assist such
broker-dealer in complying with the requirements of such Rules, including,
without limitation, by (i) if such Rules, including Rule 2720, shall so require,
engaging a "qualified independent underwriter" (as defined in Rule 2720) to
participate in the preparation of the Registration Statement relating to such
Securities, to exercise usual standards of due diligence in respect thereto and,
if any portion of the offering contemplated by such Registration Statement is an
underwritten offering or is made through a placement or sales agent, to
recommend the yield of such Securities, (ii) indemnifying any such qualified
independent underwriter to the extent of the indemnification of underwriters
provided in Section 4 hereof and (iii) providing such information to such
broker-dealer as may be required in order for such broker-dealer to comply with
the requirements of the Rules.

         (s) The Company shall use its reasonable best efforts to take all other
steps necessary to effect the registration of the Securities covered by the
Registration Statement contemplated hereby.

         3. Registration Expenses. (a) All expenses incident to the Company's
performance of and compliance with this Agreement will be borne by the Company,
regardless of whether a Registration Statement is ever filed or becomes
effective, including without limitation;

                (i) all registration and filing fees and expenses;

                (ii) all fees and expenses of compliance with federal securities
        and state "blue sky" or securities laws;

                (iii) all expenses of printing, messenger and delivery services
        and telephone;

                (iv) all fees and disbursements of counsel for the Company;

                (v) all application and filing fees in connection with listing
        the Securities on a national securities exchange; and

                (vi) all fees and disbursements of independent certified public
        accountants of the Company (including the expenses of any special audit
        and comfort letters required by or incident to such performance).

The Company will bear its internal expenses (including, without limitation, all
salaries and expenses of its officers and employees performing legal or
accounting duties), the expenses of any annual audit and the fees and expenses
of any person, including special experts, retained by the Company.

         (b) In connection with any Registration Statement required by this
Agreement, the Company will reimburse the Purchasers and the Holders of Transfer
Restricted Securities who are selling or reselling Securities pursuant to the
"Plan of Distribution" contained in the Registration Statement for the
reasonable fees and

                                       5
<PAGE>

disbursements of not more than one counsel, who shall be CRAVATH, SWAINE & MOORE
unless another firm shall be chosen by the Holders of a majority in principal
amount of the Securities for whose benefit such Registration Statement is being
prepared.

         4. Indemnification. (a) The Company agrees to indemnify and hold
harmless each Holder of the Securities and each person, if any, who controls
such Holder within the meaning of the Securities Act or the Exchange Act (each
Holder and such controlling persons are referred to collectively as the
"INDEMNIFIED PARTIES") from and against any losses, claims, damages or
liabilities, joint or several, or any actions in respect thereof (including, but
not limited to, any losses, claims, damages, liabilities or actions relating to
purchases and sales of the Securities) to which each Indemnified Party may
become subject under the Securities Act, the Exchange Act or otherwise, insofar
as such losses, claims, damages, liabilities or actions arise out of, or are
based upon, any untrue statement or alleged untrue statement of a material fact
contained in the Registration Statement or prospectus or in any amendment or
supplement thereto or in any preliminary prospectus relating to a Shelf
Registration, or arise out of, or are based upon, the omission or alleged
omission to state therein a material fact required to be stated therein or
necessary to make the statements therein not misleading, and shall reimburse, as
incurred, the Indemnified Parties for any legal or other expenses reasonably
incurred by them in connection with investigating or defending any such loss,
claim, damage, liability or action in respect thereof; provided, however, that
(i) the Company shall not be liable in any such case to the extent that such
loss, claim, damage or liability arises out of or is based upon any untrue
statement or alleged untrue statement or omission or alleged omission made in a
Registration Statement or prospectus or in any amendment or supplement thereto
or in any preliminary prospectus relating to a Shelf Registration in reliance
upon and in conformity with written information pertaining to such Holder and
furnished to the Company by or on behalf of such Holder specifically for
inclusion therein and (ii) with respect to any untrue statement or omission or
alleged untrue statement or omission made in any preliminary prospectus relating
to a Registration Statement, the indemnity agreement contained in this
subsection (a) shall not inure to the benefit of any Holder from whom the person
asserting any such losses, claims, damages or liabilities purchased the
Securities concerned, to the extent that a prospectus relating to such
Securities was required to be delivered by such Holder under the Securities Act
in connection with such purchase and any such loss, claim, damage or liability
of such Holder results from the fact that there was not sent or given to such
person, at or prior to the written confirmation of the sale of such Securities
to such person, a copy of the final prospectus if the Company had previously
furnished copies thereof to such Holder; provided further, however, that this
indemnity agreement will be in addition to any liability which the Company may
otherwise have to such Indemnified Party. The Company shall also indemnify
underwriters, their officers and directors and each person who controls such
underwriters within the meaning of the Securities Act or the Exchange Act to the
same extent as provided above with respect to the indemnification of the Holders
of the Securities if requested by such Holders.

         (b) Each Holder of the Securities, severally and not jointly, will
indemnify and hold harmless the Company and each person, if any, who controls
the Company within the meaning of the Securities Act or the Exchange Act from
and against any losses, claims, damages or liabilities or any actions in respect
thereof, to which the Company or any such controlling person may become subject
under the Securities Act, the Exchange Act or otherwise, insofar as such losses,
claims, damages, liabilities or actions arise out of or are based upon any
untrue statement or alleged untrue statement of a material fact contained in a
Registration Statement or prospectus or in any amendment or supplement thereto
or in any preliminary prospectus relating to a Shelf Registration, or arise out
of or are based upon the omission or alleged omission to state therein a
material fact necessary to make the statements therein not misleading, but in
each case only to the extent that the untrue statement or omission or alleged
untrue statement or omission was made in reliance upon and in conformity with
written information pertaining to such Holder and furnished to the Company by or
on behalf of such Holder specifically for inclusion therein; and, subject to the
limitation set forth immediately preceding this clause, shall reimburse, as
incurred, the Company for any legal or other expenses reasonably incurred by the
Company or any such controlling person in connection with investigating or
defending any loss, claim, damage, liability or action in respect thereof. This
indemnity agreement will be in addition to any liability which such Holder may
otherwise have to the Company or any of its controlling persons.

         (c) Promptly after receipt by an indemnified party under this Section 4
of notice of the commencement of any action or proceeding (including a
governmental investigation), such indemnified party will, if a claim in respect

                                       6
<PAGE>

thereof is to be made against the indemnifying party under this Section 4,
notify the indemnifying party of the commencement thereof; but the omission so
to notify the indemnifying party will not, in any event, relieve the
indemnifying party from any obligations to any indemnified party other than the
indemnification obligation provided in paragraph (a) or (b) above. In case any
such action is brought against any indemnified party, and it notifies the
indemnifying party of the commencement thereof, the indemnifying party will be
entitled to participate therein and, to the extent that it may wish, jointly
with any other indemnifying party similarly notified, to assume the defense
thereof, with counsel reasonably satisfactory to such indemnified party (who
shall not, except with the consent of the indemnified party, be counsel to the
indemnifying party), and after notice from the indemnifying party to such
indemnified party of its election so to assume the defense thereof the
indemnifying party will not be liable to such indemnified party under this
Section 4 for any legal or other expenses, other than reasonable costs of
investigation, subsequently incurred by such indemnified party in connection
with the defense thereof. No indemnifying party shall, without the prior written
consent of the indemnified party, effect any settlement of any pending or
threatened action in respect of which any indemnified party is or could have
been a party and indemnity could have been sought hereunder by such indemnified
party unless such settlement includes an unconditional release of such
indemnified party from all liability on any claims that are the subject matter
of such action, and does not include a statement as to or an admission of fault,
culpability or a failure to act by or on behalf of any indemnified party.

         (d) If the indemnification provided for in this Section 4 is
unavailable or insufficient to hold harmless an indemnified party under
subsections (a) or (b) above, then each indemnifying party shall contribute to
the amount paid or payable by such indemnified party as a result of the losses,
claims, damages or liabilities (or actions in respect thereof) referred to in
subsection (a) or (b) above (i) in such proportion as is appropriate to reflect
the relative benefits received by the indemnifying party or parties on the one
hand and the indemnified party on the other from the sale of the Securities,
pursuant to the Shelf Registration, or (ii) if allocation provided by the
foregoing clause (i) is not permitted by applicable law, in such proportion as
is appropriate to reflect not only the relative benefits referred to in clause
(i) above but also the relative fault of the indemnifying party or parties on
the one hand and the indemnified party on the other in connection with the
statements or omissions that resulted in such losses, claims, damages or
liabilities (or actions in respect thereof) as well as any other relevant
equitable considerations. The relative fault of the parties shall be determined
by reference to, among other things, whether the untrue or alleged untrue
statement of a material fact or the omission or alleged omission to state a
material fact relates to information supplied by the Company on the one hand or
such Holder or such other indemnified party, as the case may be, on the other,
and the parties' relative intent, knowledge, access to information and
opportunity to correct or prevent such statement or omission. The amount paid by
an indemnified party as a result of the losses, claims, damages or liabilities
referred to in the first sentence of this subsection (d) shall be deemed to
include any legal or other expenses reasonably incurred by such indemnified
party in connection with investigating or defending any action or claim which is
the subject of this subsection (d). Notwithstanding any other provision of this
Section 4(d), the Holders of the Securities shall not be required to contribute
any amount in excess of the amount by which the net proceeds received by such
Holders from the sale of the Securities pursuant to a Registration Statement
exceeds the amount of damages which such Holders have otherwise been required to
pay by reason of such untrue or alleged untrue statement or omission or alleged
omission. No person guilty of fraudulent misrepresentation (within the meaning
of Section 11(f) of the Securities Act) shall be entitled to contribution from
any person who was not guilty of such fraudulent misrepresentation. For purposes
of this paragraph (d), each person, if any, who controls such indemnified party
within the meaning of the Securities Act or the Exchange Act shall have the same
rights to contribution as such indemnified party and each person, if any, who
controls the Company within the meaning of the Securities Act or the Exchange
Act shall have the same rights to contribution as the Company.

         (e) The agreements contained in this Section 4 shall survive the sale
of the Securities pursuant to the Registration Statement and shall remain in
full force and effect, regardless of any termination or cancellation of this
Agreement or any investigation made by or on behalf of any indemnified party.

         5. Additional Interest Under Certain Circumstances. (a) Additional
interest (the "ADDITIONAL INTEREST") with respect to the Offered Securities
shall be assessed as follows if any of the following events occur (each such
event in clauses (i) through (iii) below being herein called a "REGISTRATION
DEFAULT"):

                                       7
<PAGE>

        (i)     If the Registration Statement required by this Agreement is not
                filed with the Commission on or prior to the Filing Deadline;

        (ii)    If the Registration Statement has not been declared effective by
                the Commission by the Effectiveness Deadline; or

        (iii)   If the Registration Statement has been declared effective by the
                Commission but (A) such Registration Statement thereafter ceases
                to be effective or (B) such Registration Statement or the
                related prospectus ceases to be usable in connection with
                resales of Transfer Restricted Securities during the periods
                specified herein because either (1) any event occurs as a result
                of which the related prospectus forming part of such
                Registration Statement would include any untrue statement of a
                material fact or omit to state any material fact necessary to
                make the statements therein, in the light of the circumstances
                under which they were made, not misleading, or (2) it shall be
                necessary to amend such Registration Statement or supplement the
                related prospectus, to comply with the Securities Act or the
                Exchange Act or the respective rules thereunder.

Each of the foregoing will constitute a Registration Default whatever the reason
for any such event and whether it is voluntary or involuntary or is beyond the
control of the Company or pursuant to operation of law or as a result of any
action or inaction by the Commission.

         Additional Interest shall accrue on the Offered Securities over and
above the interest set forth in the title of the Securities from and including
the date on which any such Registration Default shall occur to but excluding the
date on which all such Registration Defaults have been cured, (A) at a rate of
0.25% per annum in the case of clause (i) above and (B) at a rate of 0.50% per
annum in the case of clause (ii) and clause (iii) above (the "ADDITIONAL
INTEREST RATE").

         (b) A Registration Default referred to in Section 5(a)(iii) hereof
shall be deemed not to have occurred and be continuing in relation to a
Registration Statement or the related prospectus if (i) such Registration
Default has occurred solely as a result of (x) the filing of a post-effective
amendment to the Registration Statement to incorporate annual audited financial
information with respect to the Company where such post-effective amendment is
not yet effective and needs to be declared effective to permit Holders to use
the related prospectus or (y) other material events, with respect to the Company
that would need to be described in the Registration Statement or the related
prospectus and (ii) in the case of clause (y), the Company is proceeding
promptly and in good faith to amend or supplement the Registration Statement and
related prospectus to describe such events; provided, however, that in any case
if such Registration Default occurs for a continuous period in excess of 30
days, Additional Interest shall be payable in accordance with the above
paragraph from the day such Registration Default occurs until such Registration
Default is cured.

         (c) Any amounts of Additional Interest due pursuant to Section 5(a)
will be payable in cash on the regular interest payment dates with respect to
the Offered Securities. The amount of Additional Interest will be determined by
multiplying the applicable Additional Interest Rate by the principal amount of
the Offered Securities and further multiplied by a fraction, the numerator of
which is the number of days such Additional Interest Rate was applicable during
such period (determined on the basis of a 360-day year comprised of twelve
30-day months), and the denominator of which is 360.

         (d) "TRANSFER RESTRICTED SECURITIES" means each Security until (i) the
date on which such Security has been effectively registered under the Securities
Act and disposed of in accordance with the Registration Statement or (ii) the
date on which such Security is distributed to the public pursuant to Rule 144
under the Securities Act or is saleable pursuant to Rule 144(k) under the
Securities Act.

         6. Rules 144 and 144A. The Company shall use its reasonable best
efforts to file the reports required to be filed by it under the Securities Act
and the Exchange Act in a timely manner and, if at any time the Company is not
required to file such reports, it will, upon the request of any Holder of
Securities, make publicly available other information so long as necessary to
permit sales of their securities pursuant to Rules 144 and 144A. The Company

                                       8
<PAGE>

covenants that it will take such further action as any Holder of Offered
Securities may reasonably request, all to the extent required from time to time
to enable such Holder to sell Offered Securities without registration under the
Securities Act within the limitation of the exemptions provided by Rules 144 and
144A (including the requirements of Rule 144A(d)(4)). The Company will provide a
copy of this Agreement to prospective purchasers of Offered Securities
identified to the Company by the Purchasers upon request. Upon the request of
any Holder of Offered Securities, the Company shall deliver to such Holder a
written statement as to whether it has complied with such requirements.
Notwithstanding the foregoing, nothing in this Section 6 shall be deemed to
require the Company to register any of its securities pursuant to the Exchange
Act.

         7. Underwritten Registrations. Holders of at least 25% in aggregate
principal amount of the Transfer Restricted Securities may elect to have one
underwritten offering of the Transfer Restricted Securities. If any of the
Transfer Restricted Securities covered by any Shelf Registration are to be sold
in an underwritten offering, the investment banker or investment bankers and
manager or managers that will administer the offering ("MANAGING UNDERWRITERS")
will be selected by the Holders of a majority in aggregate principal amount of
such Transfer Restricted Securities to be included in such offering, and must be
reasonably acceptable to the Company.

         No person may participate in any underwritten registration hereunder
unless such person (i) agrees to sell such person's Transfer Restricted
Securities on the basis reasonably provided in any underwriting arrangements
approved by the persons entitled hereunder to approve such arrangements and (ii)
completes and executes all questionnaires, powers of attorney, indemnities,
underwriting agreements and other documents reasonably required under the terms
of such underwriting arrangements. The Holders participating in any underwritten
offering shall be responsible for any expenses customarily borne by selling
securityholders, including underwriting discounts and commissions and fees and
expenses of counsel to the selling securityholders to the extent not required to
be paid by the Company pursuant to Section 3 hereof. Notwithstanding the
foregoing or the provisions of Section 2(m) hereof, upon receipt of a request
from the managing underwriter or a representative of Holders of a majority of
the Transfer Restricted Securities outstanding to prepare and file an amendment
or supplement to the Registration Statement in connection with an underwritten
offering, the Company may delay the filing of such amendment or supplement as
set forth in Section 2(h).

         8. Miscellaneous.

         (a) Remedies. The Company acknowledges and agrees that any failure by
the Company to comply with its obligations under Section 1 hereof may result in
material irreparable injury to the Purchasers or the Holders for which there is
no adequate remedy at law, that it will not be possible to measure damages for
such injuries precisely and that, in the event of any such failure, the
Purchasers or any Holder may obtain such relief as may be required to
specifically enforce the Company's obligations under Section 1 hereof. The
Company further agrees to waive the defense in any action for specific
performance that a remedy at law would be adequate.

         (b) No Inconsistent Agreements. The Company will not on or after the
date of this Agreement enter into any agreement with respect to its securities
that is inconsistent with the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof. The rights granted to the
Holders hereunder do not in any way conflict with and are not inconsistent with
the rights granted to the holders of the Company's securities under any
agreement in effect on the date hereof.

         (c) Amendments and Waivers. The provisions of this Agreement may not be
amended, modified or supplemented, and waivers or consents to departures from
the provisions hereof may not be given, except by the Company and the written
consent of the Holders of a majority in principal amount of the Securities
affected by such amendment, modification, supplement, waiver or consents.

         (d) Notices. All notices and other communications provided for or
permitted hereunder shall be made in writing by hand delivery, first-class mail,
facsimile transmission, or air courier which guarantees overnight delivery:

                  (1)      if to a Holder of the Securities, at the most current
address given by such Holder to the Company.

                                       9
<PAGE>

                  (2)      if to the Purchasers;

                           Credit Suisse First Boston Corporation
                           Eleven Madison Avenue
                           New York, NY 10010-3629
                           Fax No.: (212) 325-8278
                           Attention: Transactions Advisory Group

                  (3)      if to the Company, at its address as follows:

                           King Pharmaceuticals, Inc.
                           501 Fifth Street
                           Bristol, Tennessee  37620
                           Fax No.: (423) 274-8677
                           Attention: Kyle P. Macione
                                      Executive Vice President,
                                      Corporate Affairs

                           With a copy to:

                           Linda M. Crouch-McCreadie, Esq.
                           Baker, Donelson, Bearman & Caldwell, P.C.
                           SunTrust Bank Building, Suite 300
                           207 Mockingbird Lane
                           Johnson City, Tennessee  37604
                           Fax No.: (423) 979-7623

         All such notices and communications shall be deemed to have been duly
given: at the time delivered by hand, if personally delivered; three business
days after being deposited in the mail, postage prepaid, if mailed; when receipt
is acknowledged by recipient's facsimile machine operator, if sent by facsimile
transmission; and on the day delivered, if sent by overnight air courier
guaranteeing next day delivery.

         (e) Third Party Beneficiaries. The Holders shall be third party
beneficiaries to the agreements made hereunder between the Company, on the one
hand, and the Purchasers, on the other hand, and shall have the right to enforce
such agreements directly to the extent they may deem such enforcement necessary
or advisable to protect their rights or the rights of Holders hereunder.

         (f) Successors and Assigns. This Agreement shall be binding upon the
Company and its successors and assigns.

         (g) Counterparts. This Agreement may be executed in any number of
counterparts and by the parties hereto in separate counterparts, each of which
when so executed shall be deemed to be an original and all of which taken
together shall constitute one and the same agreement.

         (h) Headings. The headings in this Agreement are for convenience of
reference only and shall not limit or otherwise affect the meaning hereof.

         (i) Governing Law. THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED
IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO
PRINCIPLES OF CONFLICTS OF LAWS.

                                       10
<PAGE>

         (j) Severability. If any one or more of the provisions contained
herein, or the application thereof in any circumstance, is held invalid, illegal
or unenforceable, the validity, legality and enforceability of any such
provision in every other respect and of the remaining provisions contained
herein shall not be affected or impaired thereby.

         (k) Securities Held by the Company. Whenever the consent or approval of
Holders of a specified percentage of principal amount of Securities is required
hereunder, Securities held by the Company or its affiliates (other than
subsequent Holders of Securities if such subsequent Holders are deemed to be
affiliates solely by reason of their holdings of such Securities) shall not be
counted in determining whether such consent or approval was given by the Holders
of such required percentage.

                                       11
<PAGE>

         If the foregoing is in accordance with your understanding of our
agreement, please sign and return to the Company a counterpart hereof, whereupon
this instrument, along with all counterparts, will become a binding agreement
among the several Purchasers and the Company in accordance with its terms.

                                       KING PHARMACEUTICALS, INC.

                                       By:  /s/ Jefferson J. Gregory
                                            ---------------------------------
                                            Name: Jefferson J. Gregory
                                            Title: President

The foregoing Registration Rights Agreement
   is hereby confirmed and accepted as
   of the date first above written.
CREDIT SUISSE FIRST BOSTON CORPORATION
J.P. MORGAN SECURITIES INC.,
BANC OF AMERICA SECURITIES LLC
UBS WARBURG LLC

By: CREDIT SUISSE FIRST BOSTON CORPORATION

    By: /s/ Paul Henderson
        ----------------------------------
        Name: Paul Henderson
        Title: Managing Director

                                       12

<PAGE>

                                   SCHEDULE A

PURCHASERS

Credit Suisse First Boston Corporation
J.P. Morgan Securities Inc.
Banc of America Securities LLC
UBS Warburg LLC
Goldman, Sachs & Co.
Merrill Lynch, Pierce, Fenner & Smith Incorporated
Morgan Stanley & Co. Incorporated
Salomon Smith Barney Inc.
CIBC World Markets Corp.
First Union Securities, Inc.
Gruntal & Co., L.L.C.
Prudential Securities Incorporated
SG Cowen Securities Corporation
Sun Trust Capital Markets, Inc.

                                       13

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00033-of-00352.parquet"}]]